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Cornell University 2016 
It is well documented that molecular processes can be thermodynamically coupled 
such that the shift in the equilibrium of one process (e.g. ligand binding) can modify 
the kinetics and/or equilibrium of another process (e.g. receptor activation). This form 
of thermodynamic coupling is known as allostery and is believed to be a ubiquitous 
mechanism of function throughout cell, especially in the function of membrane 
proteins such as G protein-coupled receptors and transporters. In addition, the 
existence of ligand-specific allosteric modulation in both transporters and GPCRs 
emphasizes the importance of understanding how allostery works in these systems in 
terms of atomic-level physical mechanisms. Towards that goal, the work described in 
this dissertation will focus on two specific aims: i) the development of theoretical 
models that provide insight into the structural and dynamic features required for 
systems to be allosteric, and ii) the development of computational methods that can 
identify these features in specific systems of interest. First, we present a new 
theoretical model of allostery, the Allosteric Ising Model, which leads to several 
analytical conclusions regarding the structural and energetic requirements for long-
distance allostery. Next, we present N-body Information Theory (NbIT) analysis, 
which improves on existing methods for identifying the structural components that act 
as allosteric channels. We illustrate the power of NbIT by identifying the allosteric 
channel underlying allosteric mod
	  in LeuT. Then we present a random forest-based method for identifying class-specific 
behavior from ensembles of the same protein bound to different ligands. This method 
is able to identify interactions that respond in a hallucinogen-specific manner in the 
serotonin receptor 5-HT2AR. Finally, we present a generalized form of the two-state 
allosteric efficacy that can be applied to discrete and continuous variables. This 
description of allosteric coupling suggests that mutual information, a common 
measure of allostery, is fundamentally related to allostery but in itself is not a good 
quantification of it. The new quantification of allosteric coupling is then used to 
identify allosteric couplings in the simplest allosteric system, alanine dipeptide.  
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1. Introduction 
Note: much of the text in this chapter has been adapted from two previously published 
manuscripts1,2, with permission from the publisher.  
1.1. Proteins as Molecular Machines 
British science fiction writer Arthur C. Clark famously stated, “any sufficiently 
advanced technology is indistinguishable from magic”3. Technology has played a 
crucial role in the evolution of human society, and while Clark’s quote is often used in 
reference to potential alien or futuristic technologies, the technology of today is often 
indistinguishable from the magic of yesterday. Since the earliest days of civilization, 
we have invented and constructed tools and machines to aid us in performing the 
many difficult tasks that are require for human survival and flourishing. In particular, 
much of the history of mankind was forged on the back of mechanical engineering – 
on the back of clocks, steam engines, pumps, and power plants. But while to the 
modern, educated eye, man-made machines are entirely distinguishable from magic, as 
we have the tools from mathematics, physics, and engineering to build them and 
understand how they work, there is a whole hidden world of machines that were not 
built by man. These machines were built over millions of years by the process of 
biological evolution. They are the machines that the human species is made of – the 
proteins, nucleic acids, and other biomolecules that make up human cells and the cells 
of every other living organism on the planet. However, because man didn’t design 
these machines, because they arose out of random mutation and natural selection, even 
the most well-studied modern scientist does not have a complete understanding as to 
how the machines work, and up to this point, there has been limited success in 
building our own synthetic biomolecular machines de novo. This lack of 
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understanding may explain to some extent, why for much of history, humanity largely 
subscribed to a vitalistic view of biology; it was believed that the matter composing 
living organisms was somehow fundamentally different from that of non-living 
matter. Vitalism4, which mistook molecular biology for magic, did eventually fall out 
of favor, in part due to Friedrich Wohler’s 1828 discovery5 that a biological substance, 
urea, could be synthesized without the use of biological material. Only within the last 
century, in 1931, did the physiologist John Scott Haldane declare “biologists have 
almost unanimously abandoned vitalism as an acknowledged belief”6. With the 
replacement of vitalism with mechanistic and reductionist scientific philosophies, 
biological entities such as protein began to be described in the language of man-made 
machines, merging the life sciences with the physical sciences and giving birth to the 
fields of biochemistry and biophysics.   
Proteins have been conceptualized as molecular machines since as early as 19507, 
when the term was used to describe the oxygen transport protein hemoglobin. Just as 
mechanical machines are not random assemblies of parts, but instead are able to 
perform their functions due to the purposeful arrangement of those parts by engineers, 
proteins are not simply linear biopolymers of amino acids, and have evolved to 
perform their many functions by folding into 3-dimensional structures that are 
composed of a hierarchy of secondary and tertiary structural elements. These 3-
dimensional structures can now be determined using techniques like x-ray 
crystallography8, nuclear magnetic resonance (NMR)9, and cryo-electron microscopy 
(cryoEM)10, and the growing accessibility of protein structural data has led to a 
conserved effort in the theme of structure-function relationships11–13, in which we 
would like to deduce the mechanism of a protein’s function through the structures the 
protein takes on.  
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However, a protein’s function cannot be fully understood through only the structures 
or states in which it can be found in. In order to describe the physical mechanisms 
involved in the function of a protein it is essential to i) define the states involved in the 
functional process in terms of molecular structure, ii) define the relations among those 
states in a kinetic model dependent on rate and equilibrium constants, and iii) express 
the protein function in terms of the kinetic model. The thermodynamics and kinetics of 
protein function have been studied by biochemists and biophysicists for some time, 
and detailed experiment and analysis has revealed that essential rate and equilibrium 
constants that describe the state and conformational changes of the protein are often 
modulated by its environment (especially in the case of membrane proteins) and by the 
ions, substrates, and ligands involved in the functional process. This crucial 
modulation of the kinetics and thermodynamics of the protein by outside actors is 
known as allostery. Despite the apparently fall of vitalism in biology, allostery is still 
largely invoked as a magic-like biophysical phenomenon with little mechanistic 
understanding. Allostery is often used as the answer for questions of “how”, such as 
“how does a ligand activate a receptor”, but this answer is not satisfying as it provides 
very little new understanding of the nature of the receptor itself or the nature of the 
specific receptor-ligand interaction. It is likely that more important are the questions 
such as “how does the ligand activate the receptor allosterically”, which is a question 
that is often difficult to answer due to the fact that allostery has been largely 
phenomenological. Developing a physics-based, mechanistic description of the 
phenomenon of allostery will allow for us to answer questions that forward out 
understanding of biomolecular machines, and has been the focus of my doctoral 
research and this dissertation.  
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1.1.1. Allostery 
1.1.1.1. History 
It is often stated that the first recorded observation of allostery was by Christian Bohr, 
who found that oxygen displayed an unusual shaped equilibrium binding curve14. In 
the simple case of a ligand L binding a protein P, the equilibrium is written as: 
 L + P kon
koff
⎯ →⎯← ⎯⎯ LP   (1.1) 
where kon and koff are the rate constants for binding and unbinding, respectively. At 
equilibrium, this defines the equilibrium binding dissociation constant, 
 LP[ ]L[ ] P[ ] =
koff
kon
= KD   (1.2) 
It can easily be shown that the fraction of ligand:protein complexes as a function of 
the concentration of ligand is simply the Michaelis-Henri equation: 
 LP[ ]P[ ]+ LP[ ] =
L[ ]
KD + L[ ]
  (1.3) 
If one plots this fraction as a function of the concentration of ligand, the resulting 
curve is known as a saturation binding curve (see Figure	  1).   
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Figure	  1.	  Expected saturation binding curve for Michaelis-Henri binding.  
The fraction of protein bound to ligand is shown as a function of ligand concentration 
(in arbitrary unites) for KD of 1 (black), 10 (red), 100 (blue), and 1000 (green). 
As hemoglobin is a four subunit protein and can binding one oxygen in each subunit, 
if the binding were independent in each subunit, (1.3) would be sufficient and binding 
would display the expected saturation behavior.  However, Bohr found that 
hemoglobin did not generate display the expected saturation binding curve, but rather 
a sigmoidal binding curve that was dependent on the partial pressure of carbon dioxide 
(see Figure 2).  
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Figure 2. Sigmoidal oxygen binding in hemoglobin.  
The original plot by Bohr14 indicating both cooperative binding of oxygen and 
competitive binding by carbon dioxide, reproduced with permission. The x-axis is the 
oxygen partial pressure in mmHg, and the y-axis is the percentage oxy-hemoglobin. 
Reproduced with permission. 
This led to the interpretation that binding in one subunit of hemoglobin was changing 
the binding affinity of oxygen binding in the other subunits. This phenomena and 
others like it are generally referred to as cooperativity. 
Despite the role of hemoglobin as a prototypical allosteric system, there were many 
examples of allostery in a non-oligomeric system by the mid 1900s. In 1963, Monod, 
Changeux, and Jacob noted that “[it] would appear, in other words, that certain 
proteins, acting at critical metabolic steps, are electively endowed with specific 
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functions of regulation and coordination; through the agency of these proteins, a given 
biochemical reaction is eventually controlled by a metabolite acting apparently as a 
physiological "signal" rather than as a chemically necessary component of the reaction 
itself”15. Here, they referred to the common process of end-product inhibition, in 
which enzymes are often inhibits by downstream metabolites in a non-competitive 
manner. While this observation can be seen at the spark that drove Monod, Changeux, 
and Jacob to being their work on a theory of allostery, which will be described in the 
following section (Section 1.1.1.2. Theoretical Background), many instances of non-
oligomeric allostery have been observed since16, and it is now believed that nearly all 
protein may be allosteric17. Of specific interest to pharmacology and medicine has 
been the allostery involved in the activation of receptor proteins such as the G protein 
coupled receptors (GPCRs). In addition, many other membrane proteins have been 
noted to be allosteric, such as the secondary active symporters. These two systems will 
be the focus of study in this dissertation, and will be described in significant detail in 
Section 1.1.2.	  Allostery	  in	  Membrane	  Proteins.  
1.1.1.2. Theoretical Background 
Due to the ubiquitous nature of allostery, many have sought to define it using 
quantitative, theoretical models. In order to interface with experiments, many of these 
models are thermodynamic in nature. The first model is known as the Monod-Wyman-
Changeux (MWC) model18 and was constructed to describe the cooperativity among 
several ligands binding to the same protein. In the following description of the model, 
we will differ from the original notation used by MWC in order to be consistent in 
model notation throughout the dissertation. Rate constants will be written as kprocessstate , 
where the subscript denotes the transformation process and the superscript denotes 
relevant characteristics about the state of the system on which the process is acting. 
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Similarly, an equilibrium constant will be written as Kprocessstate , where the state and 
process correspond to those of the forward reaction. In the cases presented throughout 
the dissertation, these characteristics will include, but are not limited to, being 
activated or bound to ligands; the unbound, inactive state will be taken as default and 
not indicated as a superscript. In the MWC model, one imagines an oligomer of 
identical protomers. Each protomer has two states, R and T, which refer to be 
“relaxed” or “tense”, respectively. Additionally, the protomers within an oligomer are 
forced to be in identical states such that the whole oligomer has only two states, R and 
T. We will refer to the protomer as P, and will note the state with subscript, and their 
equilibrium constant will be denoted as Ktense.  
 PT[ ]PR[ ]
= Ktense   (1.4) 
Ligand can bind sequentially to either state such that 
 PRL[ ]PR[ ] L[ ]
= Kbind,LR   (1.5) 
and 
 PTL[ ]PT[ ] L[ ]
= Kbind,LT   (1.6) 
We will define the ratio of these binding affinities as 
 α = Kbind,L
R
Kbind,LT
  (1.7) 
Taking into account the probabilities for n identical binding sites, the following 
equilibrium equations are written: 
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PRL[ ] = n PR[ ] L[ ]Kbind,LR
PTL[ ] = n PT[ ] L[ ]Kbind,LT
PR L( )2⎡⎣ ⎤⎦ =
n −1
2
PRL[ ] L[ ]
Kbind,LR
PT L( )2⎡⎣ ⎤⎦ =
n −1
2
PTL[ ] L[ ]
Kbind,LT
! !
PR L( )n⎡⎣ ⎤⎦ =
1
n
R L( )n−1⎡⎣ ⎤⎦ L[ ]
Kbind,LR
PT L( )n⎡⎣ ⎤⎦ =
1
n
PT L( )n−1⎡⎣ ⎤⎦ L[ ]
Kbind,LT
  (1.8) 
The fraction of protein bound to the ligand as a function of ligand concentration, YL is 
then: 
 YL =
Ktenseα
L[ ]
Kbind,LR
1+α L[ ]Kbind,LR
⎛
⎝⎜
⎞
⎠⎟
n−1
+ L[ ]Kbind,LR
1+ L[ ]Kbind,LR
⎛
⎝⎜
⎞
⎠⎟
n−1
Ktense 1+α
L[ ]
Kbind,LR
⎛
⎝⎜
⎞
⎠⎟
n
+ 1+ L[ ]Kbind,LR
⎛
⎝⎜
⎞
⎠⎟
n   (1.9) 
In the MWC model, the parameters that control the observed coopertivity are Ktense 
and α. Ktense, the intrinsic conformational preference of the protein, controls how 
slowly the sigmoid saturates. As Ktense is increased, the saturation occurs more slowly. 
α, which describes the degree of ligand preference for binding the R state over the T 
state, controls how sharp the sigmoidal function is (e.g. the slope around the inflexion 
point). While this model can qualitatively predict many of the features of cooperative 
proteins, several assumptions are made that limit the use. First, it assumes that the 
protomers must all be in the same state. This implies that there must be an additional 
parameter that describes the coupling between protomers, and that the parameter is at 
the limit of maximal coupling. Additionally, once a ligand binds, there is no 
equilibrium established between bound T and R states, which can only be assumed if 
there is a separation of time scales between the equilibriums between the T and R 
states while bound to ligand and all other equilibriums. While extended approaches of 
the MWC model have been developed to remove these assumptions, they most relate 
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to modeling cooperativity in oligomeric systems, which is not the specific focus of this 
dissertation.  
Even within these generalizations, the MWC model fails to describe allostery within 
monomers, such as allosteric modulation of an enzyme’s activity by a non-substrate 
ligand, or activation of a receptor by the receptor’s ligand. To describe allostery within 
the context of a ligand activating a single protomer, the two-state allosteric model 
(TSAM) was developed. As an example, one can imagine a description of protein 
function in terms of its two distinct states, one of which is “active” and the other is 
“inactive”. We can represent the equilibrium of such a protein transitioning between 
an “inactive” state (P) and an “active” state (P*). 
 P kactivate
kinactivate
⎯ →⎯⎯← ⎯⎯⎯ P*   (1.10) 
and 
 Kactivate =
kactivate
kinactivate
  (1.11) 
The binding of ligand (L) to P  
 L + P kbind,L
kunbind,L
⎯ →⎯⎯← ⎯⎯⎯ LP   (1.12) 
can modify the equilibrium between in active and active states in some way: 
 LP kactivate
L
k inactivate
L
⎯ →⎯⎯← ⎯⎯⎯ LP*   (1.13) 
so that a new equilibrium constant is achieved 
 KactivateL =
kactivateL
kinactivateL
  (1.14) 
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This corresponds to the following thermodynamic cycle connecting the activation and 
the ligand binding processes: 
	  
Scheme 1. The thermodynamic cycle for protein activation and ligand binding. 
For this thermodynamic cycle, it is possible to quantify the allosteric efficacy. The 
allosteric efficacy is a measure of the allosteric coupling between two equilibrium 
processes18–20, and can be used to characterize the allostery in the thermodynamic 
cycle presented in Scheme 1. The allosteric efficacy, α, with which this particular 
ligand binding process modifies the activation equilibrium, is expressed as the ratio of 
the equilibrium constants: 
 αactivate
bind,L = Kactivate
L
Kactivate
  (1.15) 
It should be noted that the α of the TSAM turns out to be equivalent to the α used in 
the MWC model, which may suggest that it is a fundamental characteristic of models 
of allostery in general. In an equilibrium regime, the binding equilibrium constants of 
L to P and P*, will also change proportionately, such that the allosteric efficacy can 
equivalently be defined as 
P LP 
P* LP* 
L
L
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 αactivate
bind,L =
Kbind,L*
Kbind,L
  (1.16) 
Recalling that an equilibrium constant is a function of the difference in free energy of 
the two states: 
 K = e−βΔG   (1.17) 
then 
 − 1
β
log αactivatebind,L( ) = G LP*( ) +G L + P( )−G LP( )−G L + P*( )   (1.18) 
When α = 1, the ligand binding is not coupled to the state of the protein, whereas an α 
> 1 denotes positive coupling (i.e., the binding of ligand increases the probability of 
the active state) and α < 1 denotes a negative coupling (i.e., the binding decreases the 
probability of the inactive state). This type of allostery in which the ligand modulates 
an equilibrium constant, is known as K-type allostery and is recognizable in a great 
variety of systems16,21. One of the most notable examples is the activation of receptors 
(e.g., GPCRs) by ligands, which will be discussed in the following section.  
Notably, however, in addition to K-type allosteric modulation of equilibrium 
constants, the experimental evidence pointing to the modulation of maximum velocity 
of enzymatic reaction, vmax , by allosteric ligands indicates that there is a second type 
of allosteric modulation possible. In Michaelis-Menten kinetics22, one uses a two-step, 
irreversible kinetic model: 
 E + S kbind,S
kunbind,S
⎯ →⎯⎯← ⎯⎯⎯ ES kcat⎯ →⎯ E + P   (1.19) 
The rate of product formation is then: 
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 d P[ ]dt =
vmax S[ ]
KD + S[ ]
  (1.20) 
where 
 vmax = kcat E[ ]+ ES[ ]( )   (1.21) 
The second type of allosteric modulation describes the case in which vmax is modulated 
by changing the rate constants, and is known as V-type allostery18,21. V-type allostery 
has been identified in several enzymes, although it is currently thought to be rare, 
accounting for less than 1% of allosteric mechanisms. Notably, some G proteins have 
been shown to exhibit V-type allosteric regulation. In particular, GTPase activating 
proteins (GAPs) bind to G proteins and increase the kcat of GTP hydrolysis. For 
p21ras, for example, kcat was shown to increased by over four orders of magnitude23. 
This type of allostery couples a binding reaction, 
 GAP +G kbind,GAP
kunbind,GAP
⎯ →⎯⎯⎯← ⎯⎯⎯⎯ GAPG   (1.22) 
to GTP hydrolysis, 
 G +GTP khydrolysis⎯ →⎯⎯ G +GDP + PI   (1.23) 
as is shown in Scheme 2: 
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Scheme 2. The kinetic scheme for receptor GAP binding coupled to GTP hydrolysis 
To illustrate this type of allostery we can quantify the modulation effects using the V-
type allosteric efficacy, β: 
 βbind,GAP
hydrolysis =
khydrolysisGAPG
khydrolysis
  (1.24) 
Using transition state theory (TST)24 and the Eyring-Polanyi equation25 with the rate 
constant k expressed as : 
 k = κ kBTh e
−ΔG
†
RT   (1.25) 
where kB is Boltzmann’s constant, h is Planck’s constant, κ is the transmission 
coefficient, and ΔG
†
 is the activation free energy, the V-type allosteric efficacy β can 
be written as a function of the change in the energy of the transition state upon GAP 
binding, (assuming κ is a constant) as:  
 βbind,GAP
hydrolysis = e−
ΔΔG†
RT   (1.26) 
G	  +	  GAP	   G	  +	  GAP	  +	  GDP	  +	  Pi 
GGAP	   G	  +	  GAP	  +	  GDP	  +	  Pi 
GTP 
GTP 
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While the MWC and TSAM models have a long history of illustrating their power in 
the interpretation and analysis of experiments, they both fail to provide a mechanistic 
understanding of allostery. While these models can be extended to systems with 
multiple ligand binding sites and/or allosterically regulated sites (for a detailed review 
of extension of TSAM, see 19), this clearly provides only a phenomenological 
explanation of allostery. According to this description, often considered “the 
thermodynamic” perspective, allostery occurs because of the differences in free energy 
of the respective states. However, this conclusion appears to be a definition, i.e. that 
allostery is the phenomena in which that the stability of the on state relative to the off 
state is greater when the ligand is bound, and lesser when the ligand is unbound. From 
a “structural” perspective, one needs to consider the differences in free energy as 
emerging from some feature of the underlying network of interacting structural 
components, and it is this feature that makes the system allosteric. This unresolved 
problem will be the focus in this dissertation. 
1.1.2. Allostery in Membrane Proteins 
While allostery is thought to be a ubiquitous process17, it has been frequently claimed 
to be involved in the mechanisms of membrane proteins. In particular, allostery has 
been invoked in both membrane transporters and membrane receptors, where there is 
allosteric coupling observed between the intracellular and extracellular domains of the 
proteins. The communication of information regarding the external environment to 
intracellular machinery that can initial the appropriate adaptive response is crucial to 
cellular survival, and long-distance allostery through transmembrane (TM) domains is 
an intuitive physical mechanism by which this information can be transmitted. In this 
section, thermodynamic and kinetic models of transporter and receptor function will 
be described in the context of what is known about these systems structurally, 
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thermodynamically, and kinetically, in order to motivate the need for theoretical and 
computational methods that can determine the physical mechanisms of these allosteric 
systems.  
1.1.2.2. G Protein-Coupled Receptors 
G protein-coupled receptors (GPCRs) are 7 TM receptor proteins that act as mediators 
of information flow between the extracellular space and the intracellular signaling 
machinery, playing an essential role in cell-cell signaling across many cell and tissue 
types. Given this crucial positioning in cellular physiology, GPCRs are the targets of a 
large fraction of the pharmacopeia, and there are numerous mutations across the many 
GPCR subtypes that are implicated with disease26.  
While all GPCRs have a conserved 7TM topology, when clustered by sequence 
similarity, they can be broken down into several classes. The classes include the 
rhodopsin family (Class A), secretin and adhesion family (Class B), the glutamate 
family (Class C), and the frizzled/TAS2 family. The Class A GPCRs, for which there 
is the largest and most diverse set of crystal structures, will be the focus of study in 
this dissertation. At the neuronal synapse, Class A GPCRs play a large role in 
neurotransmission and signal transduction by responding to the presence 
neurotransmitters such as dopamine, norephinephrine, and serotonin27. Most 
hallucinogens, painkillers, and anti-psychotics are thought to act by competitively 
binding to these biogenic amine GPCRs and influencing their function28,29,30 . 
The experimental investigation of these receptor systems points to allosteric 
mechanisms as the central mode of molecular function for intracellular signal 
transduction in response to extracellular ligand binding. The fraction of the 
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concentration of receptors in the active state, fP*, can be written as a function of the 
ligand concentration [L] and total concentration of receptor [P0]:  
 fP* L[ ], P0[ ]( ) =
P*⎡⎣ ⎤⎦ + P*L⎡⎣ ⎤⎦
P0[ ]
=
P*⎡⎣ ⎤⎦ + P*L⎡⎣ ⎤⎦
P*⎡⎣ ⎤⎦ + P*L⎡⎣ ⎤⎦ + P[ ]+ PL[ ]
  (1.27) 
Assuming that activation of downstream signaling is a linear function of the number of 
active receptors, simplification of (1.27) using the equilibriums described in Scheme 1 
results in: 
 activation L[ ], P0[ ]( ) ≈ Kactivate +αactivate
bind,L Kbind,LKactivate L[ ]
1+Kactivate +Kbind,L L[ ]+αactivatebind,L Kbind,LKactivate L[ ]
  (1.28) 
Equation (1.28) is analogous to (1.9) of the MWC model. An allosteric mechanism in 
which ligand binding shifts the equilibrium between the receptor’s active and inactive 
states explains the action of agonists, which activate the receptor (α > 1), neutral 
antagonists, which block activation by agonists without activating the receptor (α = 1), 
and most importantly the inverse agonists that inactivate the receptor (α < 1). These 
types of allosteric behavior have traditionally been observed through dose response 
curves (see Figure 3), in which some downstream signaling marker is observed as a 
function of the ligand. Assuming the linear model in (1.28), these experiments can 
directly monitor the allosteric efficacy of the ligand without any direct information 
regarding the structure of the GPCR or the relative probability of its active and 
inactive states.  
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Figure 3. Ideal behavior of different pharmacological classes.  
The dose-response curve for an idealized full agonist, partial agonist, neutral 
antagonist, and inverse agonist. Adapted from Wikipedia31. 
The allosteric mechanism described above predicts the existence of an active and 
inactive state for each class A GPCR, and that these states should be able to be 
crystalized through the use of strong agonists and inverse agonists, or even antagonists 
(given the receptor has low basal activity). While the model predates crystal structures 
of class A GPCRs, a large number of x-ray structures have been solved since 2007. 
These structures have largely supported the existence of active and inactive states that 
are associated with ligand binding, although it is now known that it is unlikely that 
there are singular active and inactive states associated with any given GPCR (this will 
be discussion further in Section 1.1.3.1. Ligand-specific Allosteric Modulation in 
GPCRs).  
The first crystal structure of a class A GPCR came from bovine rhodopsin, which was 
crystallized in what was assigned to be an inactive state32. Rhodopsin, unlike other 
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class A GPCRs, contains a covalently bound ligand, 11-cis retinal, and is activated 
when the ligand undergoes a light-induced cis to trans transition. While this 
mechanism differs from the above-described mechanism in detail, the state of the 
covalently bound ligand can be seen as equivalent to the binding state (bound versus 
unbound) of a non-covalently bound ligand. Thus, the structure of rhodopsin bound to 
11-cis retinal was assigned as the inactive state (also known as the “dark state”), 
whereas a hypothetical structural of rhodopsin bound to 11-trans retinal would be 
expected to be in the active state. Later, retinal-free rhodopsin (known as opsin) was 
crystalized in a state in which opsin bound to a synthetic Gα carboxy terminus (GαCT) 
peptide33, and thus the structure was expected to be active. The structure featured 
prominent conformational changes, including a 6-7 A tilt of TM6 (see Figure 4) and 
reorganization of both a salt bridge composing the conserved E(D)RY motif and an 
aromatic stacking interaction in the conserved NPxxY.  
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Figure 4. Ligand binding and conformational changes in rhodopsin.  
(A) Chemical structures of 11-cis- and all-trans-retinal. (B) 11-cis-retinal (in gray) in 
the ligand binding pocket (green, PDB: 1F88). (C) Conformational changes in retinal 
and the binding pocket of rhodopsin upon photoactivation. The photoactivated all-
trans-retinal (PDB: 3PQR) is magenta and the ground-state 11-cis-retinal (PDB: 1F88, 
gray) is superposed on the activated all-trans-retinal for comparison. The activated 
protein (PDB: 3PQR) is dark brown. (D) The outward tilting of the cytoplasmic end of 
helix 6 (indicated by the horizontal arrow) and the elongation of the cytoplasmic end 
of helix 5 (indicated by the vertical arrow). Green shows the inactive conformation 
(PDB: 1F88), and brown shows the activate conformation (PDB: 3PQR). (E) Bottom 
view of panel D. Figure and legend reproduced from 34 with permission. 
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While the opsin state requires a more complicated model than the simple two-state 
model (as the ligand has effectively three states, unbound, bound/cis, and 
bound/trans), one would expect that the GαCT-bound receptor would be in the active 
state, if it is assumed that the active state is described phenomenologically as “active” 
because it has higher affinity for the down-stream signaling G protein (i.e. the 
activation is also allosterically coupled to G protein binding via a K-type mechanism). 
However, light states were eventually crystalized in various states that were 
considered intermediates to the fully active state, such as bathorhodopsin35, 
metarhodopsin I36, and then the fully activated, deprotonated metarhodopsin II37. 
However, due to the covalent nature of the ligand, the quantum nature of light-induced 
isomerization of retinal, and the several intermediates, rhodopsin may not be the best 
model for the mechanism of activation of class A GPCRs by non-covalent agonists. 
X-ray structures of the β2 adrenergic receptor and A2A adenosine receptor in inverse 
agonist, antagonist, and agonist bound states have made it possible to directly address 
the structures involved in non-covalent ligand-induced allosteric modulation of 
function. The first crystal structure of β2AR was solved in complex with the inverse 
agonist carazolol. While the structure was incredibly similar to that of dark rhodopsin, 
with a TM RMSD of 1.56 A, there was a notable difference in TM3 and TM6 local to 
the so-called “ionic lock” composed by E6.30 and R3.50 of the E(D)RY motif, where the 
ionic lock mimicked the state seen in light-activated rhodopsin32. This difference was 
seen in the subsequent structures of a β2AR/T4L chimera bound the inverse agonist 
timolol38, avian β1AR bound to the antagonist cyanopindolol39, and human A2A 
bound to the antagonist ZM24138540. However, the active state structure of β2AR, 
bound to the high affinity BI-167107 agonist and Nb8041, a nanobody that acts as a G 
protein mimetic, revealed similar conformations changes as seen in the active state 
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opsin and rhodopsin structures, with large outward displacement of TM6. Outward 
displacements of TM6 are consonant with the predictions of early biophysical 
experiments42,43, which suggested a TM6 conformational change being characteristic 
of ligand-induced activation.  
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Figure 5. The agonist-Nb80 stabilized crystal structures of β2AR.  
The structure of β2AR-T4L bound to the inverse agonist carazolol (β2AR-Cz) is shown 
with β2AR-T4Lin blue and carazolol in yellow. The structure of BI-167107 agonist 
bound and Nb80 stabilized β2AR-T4L (β2AR-Nb80) is shown with β2AR-T4L in 
orange and BI-167107 in green. (a) The β2AR-Nb80 complex with β2AR in orange 
and CDRs of Nb80 in light blue (CDR1) and blue (CDR3). (b) Superposition of 
β2AR-Cz and β2AR-Nb80. (c) Extracellular view of the superposition of β2AR-Cz and 
β2AR-Nb80.  Extracellular view of the superposition of β2AR-Cz and β2AR-Nb80. (d) 
Intracellular view of the superposition of β2AR-Cz and β2AR-Nb80. (e) Superposition 
of β2AR-Nb80 with the structure of opsin crystallized with the C-terminal peptide of 
Gt (transducin). Adapted from 41 with permission.  
  
	  24	  
However, a later structure of β2AR in complex with a heterotrimeric GS complex44 
indicated that the conformational change required to accommodate the G protein was 
significantly larger than that expected from the structures of agonist-bound receptor 
(see Figure 6).  
 
 
Figure 6. The structure of β2AR bound to a heterotrimeric Gs protein complex.  
The overall structure of the β2AR (green) bound to an agonist (yellow spheres) and the 
heterotrimeric Gs composed of Gαs (orange), Gβ (cyan) and Gγ (purple). Reproduced 
with permission from 44. 
It should be noted that while GPCR allostery is generally discussed in the context of 
the ligand’s ability to stabilize the activate state of the GPCR, the function of the 
GPCR comes from its own ability to activate a G protein. One mechanism of 
activation of a G protein by a GPCR that utilizes allostery is a K-type mechanism in 
which either state of the GPCR can activate the G protein, but the active state of the 
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GPCR has higher affinity for the G protein, and thus the coupling of G protein binding 
to receptor activation must be considered: 
	  
Scheme	  3.	  The thermodynamic cycle for the coupling of G protein binding to 
receptor activation.  
And thus there is a K-type coupling between the activation state of the receptor and 
the binding of the G protein: 
 αactivate
bind,G = Kactivate
G
Kactivate
=
KD,Ginactive
KD,Gactive
  (1.29) 
However, there is additional evidence that G proteins may be pre-coupled to their 
receptors. If this is the case, the inactive state of the G protein may have high affinity 
for the inactive form of the receptor, and the active state of the G protein may have 
high affinity for the active form of the receptor. Thus, the allostery could involve the 
coupling of the active states (see Scheme 4). 
R GR G 
R* GR* G 
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Scheme 4. The thermodynamic cycle for receptor activation coupled to G protein 
activation. 
Thus, 
  αactivate,R
activate,G =
Kactivate,RGactive
Kactivate,RGinactive
=
Kactive,Ginactive
Kactive,Gactive
  (1.30) 
Lastly, as described in Section 1.1.1.2. Theoretical Background, the GPCR may act as 
a GAP and increase the rate of GTP hydrolysis by the G protein. 
	  
Scheme 5. The kinetic scheme for receptor GAP binding coupled to GTP hydrolysis 
Thus, the complex process of inducing intracellular G protein signaling through 
activation of a GPCR by an extracellular ligand has the potential to involve several 
GR G*R 
GR* G*R* 
GR	   GR	  +	  GAP	  +	  GDP	  +	  Pi 
GR* GR*	  +	  GAP	  +	  GDP	  +	  Pi 
GTP 
GTP 
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different allosteric mechanisms that likely will involve very different underlying 
physical mechanisms.  
1.1.2.2. Membrane Transporters 
The transport of solutes across cell membranes is an essential process in the life of 
each cell. Membrane transport maintains homeostasis and connects the cell to its 
environment by establishing and keeping ion gradients45, and absorbing essential 
substrates such as sugar46,47 and amino acids48. In multicellular organisms most 
physiological processes utilize solute transport to enable the specific function of 
tissues and organs, from concentrating the urine in the kidney49, to reuptake of 
released neurotransmitter that enables neurotransmission in the brain50. Not 
surprisingly, transport malfunction has been implicated in many disease states51, and 
the molecular machines involved in transport are the targets of both medications and 
various drugs of abuse52. 
Three main mechanisms of transport across the cell membrane have been identified, 
and each can be described in the framework of thermodynamics and chemical kinetics. 
The simplest mechanism is passive transport45, in which solutes diffuse across the 
membrane without the assistance of other molecules. The concentration gradient and 
the membrane potential determine the net direction of the diffusion. With the equation 
for a transport of a solute S from the extracellular space to the intracellular space 
written as: 
 Sout → Sin   (1.31) 
the free energy change, ΔG, associated with this transport process is simply  
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 ΔG
passive
= −RTlog Sout[ ]Sin[ ]
⎛
⎝⎜
⎞
⎠⎟
− zFEm   (1.32) 
where [Sout] and [Sin] are the solute concentrations on the outside and inside of the 
cell, R is the gas constant, T is the temperature, z is the charge of the solute, F is the 
Faraday constant, and Em is the membrane potential. The solute equilibrium can be 
written as 
 Sout
kp
k− p
⎯ →⎯← ⎯⎯ Sin   (1.33) 
where kp and k-p are the rate constants for the forward and backward passive transport, 
respectively. These rate constants implicitly include the effect of the membrane 
potential. At equilibrium, 
 ΔGpassive = −RTlog
kp
k−p
⎛
⎝⎜
⎞
⎠⎟
= 0   (1.34) 
and assuming (for simplicity) the membrane potential is 0, the new diffusion rates in 
either direction become equal, and the equilibrium substrate concentrations are such 
that 
 Sout[ ]eq = Sin[ ]eq   (1.35) 
While small, uncharged solutes can equilibrate via passive diffusion at a reasonable 
rate, the membrane is not permeable to larger, charged molecules. These move across 
the membrane through facilitated diffusion45. Facilitated diffusion is mediated by a 
class of transport proteins known as uniporters, which can be either channels or carrier 
proteins. Channels act as regulated pores that open in response to a stimulus and allow 
the free flow of specific solutes. Carrier proteins bind one molecule at a time and 
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transport it across the membrane with the solute concentration gradient. In both cases, 
uniporters act by increasing the effective membrane permeability for the solute and 
thus the rate of equilibration of concentrations on either side of the membrane.  
Denoting the transporter protein as T, the facilitated diffusion equilibrium is 
 Sout + T
kf
k− f
⎯ →⎯← ⎯⎯ Sin + T   (1.36) 
where kf and k-f are the rates of forward and reverse facilitated transport, respectively. 
Given the fact that the free energy of facilitated transport is the same as ΔGpassive, 
which depends only on the intra- and extracellular substrate concentrations and the 
membrane potential,    
 
kp
k−p
= kfk− f
  (1.37) 
However, the free energy barrier for transport is lowered, such that 
 kf > kp,k− f > k−p   (1.38) 
Both passive transport and facilitated transport are determined by the direction of the 
gradient or the electric field. However, much of the transport required for cell 
physiological processes do not occur in the direction of the solute’s concentration 
gradient. When transport of a solute alone is not thermodynamically spontaneous, a 
third mechanism of transport, active transport45, is required. To achieve transport 
against a concentration gradient, the thermodynamically unfavorable transport of the 
solute is coupled to an energy source. The nature of the energy source classifies active 
transport into “primary” and “secondary”.  
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In primary active transport45, the thermodynamically unfavorable transport process is 
coupled to a chemical reaction that proceeds in a thermodynamically favorable 
direction. This can be written as: 
 Sout +R + T
ka
k− a
⎯ →⎯← ⎯⎯ Sin + P + T   (1.39) 
where R and P are the reactant and product of the chemical reaction, respectively, and 
ka and k-a are the rate constants for forward and reverse transport. Here, the relation to 
passive transport rates is  
 kak−a
= ΔGactive < ΔGpassive   (1.40) 
Although ΔGpassive > 0, the energy released by the chemical reaction allows reversal of 
the equilibrium, such that ΔGactive < 0 when the system is out of equilibrium and 
inward transport becomes effective. A common energy source for primary active 
transport is ATP hydrolysis45, which is used by the family of transporters known as 
transmembrane ATPases53. For this family, (1.39) becomes 
 Sout +ATP + T
ka
k− a
⎯ →⎯← ⎯⎯ Sin +ADP + Pi + T   (1.41) 
The manner in which the energy from ATP hydrolysis is used to enable solute 
transport against its gradient by the primary active transporter is a key consideration in 
understanding the molecular mechanism of these membrane proteins. While the 
binding of ATP to a primary active transporter has been suspected for a long time to 
be separate from that of a solute54, it is now made clear from the known molecular 
structures of such transporters that the binding sites are well separated spatially55–57. 
By virtue of this spatial relationship, it is reasonable to consider the coupling between 
ATP hydrolysis and solute transport to involve an allosteric mechanism.  
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Indeed, potential allosteric mechanisms for the coupling of ATP hydrolysis to solute 
transport against its gradient have been proposed since as early as the 1960s. In 1966, 
Jardetzky proposed a “simple allosteric model” for phosphorylation-driven transport 
of an ion58, which corresponds to the following formulation:  
 Sout +ATP + Tout
ks
k− s
⎯ →⎯← ⎯⎯ ATP + STout krelease⎯ →⎯⎯ Sin +ADP + pTin   (1.42) 
In this mechanism, the solute binding to the transporter occurs from the outside (i.e., 
the extracellular environment) when the transporter adopts an “outward-facing” 
conformation, denoted Tout. The substrate binding and unbinding rate constants are 
denoted ks and k-s, respectively. In a second step ATP-dependent phosphorylation of 
the transporter drives it into an inward-facing conformation so that the phosphorylated 
form is pTin, which has low affinity for the solute and releases it into the cell. Because 
of the large amount of energy released by ATP hydrolysis, the second step is assumed 
to be irreversible and the transport reaction leading to intracellular substrate release is 
described by the forward rate constant krelease. This mechanism has often been referred 
to as a “rocker switch” for the transition between an outward-facing and an inward-
facing conformation of the transporter59, and is generally cited as the origin of what is 
now known as the “alternating access” model or mechanism (the authors note that 
while we were unable to locate the first instance of the use of the name “alternating 
access”, it has been in use since as early as 1977 in 60).  
The alternating access model describes transport as the following process: 
  Sout + TOF! STOF! STOCC! STIF! Sin + TIF   (1.43) 
In this mechanism, the transporter has three states: outward-facing (TOF), occluded 
(TOCC), and inward-facing (TIF). While Jardetzky’s simple representation of the 
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allosteric model (see (1.42)) for the ATP dependent transporters did not include an 
occluded state as in (1.43), it still fits within the alternating access framework, and 
there is a substantial body of work clarifying how ATP hydrolysis is allosterically 
coupled to solute transport in an alternating access manner. Indeed, for some systems 
such as the sodium/potassium exchanger Na+/K+ ATPase, the mechanism of Na+ 
import is strikingly similar to the original model61, but for the important class of 
transporters identified as the ATP Binding Cassette (ABC) transporters, it appears that 
the mechanism can be fundamentally different within subfamilies, as illustrated below.  
The ABC transporter superfamily is the largest transporter gene family and is 
responsible for the transport of many different types of substrates, both as exporters 
and importers62. Based on an abundance of structural, biochemical, and biophysical 
data, an “ATP switch” model has been proposed for ABC transporters in which the 
translocation step is driven by ATP binding and not hydrolysis63,64. According to this 
mechanism (presented for ABC exporters), substrate binding to the inward-facing 
transporters causes the transition to an occluded state of the transporter, and increases 
the transporter’s affinity for ATP. ATP binding then stabilizes the outward-facing 
conformation, which has low affinity for substrate, and substrate is released: 
  TIF + Sin +ATP! TOCCS+ATP! TOFATP+ Sout   (1.44) 
Finally, the hydrolysis of ATP is then proposed to drive the resetting of the empty 
transporter to the inward-facing state in preparation for the next cycle of substrate 
transport: 
  TOFATP→ TOCCADP + Pi! TIF +ADP + Pi   (1.45) 
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In this component of the mechanism, ATP hydrolysis with the transporter in the 
outward-facing state, leads to occlusion of the binding site from the extracellular 
environment. Dissociation of the low affinity ADP then produces an apo state of the 
transporter, which favors the inward-facing conformation. This combined mechanism 
enables primary active transport of the solute against its gradient, but appears 
considerably more complicated than Jardetzky’s simple allosteric model in (1.42). 
Despite the apparent increased complexity, this mechanism has significant empirical 
support (for reviews, see 63,64 and references therein). 
In contrast to the primary active transporters, in which the overall thermodynamically 
unfavorable substrate transport process is coupled to a favorable chemical reaction, the 
secondary active transporters couple the unfavorable transport process to the favorable 
transport process of one or several ions, (denoted as I). The ions are either transported 
in the same direction of the substrate (symport) or in the opposite direction (antiport). 
In inward symport, the equilibrium becomes: 
 Sout + Iout + T
ks
k− s
⎯ →⎯← ⎯⎯ Sin + Iin + T   (1.46) 
The net free energy change of the coupled process can be written as Δ Gsymport = Δ GS 
+ Δ GI, with the transport free energies for solute and ions defined as in (2). This 
yields: 
 ΔGsymport = −RTlog
Sout[ ] Iout[ ]
Sin[ ] Iin[ ]
⎛
⎝⎜
⎞
⎠⎟
− (zS + zI )FEM   (1.47) 
Here, zS and zI indicate the charges of the solute and ion, respectively. When DGsymport 
is negative, unfavorable substrate import can be driven against the concentration 
gradient. In particular, sodium uptake is used in many of the known secondary active 
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transports, with the large difference in extracellular and intracellular sodium 
concentrations in most tissues and environments providing a significant source of 
electrochemical energy.  
The sodium-coupled symporters are a large family of great interest because the solutes 
transported span a vast array of chemical compositions and they are essential 
components of many physiological functions. For example, sodium-coupled 
symporters play an essential role in neurotransmission, where they mediate the 
reuptake of neurotransmitter into the presynaptic and glial cells, and thus enable the 
transduction of information. Consequently, these transporters are also efficient targets 
for psychoactive therapeutics. The reasons for the attention accorded here to sodium-
coupled symporters go beyond the importance due to their sheer abundance in 
biological systems, and their diversity. It includes as well the central role of allostery 
in the mechanisms of transport that have been proposed for their various subfamilies, 
and their diversity.  
While the sodium-coupled symporters are also believed to use an alternating access 
mechanism as shown in (1.43), the molecular and thermodynamics details of the 
mechanism are not obvious. For sodium-coupled symporters, neither of the simple 
allosteric model or the model described above for the ABC transporters are supported 
by experimental or computational evidence.  
1.1.2.1.1 LeuT- a prototype for secondary transporters 
The small amino acid transporter LeuT, originally identified as a bacterial leucine 
transporter, has proven to be an extremely useful tool in understanding the allosteric 
mechanisms involved in secondary transport. LeuT was originally identified as a 12-
transmembrane segment (TM) homologue of the Na+/Cl- -dependent transporters65, 
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but with the rapid growth in structural and functional information about other 
members of the SLC6 gene family, the current view is that the pair of pseudo-
symmetric 5 TM bundles in LeuT (TMs 1-5/6-10) represent a more general protein 
fold motif termed the “LeuT-fold”, shared by many membrane proteins performing a 
variety of transport functions66.  For these reasons, the structure and dynamics of LeuT 
and its functional mechanisms became the focus of intense investigations and it 
continues to serve as a prototype for the large class of mammalian monoamine 
transporters (MATs) that are Na+/Cl--dependent neurotransmitter symporters (NSS) 
and carry out the symport of Na+ and a biogenic amine, together with Cl- antiport (see 
below). 
The first step towards understanding the transport functions of LeuT-fold proteins 
from the context of a 3D molecular structure was the determination of a high 
resolution x-ray crystal structure of LeuT bound to two sodium ions and to leucine 65, 
which is a slowly transported as a substrate (vmax = 334 pmol/min/mg). The 1.7 Å 
resolution leucine-bound structure (PDB 2A65) revealed the topology of the twelve 
TM domains, ten of which form the two TM bundles arranged in the pseudo-
symmetry characteristic to the LeuT-fold family (see Fig. 1A). The substrate binding 
site, termed S1, was found at the midpoint of the two pseudo-symmetric domains, 
local to TM3, TM8, and the unstructured regions at the centers of TM1 and TM6 
helices. Adjacent to the substrate are two distinct sodium sites, termed Na1 and Na2. 
The sodium in the Na1 site is directly coordinated by the leucine’s carbonyl oxygen 
(see Fig. 1B), as well as by residues A22 and N27 of TM1, T254 of TM6, and N286 of 
TM7. In the Na2 site, the Na+ ion does not interact directly with the substrate, but is 
coordinated by residues G20 and V23 of TM1, and A351, T354, and S355 of TM8. 
Na+ titration experiments showed that no substrate will bind in the absence of Na+, 
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and subsequent studies indicated that the binding of Na+ and leucine was 
cooperative67, as might be expected from the interaction of substrate and the Na1 
sodium identifiable in the crystal structure.  
  
	  37	  
 
Figure 7. LeuT fold and binding sites. 
(A) Crystal structure of LeuT bound to two Na+ and a leucine (2A65). The 
pseudosymmetric TM repeats are represented in silver ribbons (TMs 1–5) and gold 
illustration (TMs 6–10). TMs 11 and 12 and loops are shown in cyan ribbons. Leucine 
and Na+ are represented as orange and yellow van der Waals spheres, respectively. (B) 
Primary substrate binding site S1. Leucine is shown in orange, and the binding 
residues are colored by element (cyan for carbon, blue for nitrogen, and red for 
oxygen). Na+ ions are shown as yellow van der Waals spheres and labeled according 
to their binding site. (C) Clomipramine binding site in S2. Clomipramine is shown in 
pink, EL4 is shown as cyan ribbon, and the remaining residues and substrates are 
colored as in B, except that the backbone is omitted for clarity. 
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The detailed interactions between the Na+ ions and the substrate can be considered as 
a basic form of allostery, in which two structural components influence each other’s 
binding equilibria (hence K-type allostery) through direct interaction, as described by 
(1.15) and (1.16) in Section 1.1.1.2. Theoretical Background. But in MD simulations, 
however, the Na+ binding led to opening of the extracellular vestibule that would 
allow the substrate to bind68, thus pointing to a more intricate network of allosteric 
interactions. Indeed, later studies with electron paramagnetic resonance (EPR) 
confirmed Na+ -induced outward opening69,70, suggesting that Na+ binding may 
allosterically modulate the extracellular vestibule and the S1 site to increase substrate 
binding through a mechanism other than just direct interactions.  
Together, these results of the functional and structural analysis of LeuT functions can 
be considered to represent the first steps in an allosteric transport mechanism in 
which the transporter can only bind its substrate when the energy source to which it is 
coupled is already bound. This allosteric coupling is represented by the following 
thermodynamic cycle: 
	  
Scheme 6. The thermodynamic cycle for binding of Na+ and substrate. 
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The typical substrate binding equilibrium can be written as: 
 Leu + T kbind,Leu
kunbind,Leu
⎯ →⎯⎯⎯← ⎯⎯⎯ LeuT   (1.48) 
and the dissociation constant for leucine binding to the apo transporter will be denoted 
as: 
 KD,Leu =
kunbind,Leu
kbind,Leu
  (1.49) 
In the presence of Na+, one can write the modified equilibrium as: 
 Leu +Na2+T
kbind,Leu
Na2
+
kunbind,Leu
Na2
+
⎯ →⎯⎯⎯← ⎯⎯⎯ LeuNa2+T   (1.50) 
with the new dissociation constant 
 KD,LeuNa2
+
=
kunbind,LeuNa2
+
kbind,LeuNa2
+   (1.51) 
so that the allosteric coupling between leucine and Na+ binding can be quantified as a 
function of the dissociation or association constants: 
 αbind,Leu
bind,2Na+ =
KD,Leu
KD,LeuNa2
+   (1.52) 
Thus, α > 1 for cooperative binding. Assuming that the concentration of Na+ is 
saturating, and thus LeuT is in the sodium-bound state before binding substrate, the 
transport process can be represented as: 
 Leuout +Na2+T
kbind,Leu
Na2
+
kunbind,Leu
Na2
+
⎯ →⎯⎯⎯← ⎯⎯⎯ LeuNa2+T kcat⎯ →⎯ Leuin + 2Nain+ + T   (1.53) 
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For this process, we can write a MM equation that accounts for the K-type allosteric 
modulation of transport due to the coupling of leucine and sodium binding: 
 
d Leuin[ ]
dt =
kcat T0[ ] Leuout[ ]
αbind,Leu
bind,2Na+( )−1 KD,Leu + Leuout[ ]
  (1.54) 
Equation (1.54) demonstrates the first allosteric component in LeuT’s secondary 
active transport mechanism, with the following implications: The stronger the 
allosteric coupling between the binding of leucine and of sodium, the higher the 
transport rate will be, because more transporters will be in the fully bound state and 
prepared for release. Notably, transporters could still perform symport if these two 
binding events were independent, as long as both binding events are 
thermodynamically favorable. However, their allosteric coupling makes transport 
significantly faster when release is the rate-limiting step. 
Moreover, by favoring the fully bound state, the allosteric coupling makes the 
substrate-only bound state less populated, and thus less Na+-independent substrate 
export would be expected than when compared to binding that is not allosterically 
coupled.   
While the leucine-bound structure of LeuT described above enabled the appreciation 
of an allosteric coupling can be achieved between sodium binding and substrate 
binding, structures alone cannot show how domains of the transporter are involved in 
outward and inward opening, nor suggest the presence of any intrinsic allosteric 
coupling between these domains. These elements of allostery in the function of the 
transporter emerge from the analysis in the context of previous studies of residues 
believed to be involved in gating in mammalian homologous71,  from steered 
molecular dynamics simulations that simulated the translocation of leucine68, 
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additional structures of the sodium-bound outward-open state and a mutant apo 
inward-open state72. All these studies helped reveal the domains involved in gating, 
their potential open and closed conformations, and the networks of interactions that 
stabilized these conformations. Despite the pseudo-symmetry of the TM domains, it 
became clear from these simulations and the various structures that significant 
differences between the intracellular and extracellular domains are likely to be 
important for the functional mechanism. This is illustrated by the specific details of 
the extracellular gate (EG, see Figure 8) and the intracellular gate (IG, see Figure 9).  
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Figure 8. The extracellular gate of LeuT in the open and closed states.  
A. The structure of the extracellular gate in the outward-open (red) and outward-
closed (blue) conformations. Domains involved in the conformational change (EL4, 
TM1b, TM6a, and TM8) are shown as ribbons, while the rest of the protein is shown 
as transparent cylinders. B and C. A closer view of the open and closed extracellular 
gates, respectively. Residues involved in stabilizing the closed conformations are 
shown in pink and light blue. 
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Figure 9. The intracellular gate of LeuT in the open and closed states. 
A. The structure of the intracellular gate in the inward-closed (red) and inward-open 
(blue) conformations. Domains involved in the conformational change (TM5, TM8, 
TM6b, TM1a) are shown as ribbons, while the rest of the protein is shown as 
transparent cylinders. B and C. A closer view of the open and closed intracellular 
gates, respectively. Residues involved in stabilizing the closed conformations are 
shown in pink and light blue.  
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The EG is formed by F253, which occludes the substrate from extracellular water, a 
salt bridge between R30 and D404, and it is capped by the extracellular loop 4 v-helix 
(see Figure 8). Outward opening corresponds to the disruption of the R30/D404 salt 
bridge, isomerization of F253, a reorientation of the EL4, and the outward motion of 
TM1b, TM6a, and TM8. Conversely, the intracellular gate (IG) is composed of a more 
extensive interaction network of residues from TM1a (R5), TM6b (S267 and Y268), 
TM8 (D369), and TM2 (I187), and these interactions are all disrupted in the inward-
open mutant, leading to a large displacement of TM1a, smaller displacements of 
TM6b and TM8, and an unwinding of the TM5 kink (see Figure 9). These crystal 
structures, and the experimentally determined existence of intracellular and 
extracellular gates with open and closed states, supported the proposal of a gated pore 
alternating access mechanism for transport, in which (i)-LeuT binds an extracellular 
substrate while in an outward open/inward closed state (OO:IC), (ii)-transitions to a 
doubly-occluded state (OC:IC), and then into (iii)-an outward closed/inward open state 
(OC:IC), from which the substrate can be released into the intracellular space. 
Forward transport is often written with only three states, as: 
  2Naout
+ + Leuout + TOO:IC! LeuNa2+TOC:IC→ 2Nain+ + Leuin + TOC:IO   (1.55) 
and the mechanism is represented in the following thermodynamic cycle: 
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Scheme 7. The thermodynamic cycle for substrate binding and gating. 
However, the complete mechanism actually implies a number of additional states, 
including a doubly open state and all possible combinations of gate states bound to 
substrate.  
Notably, the simplified three-state model implied in (1.55) would be approximately 
accurate in the regime of high K-type allostery between the EG and IG (e.g. the limit 
as α goes to infinity). While an allosteric coupling between the gates appears 
reasonable given the alternating access model and the available crystal structures, this 
inference cannot be drawn from the crystal structures, each of which represents only 
one conformation in an ensemble of microstates. Because these structures do not 
provide evidence for an allosteric coupling between the gates, nor can they suggest the 
role that such an allosteric coupling would play in the molecular mechanism of 
transport, as is necessary to evaluate the relative free energies of all states in Scheme 
7, it is impossible to determine the allosteric efficacy between gate conformational 
changes. Thus, in order to understand the properties and mechanism of LeuT as a 
transporter, the determination of structures representing several conformational 
states along the transport cycle needs to be complemented by the characterization of 
TOO:IC Na+2TOO:IC Na+2STOO:IC 
2Na+ S  
TOC:IO Na+2TOC:IC Na+2STOC:IO 
2Na+ S 
Na+2STOC:IC TOC:IC 
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the many kinetic and thermodynamic parameters that are required to form a kinetic 
model of transport composed of these states. 
Soon after the initial occluded structure, several additional structures of LeuT were 
solved in which the transporter was crystallized in complex with bound 
antidepressants 73,74 that are known to act as inhibitors of mammalian NSS 
transporters, and also act as inhibitors of LeuT. In the structures of these complexes 
with LeuT, the antidepressants were bound in an extracellular vestibule containing the 
extracellular gate, and were positioned above the substrate binding site (S1) observed 
in the original leucine-bound crystal structure. This binding site is now referred to as 
the secondary substrate site S2, and its properties and proposed functions will be 
detailed further below.  
Because the inhibitors bound in S2 occludes access to S1, which contained a bound 
leucine, (see Figure 7B), it was inferred that inhibitor binding has to occur after ligand 
binding, and it was further suggested that the inhibitors impeded substrate transport in 
a non-competitive manner by locking the extracellular gate in a state that is 
incompatible with inward-opening or substrate release. In terms of the MM 
representation typically used to analyze transport, this implies that in order to achieve 
inhibition by this mechanism, inward opening must be the rate-limiting step.  In fact, 
kinetic analysis of alanine transport under saturating sodium and inhibitor 
concentrations found73 that the inhibitors decreased the vmax, (from 1890 ± 90 without 
inhibitor to 770 ± 40 pmol/min/mg) while KD was unchanged (450 ± 70 versus 480 ± 
80 nM). This indicates a V-type allosteric mechanism for antidepressant inhibition. 
Indeed, binding experiments found that inhibitors caused the transporter to retain the 
bound alanine substrate, indicating that they greatly reduced the rate constant for 
intracellular release.  
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With the assumption that substrate binds first, followed by the binding of inhibitor is 
supported by the crystal structure, so that the mechanism of transport in the presence 
of an inhibitor, Inh, can be written as: 
 Inhout + LeuNa2+T
kbind,Inh
Na2
+
kunbind,Inh
Na2
+
⎯ →⎯⎯⎯← ⎯⎯⎯ InhLeuNa2+T kcat
Inh
⎯ →⎯ Leuin + 2Nain+ + InhT   (1.56) 
The V-type allosteric efficacy is 
 βcat
bind,Inh = kcat
Inh
kcat
  (1.57) 
so that the rate of transport under saturating sodium and inhibitor concentrations 
becomes 
 
d Leuin[ ]
dt =
βcat
bind,Inhkcat T0[ ] Leuout[ ]
αbind,Leu
bind,2Na+( )−1 KD,Leu + Leuout[ ]
  (1.58) 
This analysis provided significant, quantitative evidence for allosteric modulation of 
transport that is achieved by modulating the conformation of the extracellular gate. 
However, at the time it was carried out73 there was no structure of an inward open 
state, and the structures of substrate-bound transporters were all inward closed. 
Consequently, there was no structural evidence for allosteric modulation of inward 
opening, and such an inference could be made from the existing inhibitor-bound 
structures only by assuming a model of the transporter as an allosteric gated pore. But, 
the mechanism implied by the structures differed from that of a typical gated pore, 
because the inhibitor-bound structures did not exhibit any more outward opening than 
the original leucine-bound structure, which had been described as “doubly occluded”, 
and thus was unlikely to represent an outward open state. However, a conformation 
nearly identical to the original leucine-bound structure, in which a β-octoglycoside (β-
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OG) detergent bound in S2 was crystalized later75, and EPR experiments revealed that 
the  β-OG bound conformation corresponded to an outward open state69, which led to 
the suggestion that the states may be at least partially inward open.  
Consequently, the inhibition mechanism can be considered consistent with an 
allosteric gated pore model, but without the clear open/closed two-state behavior 
described for the extracellular gate. We note, moreover, that in itself, the finding of a 
V-type allosteric mechanism of inhibition by the synthetic tricyclic antidepressants 
does not necessarily implicate V-type allostery as a required component of the 
physiological mechanism of transport. 
A detailed assessment of the function role of the allosteric coupling between the 
intracellular and extracellular gates in the physiological mechanism of transport has 
emerged from a combination of computational and biochemical experiments68. The 
results of these studies led to the conclusion that by modulating inward opening, this 
allosteric coupling could serve both to induce, and to inhibit. A particular role in this 
modulation was suggested for the functional secondary binding site (S2) that identified 
from steered molecular dynamics simulations (SMD)68 of substrate translocation. As 
leucine was pulled through the transporter in order to identify the conformational 
changes required for transport the presence of a relatively stable binding site in the 
extracellular vestibule emerged, which overlapped significantly with the inhibitor 
binding site observed in the crystal structures. As mentioned above, this site was 
deemed to be the secondary substrate site, S2. The first experimental evidence for this 
site was provided by careful evaluations of binding stoichiometry under various 
conditions using scintillation proximity assays.  These experimental results revealed a 
2:1 substrate:transporter binding stoichiometry, which was inconsistent with the 1:1 
binding stoichiometry seen in the leucine-bound structure. Interestingly, in long 
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dissociation experiments in the presence of Na+, this measured binding stoichiometry 
decreased to 1:1, with the remaining leucine trapped in the S1 site. However, addition 
of non-radiolabelled leucine led to rapid dissociation of the trapped radiolabelled 
leucine, suggesting that a second leucine was acting on the transporter in a way that 
induced release of the trapped one. Importantly, mutations of residues identified from 
the computation to be within the S2 site were shown to reduce the experimentally 
determined binding stoichiometry from 2:1 to 1:1, and prevented substrate-induced 
dissociation of trapped substrate68.  
That substrate-induced substrate release was related to transport was subsequently 
demonstrated by repeating the experiments with LeuT reconstituted in 
proteoliposomes68. These displayed both S1 substrate trapping and S2-dependent 
substrate-induced substrate release. Importantly, the S2 mutants essentially completely 
abolished transport in the proteoliposomes, indicating an essential role in the transport 
mechanism. 
The corresponding mechanism of transport dependent on substrate binding in both 
sites (assuming only the S1 substrate is released) in the MM representation can be 
described as: 
 LeuS2LeuS1Na2+T βcat
bind,LeuS2kcat⎯ →⎯⎯⎯⎯ Leuin + 2Nain+ + LeuS2T   (1.59) 
and thus the rate of transport at initial high, saturating concentrations of extracellular 
leucine would be 
 
d Leuin[ ]
dt = βcat
bind,LeuS2kcat T0[ ]   (1.60) 
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This representation of the results suggests that the S2 site could allosterically 
modulate substrate release in both positively and negatively, i.e., the binding of a 
second substrate molecule in S2 will induce the release of the S1 substrate (β >1), 
whereas inhibitor binding in S2 will inhibit the release of the substrate in S1 (β <1).  
It is interesting to note that the mechanistic model implies that by increasing the rate 
of transport when substrate is bound, the relative degree of substrate-independent Na+ 
import (which we will refer to as “leak”, but note to the reader that we refer here to ion 
transport, rather than a conductive, channel-like process) could be minimized is the 
transporter has low, substrate-free inward opening.  
The key elements that were revealed by the SMD simulations regarding the molecular 
process required for leucine to be released intracellularly included (i)-the evidence for 
the S2 site, (ii)-conformational changes that resulted in outward opening movements 
of intracellular domains TM1a and TM6b, and (iii)-the increased accessibly of water 
from the intracellular side that reached all the way to the substrate and ion binding 
sites. The binding of substrate in the S2 site has not yet been confirmed by 
crystallographic evidence, and it became clear from a well-documented controversy75–
80 that the experimental conditions have much to do with the availability of this site for 
ligand binding. However, the specific structural rearrangements suggested by the 
simulation results were confirmed by the subsequently determined x-ray structure of a 
LeuT mutant in the apo inward-open state72. Moreover, MD simulations suggested 
that binding of alanine in S2 was strongest when the extracellular gate was closed and 
the intracellular gate was in the process of opening81. This is consistent with the gated 
pore allosteric mechanism, according to which binding in S2 can facilitate the opening 
of the intracellular gate.  
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Together, the various results from computational modeling suggested that intracellular 
conformational changes at the intracellular end of the transporter involve TM1a and 
TM6b, and that these conformational changes can be induced by binding of substrate 
in S2. It should be noted, however, that the potential conformational transitions 
between gate opening states were proposed on the basis of SMD simulations68, which 
like other trajectories calculated subsequently using MD and path finding 
algorithms81–83, provide important information regarding the processes by which the 
states exchange, but do not on their own suggest anything about an allosteric coupling 
mechanism that modulates the equilibrium between those states. In order to extract 
any suggestions about allosteric mechanisms themselves from these simulations, 
accurate free energy differences and barriers would need to be calculated. Thus, 
notwithstanding the reasonable and compelling mechanistic models inferred from both 
computation and experiment, direct evidence that intracellular gate opening is rate 
limiting, or modulated by the inhibitors, remained elusive.  
The direct measurement of molecular dynamics of LeuT in experiments utilizing 
single molecule Förster resonance energy transfer (smFRET)84,85 and electron 
paramagnetic resonance (EPR)69,70, have provided important support and validation 
for the conformational changes observed in the SMD simulations and from the 
comparisons of various x-ray structures. Moreover, these results also provided 
quantitative measures of the equilibrium populations of states visited by the LeuT 
protein in the corresponding experimental conditions, as well as the rates of transition 
between. This type of information is essential for building a full model of transport, 
and as detailed below it supports the proposed allosteric modulation of the 
conformational changes by substrates and inhibitors. 
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The smFRET experiments on LeuT84,85, the first such investigations of a membrane 
transporter, revealed intrinsic gating dynamics, as well as allosteric modulation of 
those gating dynamics by substrates and inhibitors. Specifically, intracellular gating 
dynamics were measured in this set of experiments from the interactions of 
fluorophore labels at the positions of His7 in the N-terminus and Arg86 in intracellular 
loop 1 (IL1). The dynamics of the extracellular gate were assessed with labels at the 
position of Lys239 in extracellular loop 3 (EL3) and His480 in EL6. The results 
showed that on the intracellular side, the apo transporter dynamically exchanged 
between two kinetically distinct FRET states (referred to as the high and low FRET 
states), but preferred the low FRET state. Based on their positions and response to 
ligands, these states were presumed to correspond to inward closed (IC) and inward 
open (IO) states of the transporter, respectively. The equilibrium between these states 
can be written as 
 TIC
kopen
kclose
⎯ →⎯⎯← ⎯⎯ TIO   (1.61) 
where 
 Kopen =
kopen
kclose
<1   (1.62) 
Addition of saturating Na+, leucine, or the inhibitor CMI further stabilized the high 
FRET, inward closed state. Thus,  
 αopen
bind,Leu =
KopenLeuNa2
+
Kopen
<1   (1.63) 
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Additionally, under conditions of saturating Na+, or leucine in the presence of non-
saturating Na+, or CMI, decreased the rate of transitions between states (7-fold, 3.5-
fold, and unreported, respectively)85.  Thus, 
 βopen
bind,Leu =
kopenLeuNa2
+
kopen
<1   (1.64) 
In fact, transition state theory (TST) calculations suggested that the combination of 
Na+ and leucine led to an increase in the transition state energy of approximately 3 
kJ/mol, which, corresponds to a β value of ~ 0.3.   
The mechanistic inferences from the smFRET study were aided by the investigation of 
mutants with previously determined, well-known functional properties86. Thus, 
constructs with mutations in the intracellular gate, R5A and Y268A, were found to 
exhibit a stabilized low FRET state, reinforcing the expectation that the low FRET 
state indeed corresponded to a state in which the intracellular gate was open, in 
agreement with the SMD simulations68 and inward-open crystal structure72; 
conversely, the high FRET state corresponded to a state in which the intracellular gate 
was closed, as had been seen in the leucine-bound65 and inhibitor-bound73,74 crystal 
structures. Notably, the result that the tricyclic antidepressant CMI both closed the 
intracellular gate and decreased the transitions between the open and closed state, 
supports a mechanism in which it blocks transport via V-type allosteric modulation of 
the inward opening.  
The smFRET studies also showed that on the extracellular side, the apo transporter 
displayed a unimodal FRET distribution. Importantly, this distribution was found to be 
sensitive to the R5A and Y268A mutations at the distal, intracellular end of the 
transporter: they shift the FRET distribution to higher values, indicating that the 
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extracellular domain may become more closed as the intracellular gate opens. Taken 
together, the evidence for induction of intracellular closing by CMI and for 
extracellular closing induced by the intracellular gate mutants supports the model of 
an allosteric gated pore mechanism for transport by LeuT. But it also suggests that the 
behavior at the extracellular gate may not be well described by a two-state model.  
The main inferences about the allosteric interconnection of the intracellular and 
extracellular gates of LeuT obtained from the smFRET studies were supported by 
results from extensive mapping of LeuT’s structural ensemble obtained using site-
directed spin labeling and double electron-electron resonance (DEER) EPR 
experiments70 under varying conditions of ion and substrate concentrations, and 
mutations. The results from these measurements were interpreted in a structural 
context70 with the application of restrained ensemble MD (REMD) calculations87. 
Measurements of extracellular pairs revealed distinct open and closed populations 
(unlike what had been seen in smFRET) that displayed Na+-induced opening and Na+-
and leucine-induced closing69. On the intracellular side, EPR measurements of the 
H7C/R86C pair reproduced the smFRET results84,85 with the finding of two well-
separated peaks in the distance distribution that were modulated by ions and substrate 
to favor a closed state. In addition, the EPR measurements revealed modulation of 
several other distances on the intracellular side, primarily involving the TM6b 
segment and TM770. However, the measurements in this study did not support the 
large conformational change in TM1a suggested by the inward-open crystal 
structure72. Instead, these measurements suggested that the conformational change 
observed by monitoring H7C/R86C pair in both smFRET and EPR corresponded to 
the movement of the N-terminus rather than a substantial movement of TM1a. 
Notably, both the Y268A mutation, which had been used to stabilize the inward-open 
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state captured in the crystal structure72, and the R5A mutation yielded large 
displacements of TM1a in the EPR measurements. This led to the suggestion that the 
large displacement of TM1a seen in the crystal structure could be an artifact of the 
mutated construct used for crystallization, in which an intrinsically available motion of 
this TM1a segment was exacerbated when the mutations loosened constraints on that 
region of the transporter structure.  
Despite their disagreement with the x-ray structure, the combined results from 
smFRET84,85 and EPR69,70 demonstrate definitively the allosteric modulation produced 
by the substrate and ions. Even if the exact atomic details of the conformational 
changes are still not entirely clear, the biophysical evidence from these and other 
experiments, amplified by, and interpreted in the context of results from simulations of 
various states of the transporter, implicate the binding processes at a distal part of the 
transporter in the allosteric modulation of the conformational ensemble and dynamics 
of the intracellular gate. 
The mammalian monoamine transporters (MATs) in the subclass of the LeuT-fold 
transporters are Na+/Cl--dependent neurotransmitter:symporters, which carry out the 
symport of Na+ and a biogenic amine, together with Cl- antiport. The three major types 
of plasma membrane synaptic MATs (sMATs) include the dopamine transporters 
(DAT), serotonin transporters (SERT), and norepinephrine transporters (NET). The 
three classes share high homology and are believed to be both structurally and 
functionally similar to each other, and to a lesser extent, to LeuT71. It is reasonable to 
question if and how the allosteric mechanism described above for LeuT translates to 
these transporters, as they are of great importance in basic neurobiology (for their role 
in the fundamental mechanisms composing neurotransmission) and medicine (for their 
role as validated targets for a large variety of drugs).  
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Given the great interest in mechanistic insights about the sMATs, they were subjected 
to kinetic analyses long before the molecular structures of NSS family members 
became available from x-ray crystallography. Kinetic analysis of dopamine uptake in 
rat striatal synapatosomes88 revealed that the sodium dependence of DAT function was 
evident both in a change in maximum velocity due to the sodium gradient, and in a 
change in the affinity of dopamine for DAT. The reported allosteric efficacy of ~2 for 
DA binding was observed as well for SERT89. These results are consistent with the 
findings for LeuT, and suggest that K-type allosteric coupling between Na+ and 
substrate binding discussed in the previous Sections is a fundamental component of 
the family’s transport mechanism. Interestingly, the more recent x-ray structures90–92 
and homology models93,94 of sMATs found that the Na+ ions do not interact directly 
with the substrate as is seen in LeuT65, indicating that the coupling can be 
accomplished via more than one structural mechanism.   
The presence of an allosteric coupling between ligand binding and the proposed 
extracellular and intracellular gates of the sMATs had been inferred from structure-
function analysis with a variety of approaches by monitoring ligand-induced 
conformational changes with the substituted cysteine accessibility method (SCAM)95–
98. In DAT, such experiments in which the sensitivity of extracellular and intracellular 
cysteine point mutants to reaction with methanethiosulfonate was monitored, revealed 
that the binding of cocaine, a transport inhibitor, increased the accessibility of 
extracellular residues, while decreasing the accessibility of intracellular residues95. 
The binding site of cocaine was unknown at the time, and these results suggested that 
cocaine locked DAT in a conformational state with outward-open/inward-closed 
characteristics. To various degrees, combinations of such conformational changes 
were identified for other substrates and inhibitors as well, clearly demonstrating a 
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coupling between accessible conformations and ligand binding97. The finding that 
homologous intracellular residues in SERT were also shown to be less reactive after 
binding serotonin or cocaine99,100 reinforced the consideration of common coupling 
mechanisms in the sMAT family. The structural context for such coupling 
mechanisms was offered recently by x-ray structures of drosophila DAT (dDAT) 
bound to various inhibitors90–92, including cocaine, as well as dopamine, which were 
found in outward open/inward closed configurations. Furthermore, the intracellular 
Cys342 in DAT was shown to become more reactive during Na+-dependent, inward 
transport of the substrate m-tyramine, and this was interpreted as an indication that an 
opening of this intracellular region was required for transport98.  
Other structure-function studies also pointed to residues in the intracellular domain 
that were involved in determining the intracellular conformation equilibrium. 
Specifically, an endogenous Zn2+ binding site in DAT was used to show that while 
Zn2+ binding usually inhibits transport101, the Y355A transport-inactivating mutation 
reversed this effect of Zn2+ binding, so that Zn2+ activated transport in the inactive 
mutant102. The Y355A mutant also decreased the affinity of cocaine-like inhibitors, 
suggesting that this tyrosine was somehow required for the stabilization of an inward-
closed conformation usually associated with cocaine binding.  
Computational analysis of the conformational changes associated with the Y355A 
mutation in models of hDAT constructed by homology to LeuT attributed the effects 
to the role of Y355 as part of the conserved intracellular network described in 86. 
Indeed, mutations of other residues in this network, R60A and D436A, were shown to 
lead as well to transport inhibition, and to activation of transport by Zn2+ binding86. 
The proposed mechanism for the effects of these mutations was the stabilization of an 
inward open state, and this was confirmed when the homologous mutations in LeuT 
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(Y265A and R5A) were examined with smFRET84, EPR66, and x-ray crystallography72 
and found to stabilize the inward open state (for details see above).  
A LeuT-based hDAT homology model was further used to investigate the 
conformational changes associated with substrate release, as well as the existence and 
mechanistic role of the secondary substrate binding site S2 in the extracellular 
vestibule that had been previously identified in LeuT93. By using an SMD procedure 
based on the one used to study LeuT68, a homologous S2 site was identified in hDAT, 
and so were many of the same conformational changes observed in LeuT during the 
transition to an inward-open conformation.  
1.1.3. Ligand-Specific Allosteric Modulation 
While allostery is well documented in both GPCRs and transporters, the simple 
models of allostery described in Section 1.1.1.2. Theoretical Background are not 
sufficient to describe many new functional observations. In particular, growing 
evidence suggests that the functions of these two classes of membrane proteins 
(GPCRs and transporters) are not binary. GPCRs are not simply active or inactive, and 
transporters do not simply transport whatever substrate can bind to their substrate 
binding site. Instead, the allosteric modulation of functional equilibrium and kinetics 
function appears to be ligand-specific. In the section below, we refer to this new 
behavior as ligand-specific allosteric modulation.  
1.1.3.1. Ligand-specific Allosteric Modulation in GPCRs 
The traditional allosteric receptor activation model assumes the receptor is 
phenomenologically a two-stat system (active and inactive, in respect to its ability to 
activate a G protein) and also assumes that ligand binding modifies the relative energy 
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of the two states without modulating the distribution (or ensemble) of conformations 
within those states. However, this model predicts that a GPCR only has a single mode 
of activation. This prediction has been long contested by the observation that GPCRs 
can activate many different G proteins (e.g., Gi, Gs, and Gq) to different extents103, in 
addition to signaling through of arrestin104,105. However, if one invokes a phenomenon 
known as “biased signaling”, the two-state model’s parsimony is preserved. It has 
been observed that different receptors can have their own inherent efficacy for 
activating different pathways, due to differences in either sequence or structure, and 
thus it would be expected that there exists receptor-specific active and inactive states, 
and each receptor can still be a two-state system. While biased signaling can explain 
multi-model signaling with different efficacies profiles, the two-state model has 
recently been refuted by the observation that ligands of differing structures that target 
the same receptors appear to activate these multi-model signaling profiles in ligand 
specific manners (for examples, see 106). The preferential activation of specific 
signaling or downstream phenotypes is referred to as “functional selectivity” or 
“biased agonism”107,108,109. The existence of functional selectivity requires a more 
complex model for GPCR activation. This new model must either i) allow for more 
“active” states, i.e. at least one state per potential signaling modality, ii) allow for 
ligand-specific active states, i.e. that the character of the active state is modulated by 
the ligand itself, or iii) some combination of the two, i.e. within the active state there 
are substates that are involved in activating different signaling modalities, and thus the 
overall active state is stabilized by all agonists, but the specific distribution of 
functional substates are modulated differently depending on the agonist. However, 
multiple activate states present a major problem for crystallography, which has 
generally relied on the assumption that ligands stabilize a single crystallographically 
resolved structure given their two-state pharmacology. If many different active states 
	  60	  
exist, which of these states have been captured in past structures? Can these states be 
observed without the downstream effector bound? The second model, in which the 
active state is specific to the ligand, also presents a problem crystallographically, as it 
would be difficult to infer the activation mechanism of a GPCR by one ligand based 
on previously solved structures of that GPCR with other ligands, unless their 
activation profiles are significantly similar. However, mass spectroscopy studies of 
β2AR support the second model. The accessibility of nine endogenous cysteine and 
lysine residues to reaction with N-ethylmaleimide and succinic anhydride reagents 
was quantified, and compared for nine ligands of differing pharmacology. While two 
residues, Cys772.48 and Cys3277.54, were found to respond in accordance with the 
pharmacological class of the ligand (agonist versus antagonist/inverse agonist), many 
other residues were found to respond in a ligand-specific manner without any 
correlation with the functional output of the ligand (see Figure 10). These data 
suggested that while GPCRs may have somewhat discrete active and inactive states, 
these active states display significant ligand-specific character, which is currently not 
understood through any physical mechanism.
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Figure 10. Ligand-specific allosteric modulation of β2AR.  
Top: effects of nine β2AR ligands on neM reactivity at cys77 (a) and at cys327 (b). 
Bottom: (a–g) The effects of various ligands on the changes in the l-factors of seven 
different sites of the β2AR, expressed relative to the receptor without ligand: cys125 
(a), lys140 (b), lys227 (c), lys235 (d), lys263 (e), cys265 (f) and lys305 (g). Data 
correspond to the means ± standard errors from at least three independent experiments. 
Asterisks indicate statistical significance (*P < 0.05) compared to control receptor 
alone by one-way ANOVA. 
1.1.3.2. Ligand-Specific Allosteric Modulation in Transporters 
While LeuT does transport leucine, it does so at an incredibly slow rate (vmax = 334 
pmol/min/mg)110.  In contrast, LeuT transports alanine much more efficiently (vmax = 
1730 pmol/min/mg)110, and thus alanine has become a popular substrate for functional 
	  62	  
and dynamics experiments. Interestingly, smFRET experiments85 reveal that unlike 
leucine, which closes the intracellular gate and reduces dynamics, alanine increases 
the dynamics at the intracellular end of the transporter without altering the relative 
populations of each state with a β value of  ~ 5. The differential effects of the 
substrates and their consequences for the transport function led to the proposition85,111 
that the increased dynamics are responsible for the increased vmax measured 
experimentally. This proposal is consistent with the theoretical result encoded in 
(1.60), namely that the velocity of transport can be increased by a greater rate of 
inward opening, and not necessarily by an increase in the equilibrium population of 
that inward open state. 
However, while this striking observation of ligand-specific allosteric can be linked to 
transport on a theoretical level, the physical basis for this allosteric effect was 
unknown at the time. While several x-ray structures of LeuT bound to various 
substrates in S1 have been solved110, nearly all of them were identical in terms of Cα 
RMSD, with only very minor differences in the binding pocket. Furthermore, these 
structures were for the most part the same state as the original leucine-bound structure 
– only tryptophan crystallized in a new state, which was outward open with tryptophan 
bound in both S1 and S2. With these structures alone, it is not possible to make any 
strong hypotheses regarding the mechanism of allosteric modulation of intracellular 
gating, nor is it clear as to how the various substrates of different transport efficacies 
were engaging that mechanism differently. These open questions will be addressed in 
this dissertation.  
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1.2. Dissertation Overview 
The existence of ligand-specific allosteric modulation in both transporters and GPCRs 
emphasizes the importance of understanding how allostery works in these systems in 
term of atomic-level physical mechanism. In order to understand how ligand-specific 
allostery occurs, a general model of allostery that allows for ligand-specific allosteric 
modulation is required, and thus it must be a physical model rather than a 
phenomenological model. The overarching hypotheses driving the work described in 
this dissertation is that proteins such as transporters and GPCRs are intrinsically 
allosteric (i.e. structural components are allosterically coupled in the absence of 
external perturbations) and that ligand-specific allosteric modulation is due to 
differential engagement of structural components involved in the protein’s intrinsic 
allosteric behavior (i.e. the response of the receptor to ligands with different 
pharmacological profiles is the results of ligand-specific engagement of the structural 
components involved in activation). Towards that goal, the work described in this 
dissertation will focus on two specific aims: i) the development of theoretical models 
that provide insight into the structural and dynamic features required for systems to be 
allosteric, and ii) the development of computational methods that can identify these 
features in specific systems of interest. The utility of these aims will be demonstrated 
through application to the membrane transporters LeuT and DAT, and the serotonin 
receptor 5-HT2AR. In specific, these advances will be used to i) generate new 
understanding regarding the ligand-specific allosteric effects that have been observed 
in these systems, and ii) generate novel hypotheses that can be addressed 
experimentally. 
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2. Theoretical Models and Computational Methods 
The following section will describe theoretical models and computational methods 
that were developed towards the goals of the dissertation. The section is divided into i) 
Allosteric Ising Models, a theoretical model for allostery that can be related 
analytically to the allosteric efficacy for simple systems, ii) N-body Information 
Theory Analysis, a computational method for identifying allosteric channels in 
proteins, and iii) a random forest-based method for differentiating class-specific 
allosteric modulation from ligand-specific allosteric modulation.  
2.1. Allosteric Ising Models 
Note: much of the text in this chapter has been adapted from a previously published 
manuscript2 with permission from the publisher.  
2.1.1. Motivation for Model 
As described in Section 1.1.1.2. Theoretical Background, the allosteric efficacy is a 
powerful tool for quantifying the allosteric coupling between molecular processes. 
However, it provides only a phenomenological explanation of allostery. According to 
the description, often considered “the thermodynamic” perspective, allostery occurs 
because of the differences in free energy of the respective states. However, this 
conclusion appears to be a definition, i.e. that allostery is the phenomena in which that 
the stability of the on state relative to the off state is greater when the ligand is bound, 
and lesser when the ligand is unbound. From a “structural” perspective, one needs to 
consider the differences in free energy as emerging from some feature of the 
underlying network of interacting structural components, and it is this feature that 
makes the system allosteric.  
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To understand allostery at a level that explains how allosteric biomolecular systems 
work in a structural context requires a quantitative theoretical description that bridges 
the features of the structural components and their interactions, to the thermodynamic 
allosteric parameters.   
2.1.1.1. Previous Statistical Mechanical Models of Allostery 
While the structural features of proteins are often invoked when attempting to describe 
the physical mechanism underlying a particular allosteric response in a particular 
system, little has been done to construct a theory which can describe how the 
energetics of individual structural components and networks of their interactions 
between them leads to the emergence of allostery. At the thermodynamic level, 
allostery can be described through the free energy of specific states, and thus a theory 
of allostery must be able to calculate probabilities of specific states system and express 
those probabilities in terms of the system’s potential energy function. One model that 
comes close to providing this level of insight in the framework of statistical mechanics 
is the ensemble allosteric model (EAM)112, which describes multi-component 
cooperative systems. For the sake of brevity, we will describe the model in terms of a 
two-component cooperative system, although the model is not limited in size in 
theory. In the EAM, each component of the system has two states, R or T, but the 
system is not presumed to be a homo-oligomer. The reference state is taken to be RR. 
The free energy difference between each other possible state (TR, RT, TT) from RR is 
expressed as a change in free energy due to the conformational change, and then a 
change free energy due to the interaction between the domains. There is an identical 
change in free energy due to the interaction between the domains for all non-RR 
states. From here, the partition function can be calculated (see Figure 11). To account 
of the effect of ligand binding, it is assumed that ligands can bind their respective 
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domains only when the domain is in the R state. Given that assumption, one can 
calculate how the binding of ligand B binding in domain 2 modulates the binding of 
ligand A in domain 1 by calculating the change in probability of state RR when the 
free energy of states RR and TR is increased or decreased by a given ligand binding 
energy. 
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Figure 11. The two-domain ensemble allosteric model.  
(a) A hypothetical two-domain protein (blue and orange boxes) contains effector and 
active sites. (b) Each state of the two-domain protein (RR, TR, RT, and TT), where the 
T state is denoted as a grey random loop. The free energy differences from the RR 
state, the statistical Boltzmann weight, and the probability are shown for each. (c) The 
relative free energy of the states before and after ligand binding. The values used for 
this example are ΔG1 = −0.7 kcal mol−1, ΔG2 = −2.3 kcal mol−1, Δgint = +1.6 kcal 
mol−1, ΔgLig,B = −3.0 kcal mol−1. Reproduced from 112.  
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To quantify the allostery in these systems, the allosteric efficacy is not calculated, 
although it is possible. Instead, the coupling response (CR) is calculated: 
 CR = pB RR( ) + pB RT( )− p RR( )− p RT( )log ZB( )− log Z( )
  (1.65) 
The CR describes the change in probability relative to the amount of free energy 
introduced into the system due to the binding of ligand B.  
The EAM suffers from some severe limitations that narrow the applicability of its 
predictions. First, while it is not required, the model assumes that a ligand can only 
bind to the R state of its corresponding domains, which is referred to as the “high 
affinity state”. This is assumption is non-physical, and implicitly assumes that the 
allosteric efficacy for the “activation” of any binding domain by its ligand is INF, 
which is contradicted by the known existence of ligands that bind at the same site of 
the same protein with similar affinities and yet have different allosteric effects in terms 
of agonism/antagonism/inverse agonism. In the EAM, the allosteric effect is encoded 
in the coupling between the domains, and thus does not allow for different ligands to 
differentially modulate the same system. Even if the “high affinity state” is switched 
from R to T to model an antagonist, partial agonism and antagonism is not possible. 
Thus, it is necessary to add the ability of the ligand to bind both states is required. 
Additionally, the use of CR rather than allosteric efficacy as a quantification of 
allostery leads to apparent insights that are actually just artifacts of the CR function. 
For example, as the CR uses raw changes in probabilities, changing the free energy of 
the R and T states by the same amount will always result in a larger CR if the R state 
was initially low probability. Thus, the prediction that systems that begin in the T state 
are more allosteric is simply due to the construction of the CR measure. Furthermore, 
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while it has been claimed that the EAM model proves that a structural pathway for 
allosteric coupling is unnecessary, this apparent insight is due to the use of an 
unreasonable interaction term. There is no reason for the interaction energies between 
domains for the RT, TR, and TT states to be equivalent, and they likely are not. 
Instead, each state may have a potentially unique interaction energy term, which 
would result in a minimum of two more parameters in the model. While some of these 
parameters can be assumed to be merged into the conformational free energy changes, 
the EAM can only be recovered when ΔGint(RT) + ΔGint(TR) = ΔGint(TT), which is an 
added constraint that has no justification. In fact, the value of four potentially unique 
interaction energies is likely to relate to the specific type of interactions that can be 
formed between the differing conformations of the domains, i.e. their values report on 
something about how the two domains are interacting physically.  
In the following sections, we will present a statistical mechanical model for allostery 
that is constructed to i) include the allosteric efficacy of a ligand for shifting the 
conformation of its binding site, ii) naturally express the allosteric efficacy of a ligand 
for shifting the conformation of an allosteric site in terms of the model parameters, and 
iii) include the presence of allosteric modulation through indirect coupling through 
intermediate structural elements.  
2.1.2. Derivation and Results 
2.1.2.1. The allosteric efficacy as a function of local interactions  
We approach the problem of formulating a theory of “how allostery works” by 
studying the statistical mechanics of a system of interacting structural components. 
These structural components may be any subset of a biomolecular system that can be 
treated as a unit when described at some level of coarse-graining (i.e, a helix, a β 
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strand, a helical bundle, a binding site, etc). The approach we will pursue is 
conceptually similar to the EAM112, but with the goal of introducing a structural 
context that can be analyzed analytically. Defining an n-component system X where 
for a single configuration each component can be in one of m states, we write the 
potential energy function of a given configuration of X, U(X), as 
 
 
U X( ) = Uconf Xi( )
i=1
n
∑ +
Uint Xi,X j( )
2j=1
n
∑
i=1
n
∑   (1.66) 
The first term in (1.66) represents the conformational energy of each state of each 
component independent of other components, and the second term represents the 
pairwise interaction energy between components; all interaction terms when i = j are 
0. We can write the probability of any conformation of the system according to the 
Boltzmann distribution as: 
 
 
p X( ) = e
−βU X( )
Z
  (1.67) 
β is 1/kBT, where kB is the Boltzmann constant and T is the temperature in Kelvin. The 
numerator is known as the Boltzmann factor, and Z is the partition function, which 
sums over the Boltzmann factors of all states and normalizes the probability 
  Z = e
−βU X( )∑   (1.68) 
We can then define the specific case of ligand binding to a two-state receptor. This 
system can be defined as a two-component system in which each component is two-
state: one component representing the receptor, R, with states on and off, and the 
second component representing the ligand, L, with states bound and unbound. It 
should be noted that for the ligand, the conformational energy term represents the 
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component of the binding energy that is independent of the state of the receptor. Using 
the explicit definition of the concentration: 
 
 
X⎡⎣ ⎤⎦ =
NX
V
  (1.69) 
where Nx is the number of molecules of X and V is the volume, we can rewrite (1.7) 
with the explicit definition of protein concentration,   
 
 
K =
Nfon
V
Nfoff
V
=
fon
foff
  (1.70) 
where N is the total number of receptors and fon and foff are the fraction of receptors in 
the on and off states, respectively. Given that the system is ergodic, the frequency of a 
given state at steady state will converge to the ensemble probabilities. Rewriting (1.7) 
by substituting thermodynamic equilibrium constants with ratios of probabilities, we 
can define the allosteric efficacy as 
 
 
α
p L = unbound,R = on( )
p L = unbound,R = off( ) =
p L = bound,R = on( )
p L = bound,R = off( )   (1.71) 
Using (1.67) and (1.68), we can write (1.71) as 
 
 
α e
−β Uconf L=unbound( )+Uconf R=on( )+Uint L=unbound,R=on( )⎡⎣ ⎤⎦
e
−β Uconf L=unbound( )+Uconf R=off( )+Uint L=unbound,R=off( )⎡⎣ ⎤⎦
= e
−β Uconf L=bound( )+Uconf R=on( )+Uint L=bound,R=on( )⎡⎣ ⎤⎦
e
−β Uconf L=bound( )+Uconf R=off( )+Uint L=bound,R=off( )⎡⎣ ⎤⎦
 (1.72) 
Equation (1.72) reduces to 
  α = e
−β Uint L=bound,R=on( )−Uint L=bound,R=off( )( )+ Uint L=unbound,R=off( )−Uint L=unbound,R=on( )( )⎡⎣⎢ ⎤⎦⎥   (1.73) 
We then find the analogous expression of (1.18): 
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− 1
β
log α( ) = Uint L = bound,R = on( )− Uint L = bound,R = off( )( ) + Uint L = unbound,R = off( )− Uint L = unbound,R = on( )( )  (1.74) 
As (1.74) indicates, the allosteric efficacy is a function the interaction energy between 
the states, and we have succeeded in expressing the thermodynamic allosteric efficacy 
as a function of local interactions in our simple two-component ligand/receptor 
system. However, this result is significantly more useful for considering multi-
component systems if additional energetic symmetries are imposed by using an Ising 
model potential energy function. While these symmetries are not strictly realized in a 
biomolecular system, we will show that their application leads to concise analytic 
expressions that are qualitatively and quantitatively accurate as well for systems in 
which these symmetries are not present. 
2.1.2.2. The Allosteric Ising Model (AIM) for multicomponent systems 
The Ising model is a statistical mechanical model originally developed to describe 
phase behavior in ferromagnetic materials 113. The Ising model, as well as Ising-like 
models, have since been applied to other complex systems with collective behavior 
114,115, including cooperativity during folding 116–118 and in oligomeric assemblies  
119,120. In the Ising model, each particle has two states, corresponding to a spin state of 
up or down 
 
 
sX =
−1 X =↓
1 X =↑
⎧
⎨
⎪
⎩⎪
  (1.75) 
The potential energy function of an n-component Ising model is: 
 
 
U X( ) = − hisi
i=1
n
∑ −
jij
2j=1
n
∑
i=1
n
∑ sis j   (1.76) 
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In the Ising model, hi is the potential energy of particle i due to the magnetic field, and 
jij is the spin coupling between particles i and j, where jii is taken to be 0. If the field 
term is taken to be site-specific, one can see that the field term can be considered to 
correspond to the conformational energy, and the spin coupling term to the pairwise 
interaction energy. We can rewrite the potential function as: 
 
 
U X( ) = uiconfsi
i=1
n
∑ +
ui,j
int
2
si
j=1
n
∑
i=1
n
∑ s j   (1.77) 
where  ui
conf
 is the conformation energy of component i and  
ui,j
int
  is the interaction 
energy of components i and j. By using (1.77) for the potential energy function, we 
impose the following symmetries on the two-state components (with binary states 
represented by up and down arrows): 
 
 
Uconf X =↑( ) = −Uconf X =↓( )
Uint Xi =↑,X j =↑( ) = Uint Xi =↓,X j =↓( ) = −Uint Xi =↑,X j =↓( ) = −Uint Xi =↓,X j =↑( )
 
 (1.78) 
For Ising models composed of several components and various interaction topologies, 
these symmetries allow for concise analytical expression for the allosteric efficacy and 
binding affinity. We will refer to these models as Allosteric Ising Models (AIMs).  
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Figure 12. Schematic representations of allosteric Ising models (AIMs). 
In the 4 AIMs analyzed here the ligand, L, is represented as a red triangle, and the 
protein is the blue circle subdivided into various constituent structural components. 
Lines separating ligand from protein or protein structural components from each other 
are labeled with the appropriate interaction energy term (as used in the text). Allosteric 
effective interactions are represented with green dotted lines. The schemes in (A) to 
(D) represent, respectively: (A): The simple two-component ligand/receptor system. 
(B): A three-component ligand/receptor system with two allosteric sites, A1 and A2. 
(C):  A three-component ligand/receptor system with one channel, C, coupling the 
ligand and the allosteric site A. (D): A four-component ligand/receptor system with 
two channels, C1 and C2, coupling the ligand and the allosterically coupled site A. 
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Considering the analogy to the ligand(L)-receptor(R) systems and treating the on/off 
and bound/unbound states as up/down spins (see Figure 12A), the potential energy 
function according to (1.77) can be written as: 
 
 
U sL ,sR( ) = uLconfs L+uRconfs R+uL,Rint s Ls R   (1.79) 
As the interaction energy between the receptor and the ligand must be zero when the 
ligand is in the unbound state, we write an alternative non-Ising potential energy 
function where the interaction energy is 0 when the ligand is unbound: 
 
 
U sL ,sR( ) = uLconfsL + uRconfsR + uL,Rint sL +12 sR   (1.80) 
This equation can be re-written as an Ising model potential energy function: 
 
 
U sL ,sR( ) = uLconfsL + uRconf +
uL,R
int
2
⎛
⎝
⎜
⎞
⎠
⎟ sR +
uL,R
int
2
sLsR   (1.81) 
Thus we will proceed with (1.79) despite the seemingly non-physical interaction, and 
later confirm that the relationships derived using this model accurately represent those 
of non-Ising systems. The allosteric efficacy using this potential energy function is: 
 
 
α
p L =↓,R =↑( )
p L =↓,R =↓( ) =
p L =↑,R =↑( )
p L =↑,R =↓( )   (1.82) 
and we can simplify (1.73) to: 
  α = e
−4βuL,R
int
  (1.83) 
Equation (1.83) indicates that in the Allosteric Ising Model for the ligand/receptor 
system (“ligand/receptor AIM”), the allosteric efficacy is simply a function of the 
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ligand-receptor interaction energy term. Positive allostery (agonism) is attributed to 
negative interaction energy; negative allostery (inverse agonism) is attributed to 
positive interaction energy. Note that as the interaction energy between the ligand and 
receptor is related to the allosteric efficacy by a log transformation, we will use here 
the allosteric efficacy and interaction energy interchangeably, and specifically use 
interaction energy for visual representations, where the log scale is required.  
The two-component model assumes that the protein is entirely rigid, with two global 
states. However, it is possible for the ligand to allosterically modulate multiple distinct 
allosteric sites (see Figure 12B). It is well known that GPCRs can signal through 
multiple downstream signaling pathways through coupling to various G protein 
subtypes and β arrestin121,122, and that different ligands can differentially activate these 
pathways106,107. This distinction is therefore necessary in the representation of receptor 
allostery. If we introduce two non-interacting allosteric sites, A1 and A2, we can write 
the potential energy function as: 
 
 
U L,A1,A2( ) = uLconf + uA1conf + uA2conf + uL,A1int + uL,A2int   (1.84) 
Then the allosteric efficacy at a site as: 
 
 
α
p L =↓,A1 =↑( )
p L =↓,A1 =↓( )
=
p L =↑,A1 =↑( )
p L =↑,A1 =↓( )
  (1.85) 
The probabilities of each state is the sum of the probability of two underlying states: 
 
 
αL,A1
p L =↓,A1 =↑,A2 =↑( ) + p L =↓,A1 =↑,A2 =↓( )
p L =↓,A1 =↓,A2 =↑( ) + p L =↓,A1 =↓,A2 =↓( )
=
p L =↑,A1 =↑,A2 =↑( ) + p L =↑,A1 =↑,A2 =↓( )
p L =↑,A1 =↓,A2 =↑( ) + p L =↑,A1 =↓,A2 =↓( )
  (1.86) 
which is equal to: 
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αL,A1
e
−β −uL
conf +uA1
conf +uA2
conf −uL,A1
int −uL,A2
int⎡
⎣⎢
⎤
⎦⎥ + e
−β −uL
conf +uA1
conf −uA2
conf −uL,A1
int +uL,A2
int⎡
⎣⎢
⎤
⎦⎥
e
−β −uL
conf −uA1
conf +uA2
conf +uL,A1
int −uL,A2
int⎡
⎣⎢
⎤
⎦⎥ + e
−β −uL
conf −uA1
conf −uA2
conf +uL,A1
int +uL,A2
int⎡
⎣⎢
⎤
⎦⎥
= e
−β uL
conf +uA1
conf +uA2
conf +uL,A1
int +uL,A2
int⎡
⎣⎢
⎤
⎦⎥ + e
−β uL
conf +uA1
conf −uA2
conf +uL,A1
int −uL,A2
int⎡
⎣⎢
⎤
⎦⎥
e
−β uL
conf −uA1
conf +uA2
conf +uL,A1
int −uL,A2
int⎡
⎣⎢
⎤
⎦⎥ + e
−β uL
conf −uA1
conf −uA2
conf −uL,A1
int −uL,A2
int⎡
⎣⎢
⎤
⎦⎥
  (1.87) 
This reduces to: 
 
 
αL,A1 = e
−4βuL,A1
int
  (1.88) 
which indicates that the allosteric efficacy of a ligand for an allosteric site is 
independent of other allosteric sites it also modulates (provided the allosteric sites are 
not coupled through another interaction). In terms of receptor signaling, this analysis 
predicts that for ligands with absolute bias for only one signaling pathway to exist, the 
downstream effectors (i.e., G proteins, β arrestin) would need to interact with unique 
and independent allosteric sites.  
In addition to the existence of multiple allosteric sites, allosteric conformational 
coupling can be propagated through specific regions within the protein, often called 
“paths” or “channels”. Using the AIM approach described here, we can expand the 
treatment of allostery to proteins with multiple structural components, where some 
components are allosterically regulated, and some mediate the allosteric regulation. 
We begin with a three-component model, composed of the ligand L, a channel C, and 
an allosteric site A (see AIM represented in Figure 12C). The potential energy 
function is 
 
 
U L,C,A( ) = uLconfsL + uCconfsC + uAconfsA + uL,Cint sLsC + uC,Aint sCsA + uL,Aint sLsA   (1.89) 
The allosteric efficacy is then 
 
 
αL,A1
e
−β −uL
conf +uC
conf +uA
conf −uL,C
int −uL,A
int +uC,A
int⎡
⎣
⎤
⎦ + e
−β −uL
conf +uC
conf −uA
conf −uL,C
int +uL,A
int −uC,A
int⎡
⎣
⎤
⎦
e
−β −uL
conf −uC
conf +uA
conf +uL,C
int −uL,A
int −uC,A
int⎡
⎣
⎤
⎦ + e
−β −uL
conf −uC
conf −uA
conf +uL,C
int +uL,A
int +uC,A
int⎡
⎣
⎤
⎦
= e
−β uL
conf +uC
conf +uA
conf +uL,C
int +uL,A
int +uC,A
int⎡
⎣
⎤
⎦ + e
−β uL
conf +uC
conf −uA
conf +uL,C
int −uL,A
int −uC,A
int⎡
⎣
⎤
⎦
e
−β uL
conf −uC
conf +uA
conf +uL,C
int −uL,A
int −uC,A
int⎡
⎣
⎤
⎦ + e
−β uL
conf −uC
conf −uA
conf −uL,C
int −uL,A
int +uC,A
int⎡
⎣
⎤
⎦
 (1.90) 
Equation (1.90) simplifies to 
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αL,A = e
−4βuL,A
int cosh 2β uL,C
int + uC,A
int( )( ) + cosh 2βuCconf( )
cosh 2β uL,C
int − uC,A
int( )( ) + cosh 2βuCconf( )   (1.91) 
where cosh is the hyperbolic cosine function, 
 
 
cosh x( ) = e
x + e−x
2
  (1.92) 
It should be noted that the exponential term in (1.91) is the conditional allosteric 
efficacy (i.e. the allosteric efficacy contributed by the direct interaction between the 
two components). The conditional allosteric efficacy can be written as the sum of 
weighted allosteric efficacies, with each allosteric efficacy conditioned on a different 
state of the channel and then weighted by the corresponding probability of that state: 
 
 
αL,A C = p C =↑( )αL,A C=↑ + p C =↓( )αL,A C=↓   (1.93) 
where for a given state, s, of C, 
 
 
αL,A C=s =
p L =↑,A =↑,C = s( )p L =↓,A =↓,C = s( )
p L =↑,A =↓,C = s( )p L =↓,A =↑,C = s( )   (1.94) 
Equation (1.94) simplifies to 
 
 
αL,A C = e
−4βuL,A
int
  (1.95) 
Comparing (1.95) with the allosteric efficacy of the two-component ligand/receptor 
system expressed in (1.83), it is clear that the conditional allosteric efficacies in the 
three-component system are simply the allosteric efficacies of the corresponding two-
component systems.  
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We can then differentiate the allosteric efficacy contributed by the direct interaction of 
two components, the conditional allosteric efficacy, from the indirect contributions 
and write: 
 
 
αL,A = αL,A CαL,A
indirect   (1.96) 
where the allosteric efficacy contributed by the indirect interaction is: 
 
 
αL,A
indirect,C =
cosh 2β uL,C
int + uC,A
int( )( ) + cosh 2βuCconf( )
cosh 2β uL,C
int − uC,A
int( )( ) + cosh 2βuCconf( )   (1.97) 
Importantly, (1.97) provides a description of the allosteric efficacy as a function of the 
channel through which it is propagated. There are immediate inferences that can be 
drawn from this representation. First, the channel must have little preference for either 
one of its conformations, so that signaling through it can have a high intrinsic signal-
to-noise ratio. Based on this inference, mutations that further stabilize the intrinsically 
preferred conformation of a channel will decrease the allosteric efficacy of a ligand, 
whereas mutations that destabilize that conformation will increase the allosteric 
efficacy. The existence of these two classes of mutations has immediate implications 
for the ability to test experimentally the role of specific domains in allosteric 
signaling. Second, because allosteric transmission through the channel depends on a 
balance between the channel’s conformational energy and the interaction energy 
between the channel and ligand, and the channel and allosteric site, it follows that a 
low intrinsic signal-to-noise ratio can be overcome by an increased coupling of the 
ligand to the channel. Lastly, if the sign of the coupling of the ligand to the channel is 
opposite that of the channel to the allosteric site, the allosteric signal can be reversed. 
Consequently, a binding site on a protein that has been evolved for positive allostery 
by endogenous ligands can be targeted as a site for negative allosteric modulation, 
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and vice versa. It is well known that endogenous agonist-binding sites can be targeted 
by inverse-agonists, so this result is anchored in experimental evidence.  
Comparison of (1.94) with (1.95) indicates that the allosteric efficacy can be written in 
terms of the conditional allosteric efficacies due to direct interactions: 
 
 
αL,A = αL,A C
cosh 1
2
log αL,C AαC,A L( )⎛⎝⎜ ⎞⎠⎟ + cosh 2βuCconf( )
cosh 1
2
log
αL,C A
αC,A L
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
+ cosh 2βuC
conf( )
  (1.98) 
In effect, the conditional allosteric efficacy is the signal-to-noise ratio for a single step 
in the signal propagation process, and the effective signal-to-noise ratio for the entire 
signal propagation system can be described by a non-linear function of all the 
constituent propagation steps.  
Equation (1.98) can also be written as the effective interaction energy,  
uL,A
int ∗
  
 
 
uL,A
int ∗ = uL,A
int − 1
4β
log
cosh 2β uL,C
int + uC,A
int( )( ) + cosh 2βuCconf( )
cosh 2β uL,C
int − uC,A
int( )( ) + cosh 2βuCconf( )
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
  (1.99) 
and thus as the sum of the direct and indirect interactions 
 
 
uL,A
int ∗ = uL,A
int + uL,A
indirect,C   (1.100) 
It should be noted that the designation of channel versus allosteric site is purely an 
operational definition in which the site that performs the function of interest is referred 
to as the allosteric site. If both sites are functional, such as in the case of two 
independent allosteric sites described above, and if they interact, we can rewrite (1.98) 
as 
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αL,A1 = αL,A1 A2
cosh 1
2
log αL,A2 A1αA1,A2 L( )⎛⎝⎜ ⎞⎠⎟ + cosh 2βuA2conf( )
cosh 1
2
log
αL,A2 A1
αA1,A2 L
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
+ cosh 2βuA2
conf( )
  (1.101) 
The description of the allosteric efficacy as a function of the channel through which it 
is propagated, in (1.97), indicates that if the channel is a one-dimensional chain of 
interacting structural components, the allosteric efficacy is quickly diminished (it has 
been shown that the spin correlation function decays exponentially with distance in 
one-dimensional Ising models 113).  In Figure 13, the effective interaction energy 
between the first and last components of one-dimensional Ising chains with uniform 
conditional allosteric efficacies of 10, 100, 1000, 10000, and 100000 are shown as a 
function of chain length. For weakly interacting systems, channels formed by 
structural components interacting in series do not appear to be good mediators of 
allosteric efficacy. The prevalence of multi-segment transmembrane signaling 
complexes may indicate an evolutionary mechanism to overcome the limitations of 
serial channels. 
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Figure 13. The effective interaction energy through serial channels. 
Effective interaction energies of the first and last components of one-dimensional 
Ising chains are plotted as a function of chain length for direct allosteric efficacy 
values of 10 (black), 100 (blue), 1000 (purple) 10000 (red) and 100000 (orange). The 
inset shows detail for short chain lengths. The effective interaction energy is seen to 
decay exponentially with channel length. 
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As described above, this analysis is made possible through the energetic symmetries 
imposed by the Ising model. However, it is unlikely that these energetic symmetries 
exist in real allosteric proteins. Thus, it is important to consider how well the 
relationships derived from AIMs describe non-Ising two-state models, which are 
expected to be better representations of the types of interaction networks present in the 
biomolecular systems of interest.  
To consider this problem, we sampled 100,000 non-Ising two-state allosteric systems 
with interaction energies and configurational energies sampled from normal 
distributions of mean 0 and standard deviation of β-1, 3/β, or 5/β.  The exact allosteric 
efficacies, calculated from the exact probabilities of each state, were then compared to 
the allosteric efficacies estimated from (1.98) using the direct allosteric efficacy terms.  
We should note that while direct allosteric efficacies can be calculated for non-Ising 
model, the calculation of the configuration energy term followed 
 
 
2uC
conf ≈ Uconf C =↑( )− Uconf C =↓( )   (1.102) 
As above, we addressed problems that may arise from the non-physical interaction 
energy between unbound ligand and the protein by setting to 0 all interaction energies 
with the unbound ligand. Results of these calculations are shown in Figure 14, where 
the corresponding effective interaction energies have been used for clarity. Our 
calculations indicate that (1.98) is a good estimate of the true allosteric efficacy in 
non-Ising systems in which the allosteric efficacy is high (see Figure 14A). As the 
standard deviation on the energy term distribution increases, and more systems have 
significant deviation from Ising-like behavior, two distinct groups of false positives 
(exact effective interaction energy is 0 but estimated interaction energy is non-zero) 
and true negatives appear (exact effective interaction energy is non-zero but estimated 
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interaction energy is 0), but the sign of the allosteric modulation is conserved (see 
Figure 14B-C). That the model maintains high accuracy for systems with high 
allosteric efficacy in spite of the two groups of inaccuracy, suggests that this model 
should reflect many of the qualitative and quantitative properties of actual allosteric 
systems. 
 
Figure 14. Using the Ising model to estimate effective interaction energies in non-
Ising three-component/two-state systems.  
The exact effective interaction energies of 100,000 three-component/two-state non-
Ising systems are plotted against the effective interaction energy estimated using the 
equations derived for the three-component Ising model. The systems are generated 
using energy terms sampled from a normal distribution of mean 0 and standard 
deviation of 1/β (A), 3/β (B), and 5/β (C) and the points are plotted with 10% opacity. 
Efforts to identify allosteric sites and channels in the structures of functional 
biomolecules have utilized estimates of correlation or mutual information between the 
structural dynamics of known allosteric sites and candidate modulation sites or 
channels, most often based on the analysis of molecular dynamics (MD) trajectories 
111,123–125 or elastic network models (ENMs) 126,127. Equation (1.99) indicates that 
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structural components that can act as channels will have high effective interaction 
energy with known allosteric sites (e.g.,  uC,A
int
).  
It is not clear, however, how this relates to the mutual information that is evaluated 
from an MD simulation. As we and others have used mutual information successfully 
to interpret the structural dynamics and allostery from MD trajectories 111,125,128, it is 
interesting to test the use of mutual information as an identifier of allostery in the 
context of AIMs. To this end we calculated the symmetric uncertainty 129, a 
normalized variant of the mutual information, between each component in two-
component Ising models and two-component non-Ising models, and compared the 
symmetric uncertainty to the absolute interaction energy.  The symmetric uncertainty 
(SU) between components is 
 
 
SU Xi,X j( ) =
2I Xi,X j( )
H Xi( ) + H X j( )
  (1.103) 
where I is the mutual information 
 
 
I Xi,X j( ) = H Xi( ) + H X j( )− H Xi,X j( )   (1.104) 
and H is the Shannon entropy  
 
 
H X( ) = − p X( )log p X( )( )∑   (1.105) 
We generated 100,000 two-component Ising systems and 100,000 two-component 
non-Ising systems with energy terms sampled from a normal distribution with mean 0 
and standard deviation of 1, and calculated the symmetric uncertainty and allosteric 
efficacy of each. We find that the symmetric uncertainty enforces a lower limit on the 
allosteric efficacy, and allosteric efficacy increases with higher symmetric uncertainty 
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(see Figure 15). Thus, mutual information is a good predictor of allosteric activity in 
the two-state models explored here. The use of mutual information in systems that are 
not two-state will be discussed further below. 
 
Figure 15. Calculated mutual information between the channel and allosteric sites 
sets a lower bound on the allosteric efficacy.  
The symmetric uncertainty between the two components is plotted against the absolute 
effective interaction energy for 100,000 two-component/two-state non-Ising models 
(A), and two-component Ising models (B). The systems are generated using energy 
terms sampled from a normal distribution of mean 0 and standard deviation of 1/β, and 
the points are plotted with 10% opacity. 
Many proteins have been suggested to have multiple allosteric channels 130. Assuming 
that the channels are independent, careful algebra (not shown) reveals that to study the 
allosteric efficacy of a multi-channel system one can iteratively replace the direct 
interaction energy term with a direct interaction and indirect interaction of the same 
effective interaction energy. The effective interaction energy due to multiple 
independent channels is additive: 
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uL,A
int ∗ = uL,A
int + uL,A
indirect,CN
i=1
N
∑   (1.106) 
and the allosteric efficacy is then multiplicative 
 
 
αL,A = αL,A C1,...,CN{ } αL,A
indirect,CN
i=1
N
∏   (1.107) 
This formally obvious result reveals the advantage of multiple channels in an allosteric 
protein: perturbations such as mutations that disrupt the conformational stability of 
one channel will not abolish allosteric function completely. Many parallel weak 
channels introduce significant robustness when compared to the allosterically 
equivalent single strong channel built in series, because the latter is completely 
eliminated by disruption of even a single interaction between two of its structural 
components. 
To test the ability of (1.107) to reflect accurately the behavior of non-Ising systems, 
we again constructed 100,000 two- and three-channel non-Ising allosteric systems 
using the methodology described for single channel systems, and compared the 
resulting allosteric efficacy to that calculated using (1.107) (see Figure 16). Again, we 
find good agreement between the estimates using (1.107) and the exact calculated 
efficacies, although the accuracy is slightly reduced as the number of channels 
increases from two to three.  
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Figure 16. Relation of effective interaction energies in non-Ising two-state systems 
with multiple independent channels to estimates from the corresponding Ising 
model.  
The exact effective interaction energies of 100,000 two-state non-Ising system is 
plotted against the effective interaction energy estimated using the equations derived 
for the n-channel Ising model for two (A), and three (B) independent channels. The 
systems are generated using energy terms sampled from a normal distribution of mean 
0 and standard deviation of 1/β, and the points are plotted with 10% opacity.  
Because it is unlikely that allosteric proteins consist of absolutely independent 
channels, we explored the effect of interaction between channels through the use of 
two AIMs: one two-channel system where both channels provide equal magnitude 
positive allosteric coupling, and one two-channel system where both channels are of 
equal magnitude but opposite direction. The allosteric efficacy was calculated for each 
system as a function of the interaction energy between the two channels of allostery 
for ligands that are coupled to one, or both channels.  
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As depicted in Figure 17, we found that when two channels mediating positive 
allosteric modulation have negative interaction energy, the allosteric efficacy of the 
ligand is increased, even if the ligand only interacts with one channel (Figure 17A). 
This is not unexpected; the second channel acts as an indirect channel from the first 
channel to the allosteric site and additionally multiplies the allosteric efficacy of the 
channel. However, if the ligand interacts with both channels, the allosteric efficacy is 
not the square of the allosteric efficacy of binding to one channel as would be for two 
identical, independent channels. This is because the interaction of the ligand with the 
first channel has already partially shifted the conformational distribution of the second 
channel, decreasing its channel efficacy by effectively increasing its intrinsic 
conformational preference.  
For the second two-channel system, with channels providing allosteric coupling in 
opposite directions, we find that when the interaction energy between the channels is 
negative, there is decreased allosteric efficacy for the ligand in either channel, whereas 
positive interaction energy between the channels leads to increased allosteric efficacy 
(Figure 17B). From the perspective of the positive channel, if the channels are 
positively coupled the second (negative) channel is an indirect channel that flips the 
sign of the allosteric signal, which leads to reduced overall allosteric efficacy due to 
negation. However, if they are negatively coupled, the signal through the second 
channel is flipped twice and left unchanged, leading to increased allosteric efficacy. 
Interestingly, if the ligand interacts with both channels equally, the effective 
interaction energy from this pair of channels is 0, independent of the interactions 
between the channels. In a receptor with these characteristics, antagonists could 
interact with each channel without conformational preference for the channel, or 
interact with both channels with the same sign, leading to no allosteric signal.  
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Figure 17. The effective interaction energy of a two-channel AIM as a function of 
the interaction energy between the channels.  
(A): The two-channel system in which each channel contributes to positive allosteric 
modulation is shown for a ligand that interacts with one channel (blue) or both 
channels (black). (B): A two-channel system with one positive allosteric channel and 
one negative allosteric channel is shown for a ligand that interacts only with the 
positive channel (blue), only with the negative channel (red), or both channels (black). 
The effect of interactions between channels is seen to modify significantly the 
allosteric signal transduction. 
2.2. N-body Information Theory Analysis 
Note: much of the text in this chapter has been adapted from two previously published 
manuscripts111,131, with permission from the publishers.  
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2.2.1. Motivation for Method 
As mentioned previously, the specific process of allosteric signal propagation in a 
molecular system through intramolecular interactions between structural components 
has not yet been subjected to direct experimental measurements. This is somewhat 
surprising, because the allosteric effects can be observed experimentally from the 
apparent relation between distal parts of a macromolecule. Indeed, to date, there are no 
experimental methods capable of specifically and definitively defining the role of the 
intramolecular interactions involved in propagating allostery. Most proposed 
mechanisms are descriptions of series of local rearrangements that are at best 
presumed (but not demonstrated) to be causally sequential, but a specific, quantitative 
definition of the information flow does not exist. For example, a successful 
experimental method for determining residues that are coupled to ligand binding is the 
mutant cycle analysis132. While it is able to quantify thermodynamic coupling at a 
distance, the approach relies on these sequential descriptions to propose the underlying 
mechanism of propagation. In addition, the simple procedure of mutating a residue 
and measuring the allosteric efficacy in the mutant does not directly test hypotheses 
regarding the role of that residue in a specific mechanism under wild-type conditions. 
Viewing the system from the perspective of the AIM described above, one would like 
to be able to test if either the conformational preference of that residue, or its 
interaction with another residue, is involved in allostery. While the mutation of a given 
residue to a “benign” residue such as alanine, as is traditional, can modify interactions 
between residues involved in propagation, it also modifies the states that residue can 
adopt and their distribution. Thus, a mutation does not simply remove a residue from 
the AIM, but instead modifies its role in the AIM in a possibly unpredictable way. If a 
mutation is to be performed to test hypotheses regarding the role of a specific residue 
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in an allosteric mechanism, this must be done with specific care for the local structural 
ensemble both before and after mutation.  
Due to this difficulty, many have developed computational methods through which 
structural information is used to derive an allosteric mechanism. Largely, these 
methods can be subdivided in two ways. In the first subbdivision, most methods can 
often be classified by the data they use: they are either structure-based or ensemble-
based. In structure-based approaches, allosteric mechanisms are derived from one or 
more experimentally determined 3-dimensional structures, while in ensemble-based 
approaches, allosteric mechanisms are derived from the ensemble of conformations 
the system can adopt, generally estimated using a physics-based sampling method 
such as Molecular Dynamics. In the second, the methods can be classified by the 
observable that is used to indicate the presence of allostery: they either look for 
allosterically-induced conformational changes in terms of significant differences in the 
structure or ensemble between the apo and ligand-bound state, or for allosteric 
couplings between domains in terms of statistical or graph theoretical associations. 
Below, some of these methods will be briefly described. 
2.2.2. Previous Methods 
2.2.2.1. Structure-based Methods 
The simplest method for proposing an allosteric mechanism is through the 
investigation of the differences between an apo and ligand-bound structure of a 
comparable construct. At the limits of very large allosteric efficacy and very low basal 
activity, one might expect that for a ligand-activatable protein, the apo structure is 
likely to be in an inactive state, whereas the ligand-bound state is likely to be in the 
active state. It is often, but not always, possible to trace conformational changes from 
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the ligand-binding site to distant domains. However, observations of an allosteric 
conformational change do not themselves generate hypotheses as to why that specific 
conformational change occurred. Rather, mechanistic hypotheses are generally 
constructed by visually investigating the structure and invoking biophysical intuition.  
Returning to the statistical mechanical models of allostery, it should be possible to 
predict what kinds of allosteric behaviors are possible and the components crucial for 
those behaviors if one knows the components and their interactions, as well as their 
intrinsic conformational preferences. While a single structure does not inform about 
the conformational preferences of its structural components, it does contain the 
topology of interactions for one of the states. Most often, electrostatic or Lenard-Jones 
interactions are considered, and are inferred from certain geometric criteria, such as 
contact distances, or angles of relative orientation between atoms133,134. Many methods 
rely on the analysis of the interaction topology by using graph theoretical statistics135–
137, such as centrality, which quantifies the extent to which a given residue plays a role 
in the overall connectivity of the network. While these methods do not always directly 
reveal allosteric networks, as not all pathways identifiable from an interaction network 
will contribute strongly to the emergent allosteric efficacy, these methods have been 
able to find some motifs in protein structure, such as interaction hubs136,138 of densely 
connected elements, and conclude that differences between these networks highlight 
interactions that may stabilize one conformational state over others139. 
2.2.2.1. Ensemble-based Methods 
As allostery is fundamentally a statistical mechanical phenomenon that pertains to the 
relative probability of specific states of the system, methods that draw conclusions 
from the ensemble of conformational states available to the allosteric system of 
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interest are likely to generate more reasonable predictions regarding the underlying 
physical mechanism. The generation of these ensembles is not trivial however, as 
there is no existing experimental method for determining a multi-dimensional 
conformational ensemble, even at a coarse-grain scale. For example, while EPR can be 
used to determine many distance distributions simultaneously, it can only measure 
these distributions independently, and thus the full multivariate ensemble cannot be 
recovered from the experiment alone. In addition, while multi-color smFRET 
experiments could in theory measure a multivariate distribution, to our knowledge 
there are few examples of more than two distances being measured simultaneously, 
and the conformation of transmembrane domains is not accessible due to the bulk of 
the dyes required for smFRET. Due to these experimental limitations, computational 
conformational sampling approaches such as elastic network models (ENM) and 
Molecular Dynamics simulations (MD) have been extremely useful.  
In ENMs140, the system is represented with only the Calpha carbons, and each carbon 
is attached to each other carbon within a given cut-off distance by a spring. Here, we 
will detail only the Gaussian network, although other variants have been proposed141. 
The potential energy function is: 
 
 
UENM =
γ
2 Δ
!riΓ ijΔ
!rj
j
N
∑
i
N
∑⎡
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  (1.109) 
The covariance between the fluctuations of any two atoms can be shown to be: 
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Δ!ri ⋅ Δ
!rj =
3kBT
γ
Γ−1( )ij   (1.110) 
The covariance matrix, C, is then defined as: 
 C = 3kBT
γ
Γ−1( )   (1.111) 
An eigenvalue decomposition of C can be performed, 
 Γ−1 = UΛUT = λk−1 ukukT⎡⎣ ⎤⎦
k=1
N−1
∑   (1.112) 
which leads to independent normal modes whose low frequency (high eigenvalue) 
models contribute most to equilibrium fluctuations. 
It should be noted that the covariance measure defined in (1.110) is not the typical 
covariance between variables, which will be discussed later. The dot product between 
two vectors is 0 whenever the vectors are orthogonal to each other. Thus, this 
covariance measure is dependent on the relative orientation of the fluctuation vectors, 
which is not desirable. We will refer to this measure as the vector covariance to 
differentiate it from other measures of covariance.  
When using ENM approaches to study allostery, it is implicitly assumed that 
perturbations that have allosteric effects, such as ligand binding or mutations at key 
position in an interaction network, modulate the dominant eigenmodes. This 
assumption appears to be reasonable and has yielded important mechanistic insights 
about collective conformational changes, e.g., in response to different ligands binding 
to GPCRs142, or to mutations at the intracellular gate of LeuT86. The successful 
investigation of such perturbations has been extended to even larger membrane protein 
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systems (as reviewed in 143), such as the role of inter-domain or lipid–protein 
interactions in the conformational transition energy in GltPh144,145 
While there are some successful applications of ENMs, modeling the free energy 
landscape as a single harmonic basic around an x-ray structure is unlikely to 
accurately represent the true ensemble of the system. In order to generate a more 
accurate estimate of the conformational ensemble, MD is used. In MD, the system is 
represented at the classical, atomic scale. The potential energy function, also known as 
the force field, defines the types of interactions between the atoms and the parameters 
of these interactions for a given set of atom types. A typical force field includes 
bonded and non-bonded potential energy terms: 
 U = Ubonded +Unonbonded   (1.113) 
The bonded terms are harmonic energy terms for the bond, angles, dihedrals, improper 
angles, Urey-Bradley, and correction map (CMAP) terms: 
 
Ubonded = Ubond +Uangle +Udihedral +Uimproper +UUB +UCMAP
Ubond = kr r − r0( )2
bonds
∑
Uangle = kθ θ − θ0( )2
angles
∑
Udihedral = kϕ 1+ cos nϕ + δ( )( )( )
dihedrals
∑
Uimproper = kw ω −ω0( )2
angles
∑
UUB = kub r1−3 − r01−3( )2
Urey−Bradey
∑
UCMAP = uCMAP
residues
∑ Φ,Ψ( )
  (1.114) 
In each equation, k represents a force constant. The Urey-Bradley terms impose an 
additional energetic constraint on each atom by imposing a pseudo-bond between the 
first and third atom, whereas the CMAP correction biases the backbone angles of each 
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residue to better resemble those sampled in quantum mechanical calculations. The 
non-bonded terms include the electrostatics and van der Waals interactions: 
 
Unon−bonded = Uelectrostatic +UVDW
UVDW = εij
rijmin
rij
⎛
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⎞
⎠⎟
12
− 2 rij
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rij
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⎦
⎥
⎥non−bonded
∑
Uelectrostatic =
qiq j
εrijnon−bonded∑
  (1.115) 
Here, the VDW term uses the standard 6-12 Leonard-Jones potential. Given this force 
field, a set of coordinates and velocities, and a function to numerically integrate 
Newton’s equations of motion, the dynamics of the system can be simulated. 
Newton’s equations define the force, F, exerted on a given particle as: 
  
!F = m!a   (1.116) 
where m is the particle’s mass and a is its acceleration. Additionally, the force is equal 
to the negative of the potential energy gradient: 
  
!F = −∇U   (1.117) 
Combining the two leads to: 
 − dUdr = m
d2r
dt2   (1.118) 
Typically, the equations of motion are numerically integrated using an algorithm such 
as Velocity Verlet146: 
 
 
!xt+Δt =
!xt +
!vtΔt +
!at
2 Δt
!vt+Δt =
!vt +
!at +
!at+Δt
2 Δt
  (1.119) 
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MD can be used to estimate the conformational ensemble of a system given that 
system is ergodic, i.e. the system is not periodic and there exists a number of time 
steps, n, in which the system can evolve from any state i to any other state j. If these 
conditions are met, the time average of some observable will approach the ensemble 
average of that observable: 
 
 
lim
T→∞
A !rt( )
T dt0
T
∫
⎡
⎣
⎢
⎤
⎦
⎥ = A !r( )p !r( )∫ d!r = A !r( )   (1.120) 
Thus, the desired conformational ensemble can be estimated at the limit of very long 
simulation times: 
 
 
A !r( ) ≈ A
!rt( )
Tt=1
T
∑   (1.121) 
From an MD simulation of N atom for T time steps, the 3N x T time series X is 
produced: 
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r1,2 r2,2 ! r3N,2
! ! " !
r1,T r2,T ! r3N,T
⎡
⎣
⎢
⎢
⎢
⎢
⎢
⎤
⎦
⎥
⎥
⎥
⎥
⎥
  (1.122) 
From this time series, several characteristics can be calculated. First, it is important to 
note that unlike in the ENM, each x, y, and z coordinate of each atom is implicitly 
represented in these time series. Thus, (1.122), is equivalent to: 
 
 
X = X1 X2 ! XN⎡⎣ ⎤⎦   (1.123) 
where 
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  (1.124) 
As is the case for the ENMs, the vector covariance can be calculated from these time 
series: 
 
 
Ca,bvector =
!ra ⋅
!rb ≈
!ra,t ⋅
!rb,t
Tt=1
T
∑   (1.125) 
While the vector covariance has been used as an end point of analysis in the past [59], 
a better measure of covariance can be calculated. The average value of each 
coordinate can be estimated, 
 ri ≈
ri,t
Tt=1
T
∑   (1.126) 
and the 3N x 3N atomic fluctuation covariance matrix, C can be estimated: 
 Cij = ri − ri( ) rj − rj( ) ≈ ri,t − ri( ) rj,t − rj( )Tt
T
∑   (1.127) 
Unlike the vector covariance, the covariance terms in C correspond to true statistical 
covariance. However, the covariance for two atoms, a and b, is then described by a 3 x 
3 non-symmetric cross-covariance matrix: 
 Ca,b =
Caxbx Caxby Caxbz
Caybx Cayby Caybz
Cazbx Cazby Cazbz
⎡
⎣
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⎢
⎢
⎢
⎤
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⎥
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⎥
⎥
  (1.128) 
While this representation leads to difficulties in interpretation, as the covariance 
between each atom pair is represented by nine numbers rather than 1, eigenvalue 
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decomposition can also be performed on the full 3N x 3N covariance matrix. The 
eigenvalue decomposition of a covariance matrix is known as principal component 
analysis (PCA) or essential dynamics (within the MD community), and similar to 
normal mode analysis, PCA can be used to identify the system’s highest variance (and 
potential largest spatial scale) motions. However, like normal mode analysis, PCA 
only identifies the largest linearly independent motions in a given trajectory, and these 
motions are not guaranteed to be functionally relevant in terms of responding to 
allosteric perturbations.   
As PCA does not directly identify the motions that will be allosterically modulated by 
a given perturbation, methods have been developed to specifically search for networks 
of residues that are expected to mediate the long-distance allosteric couplings between 
specific residues or clusters of residues. We will refer to these methods as analyses of 
dynamical network models (DNMs)123,147,148. 
In the DNMs, network representations of the protein are built by treating each residue 
as a node and assigning weights to the edges between each node, eab, using the dot 
correlation, rho, between each atom:  
 
 
eab = − log ρabdot( ) = − log
!ra ⋅
!rb
!ra ⋅
!ra
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⎛
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  (1.129) 
In this representation, maximally dot correlated residues have an edge weight of 0, 
whereas maximally uncorrelated residues have an edge weight of ∞. This 
representation allows for the calculation of allosteric pathways through the protein by 
using shortest pathway algorithms from graph theory and network theory. In this 
framework, an allosteric pathway is defined as a sequence of residues, each of which 
has high pairwise correlation with the residues before it and after it. In addition, this 
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framework has been extended to account for sub-optimal pathways149, and allows for 
the quantification of statistics such as the centrality and the identification of structures 
such as communities150. This method has been illustrated in applications to 
tRNA:synthetase complexes123, in which the identified allosteric pathways pinpointed 
interactions between conserved residues and specific nucleotides that were shown with 
mutagenesis experiments to affect synthetase kinetics. An alternative to the original 
dynamic network analysis in DNM, which is based on linear correlations, is to use the 
mutual information from information theory151, which captures non-linear 
dependencies.  
In information theory, the entropy is a functional over the probability distribution of a 
given variable, and is defined as the average value of the information content of that 
variable: 
 H p x( )⎡⎣ ⎤⎦ = − p x( )log p x( )( )
x∈X
∑   (1.130) 
This measure of the entropy is analogous to the entropy of statistical mechanics, but 
was devised by Shannon due to its favorable characteristics: it is non-negative, is 0 
when a variable can take on only one value and is thus non-informative to measure, 
and is additive for independent variables. While the entropy is additive for 
independent variables, it is not additive for dependent variables. When variables are 
dependent, the entropy of the joint distribution is less than the sum of the entropy of 
the marginal distributions, but no less than the minimum entropy of the two 
distributions: 
 H p x( )⎡⎣ ⎤⎦ +H p y( )⎡⎣ ⎤⎦ ≥ H p x,y( )⎡⎣ ⎤⎦ ≥min H p x( )⎡⎣ ⎤⎦,H p y( )⎡⎣ ⎤⎦( )   (1.131) 
The mutual information is then defined as the entropy difference between the entropy 
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of the joint distribution and the sum of the entropy of the marginal distributions: 
 I2 p x,y( )⎡⎣ ⎤⎦ = H p x( )⎡⎣ ⎤⎦ +H p y( )⎡⎣ ⎤⎦ −H p x,y( )⎡⎣ ⎤⎦   (1.132) 
Equation (1.132) can be alternatively express as: 
 I2 p x,y( )⎡⎣ ⎤⎦ = H p x( )⎡⎣ ⎤⎦ +H p x y( )⎡⎣ ⎤⎦ = H p y( )⎡⎣ ⎤⎦ +H p y x( )⎡⎣ ⎤⎦   (1.133) 
where H[p(x|y)] is the conditional entropy of x given y: 
 H p x y( )⎡⎣ ⎤⎦ = H p x,y( )⎡⎣ ⎤⎦ −H p y( )⎡⎣ ⎤⎦   (1.134) 
Many approaches have been developed based on the mutual information152–154. 
Because mutual information ranges from 0 to ∞, it is desirable to normalize it in some 
way. Normalization is not trivial, however. The mutual information is bounded: 
 I2 p x,y( )⎡⎣ ⎤⎦ ≤min H p x( )⎡⎣ ⎤⎦,H p y( )⎡⎣ ⎤⎦( )   (1.135) 
Thus, in the discrete case, several intuitive normalizations are available. The 
symmetric redundancy, R, is particularly useful: 
 R p x,y( )⎡⎣ ⎤⎦ =
2I2 p x,y( )⎡⎣ ⎤⎦
H p x( )⎡⎣ ⎤⎦ +H p y( )⎡⎣ ⎤⎦
  (1.136) 
However, entropy is often estimated from continuous estimates of the distribution. 
This is done using the differential entropy, which is the continuous counterpart to the 
discrete entropy: 
 Hdiff p x( )⎡⎣ ⎤⎦ = − p x( )log p x( )( )dx∫   (1.137) 
Unlike the discrete entropy, the differential entropy can be negative. It is well known 
that the differential entropy is infinitely shifted from the true entropy155, but the 
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mutual information is unaffected by this property. However, because the true entropy 
in infinite, the mutual information is unbounded. To bound it, the generalized 
correlation coefficient156, which uses the relationship between the mutual information 
among two normal distributions and their correlation coefficient, r: 
 I2 p x,y( )⎡⎣ ⎤⎦ =
1
2 log 1− rxy
2( )   (1.138) 
where: 
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  (1.139) 
Assuming that the maximum mutual information scales with dimension, the 
generalized correlation coefficient between two d-dimensional distributions is then 
defined as: 
 rGC p x,y( )⎡⎣ ⎤⎦ = 1− e
−2dI2 p x,y( )⎡⎣ ⎤⎦   (1.140) 
This normalization has several problems, which will be discussed later. Despite these 
problems, using the generalized correlation coefficient with the DNM has been used in 
the analyses of allosteric networks in thrombin128 and imidazole glycerol phosphate 
synthase157 to some success, although with minimal experimental validation. 
However, while DNM and mutual information methods can identify pathways with 
high consecutive pairwise correlation or mutual information, these formulations do not 
guarantee that all components of the pathway are correlated. We will illustrate with 
the use of a simple two-dimensional three-body chain (see Figure 18) that if the axes 
of covariance are not aligned, the pairwise correlations between bodies that are 
consecutive in the chain may be high, but the system cannot transmit information.  
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Figure 18. Efficient information transmission by a 3-body system.  
Information transmission through a 3-body system (solid blue lines represent direct 
interactions), moving in 2D, is inefficient if the axes of covariance of each pair (thick 
arrow) are not aligned (left). Information transmission it is efficient if the axes of 
covariance are aligned (right); the dotted blue lines represent indirect allosteric 
interaction as a result of information sharing. 
If A and B co-vary on the blue axis, information about the position of A on the blue 
axis is present in the position of B on the blue axis, and if B co-varies with C on the 
red axis, information about the position of B on the red axis is present in the position 
of C on the red axis. When A and C co-vary with B on different axes, no information 
about the position of B on the blue axis is present in the position of C on the red axis, 
and thus no information about the position of A on the blue axis is present in the 
position of C on the red axis, i.e., there is no allosteric information transmission (see 
Figure 18, left).  
However, when the blue and red axes are aligned, A, B and C all co-vary on the same 
axis and the 3-body correlation leads to information about the position of A on the 
blue axis being present in the position of C on the red axis (see Figure 18, right). This 
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model illustrates a weakness in the use of network theoretical methods that do not 
maximize the higher n-body correlations: while shortest path analysis maximizes the 
pairwise correlations, one would expect that many pathways found using such network 
theoretical methods may not actually be efficient information channels.  
Indeed, higher-order correlations between multiple residues in the network, which can 
be described using higher-order mutual information158, are required for a system to 
transmit information through the network. In the following sections, we will present a 
method that uses these high-order mutual information terms to identify allosteric 
information channels in proteins.  
2.2.3. N-body Information Theory (NbIT) Analysis 
The new NbIT analysis method presented here utilizes a generalization of the concept 
of n-body mutual information, also known as co-information or interaction 
information158–161, an information theoretical measure which enables a description of 
the possible contribution that a variable makes to the mutual information shared 
between two other variables. The N-body information is calculated recursively as: 
 
 
IN p x1,x2,…,xN( )⎡⎣ ⎤⎦ = IN−1 p x1,x2,…,xN−1( )⎡⎣ ⎤⎦ − IN−1 p x1,x2,…,xN−1 xN( )⎡⎣ ⎤⎦   (1.141) 
where 
 
 
IN−1 p x1,x2,…,xN−1 xN( )⎡⎣ ⎤⎦ = IN−2 p x1,x2,…,xN−2 xN( )⎡⎣ ⎤⎦ − IN−2 p x1,x2,…,xN−2 xN,xN−1( )⎡⎣ ⎤⎦  
 (1.142) 
Recursion will eventually lead to the 3-body information terms, which are the central 
information measurements in the analysis. The 3-body information is: 
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 I3 p x,y,z( )⎡⎣ ⎤⎦ = I2 p x,y( )⎡⎣ ⎤⎦ − I2 p x,y z( )⎡⎣ ⎤⎦   (1.143) 
where 
 I2 p x,y z( )⎡⎣ ⎤⎦ = H p x z( )⎡⎣ ⎤⎦ +H p y z( )⎡⎣ ⎤⎦ −H p x,y z( )⎡⎣ ⎤⎦   (1.144) 
3-body information can be visualized easily using an information Venn diagram (see 
Figure 19). While several representations of this information are found in the 
literature with varying signs, we have chosen to use the sign convention described by 
159,161. Using this convention, when 3-body information is positive, the third body may 
increase the information transmission between the two others, whereas when it is 
negative, the third body diminishes it.  
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Figure 19. The 3-body information Venn diagram.  
In a 3-body system, the co-information between three variables is the 3-way intersect, 
denoted as I3(X1,X2,X3). Blue circles denote the transmitter and receiver, whereas the 
green circle denotes the channel. 
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It is important to discuss the interpretation of negative 3-body information. If X1 and 
X2 are positively correlated by direct interaction, but X2 is positively correlated to X3 
while X1 is negatively correlated to X3 (both by direct interaction), the information 
shared by X1 and X2 is diminished due to their interaction with X3 for certain 
parameters (for example, when the correlation between X1 and X2 is 0.1, the 
correlation between X1 and X3 is -0.7, and the correlation between X2 and X3 is 0.7). 
While this can occur in allosteric biomolecular systems, we have found it to be rare in 
our applications. In fact, it appears to occur when data is limited (data not shown), 
which may indicate that it is an indication of poor sampling.  
When calculating the 3-body information in order to analyze whether some body acts 
as a channel for the information transmission between two others, we will refer to the 
3-body information as co-information. In order to compare co-body information and 
quantify the potential fraction contribution of a channel variable to information 
transmission between two other residues, we calculate the normalized co-body 
information, defined as: 
 I3 p x,y,z( )⎡⎣ ⎤⎦ =
I3 p x,y,z( )⎡⎣ ⎤⎦
I2 p x,y( )⎡⎣ ⎤⎦
*100%   (1.145) 
In this normalized form, the third variable (in this case z) is specifically taken to be a 
potential channel for information transmission between the first two variables (x and 
y). This normalization is useful as it allows for a distinction between potential channel 
topologies. If x and y are conditionally independent given z, then: 
 I2 p x,y z( )⎡⎣ ⎤⎦ = 0   (1.146) 
and  
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 I3 p x,y,z( )⎡⎣ ⎤⎦ = 100%   (1.147) 
However, unless all three variables are maximally dependent, x and z will not be 
conditionally independent given y, and y and z will not be conditionally independent 
given x. Thus, 
 
I3 p x,y,z( )⎡⎣ ⎤⎦ > I3 p x,z,y( )⎡⎣ ⎤⎦
I3 p x,y,z( )⎡⎣ ⎤⎦ > I3 p y,z,x( )⎡⎣ ⎤⎦
  (1.148) 
The property in (1.148) is desirable, as the co-information itself is invariant to the 
order of the variables and thus cannot on its own reveal anything about the topology. 
In order to illustrate the power of using the normalized co-information to identify 
allosteric channels, we designed symmetric K1,4 networks of coupled univariate 
normal distributions (see Figure 20, top left). Each of the three illustrative systems - 
weak, moderate, and strong - is defined by a covariance matrix with the diagonal 
elements (the variances) equal to 1. In the weak system, the covariance between 
directly coupled distributions, rdirect, is 0.25 and the covariance between indirectly 
coupled distributions, rindirect, is 0.0625. In the moderate system, rdirect = 0.5 and rindirect 
= 0.25, and in the strong one, rdirect = 0.75 and rindirect = 0.2625. For each system, 
inverting the covariance matrix produces 0 in all the elements corresponding to 
interactions between indirectly coupled distributions, which indicates that they are 
conditionally independent as intended. 
We sampled the complete multivariate distribution of the symmetric K1,4 networks 
with observations ranging from 200 to 10000 (in multiples of 200), each with ten 
realizations, using the mvrnorm function within the R package MASS. We then tested 
how well one could differentiate node 1, which is the true channel between nodes 2 
and 3, from node 4, which is a false channel, by using the normalized co-information. 
	  110	  
The results are summarized in Figure 20, showing that even for the weak system, 
where the true indirect correlations are lower than would traditionally be considered 
for investigation, the normalized co-information can be used to determine the true 
channels from the false channels if one has over 8000 observations of the systems. For 
the moderate system, channels can be identified with fewer than 2000 observations.  
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Figure 20. Co-information and Mutual Coordination Information can identify 
channels in K1,4.  
Top left: The K1,4 network that serves to illustrate the ability of these measures to 
discriminate between true and false channels. Each circle is a node and the connecting 
lines are the edges. Edges represent direct interactions with covariance rdirect, and all 
nodes that are not connected by an edge display indirect interactions with covariance 
rindirect. Top right: Figure shows the results from separate calculations with different 
numbers of observations, of normalized co-information (red) and normalized mutual 
coordination information (blue) in the strong K1,4 network. True channels are shown in 
solid lines and false channels are shown in dashed lines, and bars represent the 
standard deviation of 10 realizations. Bottom left: Same as top right, for the moderate 
K1,4 network. Bottom right: Same as left panel, for the weak K1,4 network. 
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However, more complex information transmission networks may be imagined than the 
simple 3-body system for which co-information applies. For example, more than two 
domains may display coupled motions, and these coupled motions may be due to a 
central channel. While the N-body information can be used to quantify how much 
information in shared by all members in a set, there may be many different collective 
motions existing involving different subsets of the full set of N. To quantify overall 
amount of information shared by N bodies, including all possible n-body coupled 
motions ranging from n=2 to n=N, we can calculation the total correlation, also known 
as the multi-information: 
 
 
TC p x1,x2,…,xN( )⎡⎣ ⎤⎦ = H p xi( )⎡⎣ ⎤⎦
i=1
N
∑ −H p x1,x2,…,xN( )⎡⎣ ⎤⎦   (1.149) 
We can generalize the co-information to describe how much information that is shared 
by a set of variables of arbitrary size is also shared with another variable. This is 
calculated as the difference between the TC and the conditional TC, which we will call 
the coordination information, (CI): 
 
 
CI p x1,x2,…,xN( ),p y( )⎡⎣ ⎤⎦ = TC p x1,x2,…,xN( )⎡⎣ ⎤⎦ − TC p x1,x2,…,xN y( )⎡⎣ ⎤⎦   (1.150) 
This contribution describes the amount of total correlation in a set of variables (the 
“coordinated set”) that is shared with a variable (or multivariate distribution) that is 
not included in the coordinated set (“the coordinator”). When calculated in this 
manner, CI describes the contribution of a site to all possible n-body correlations 
within another site. We can define the normalized coordination information (NCI), 
analogous to the normalized co-information, in which the coordination information is 
normalized to the total correlation within the coordinated site: 
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CI p x1,x2,…,xN( ),p y( )⎡⎣ ⎤⎦ =
CI p x1,x2,…,xN( ),p y( )⎡⎣ ⎤⎦
TC p x1,x2,…,xN( )⎡⎣ ⎤⎦
  (1.151) 
It should be noted that coordinators are not all coordination channels. Coordinators 
can be coupled to coordination channels, and thus perturbation to the coordinator 
leads to a perturbation in the coordinated set. In order to define channels that mediate 
coordination information, we calculate the amount of coordination information that is 
shared between two residues and the same set, which we call mutual coordination 
information, (MCI):  
 
 
MCI p x1,x2,…,xN( ),p y( ),p z( )⎡⎣ ⎤⎦ = CI p x1,x2,…,xN( ),p y( )⎡⎣ ⎤⎦ −CI p x1,x2,…,xN( ),p y( ) p z( )⎡⎣ ⎤⎦  (1.152) 
The mutual coordination information can also be normalized: 
 
 
MCI p x1,x2,…,xN( ),p y( ),p z( )⎡⎣ ⎤⎦ =
MCI p x1,x2,…,xN( ),p y( ),p z( )⎡⎣ ⎤⎦
CI p x1,x2,…,xN( ),p y( )⎡⎣ ⎤⎦
  (1.153) 
Using the K1,4 network, we demonstrate how well one could differentiate node 1 - the 
true coordination channel for the coordination of nodes 2 and 3 by node 5 - from node 
4, a false coordination channel, using mutual coordination information. We find 
results similar to those of the co-information, indicating that the mutual coordination 
information is also a good tool for identify allosteric channels.  
Of additional interest is the study of rigid bodies and rigid-body-like behavior. 
Because much of the dynamics in proteins is often considered qualitatively in terms of 
“rigid body motions”, it is of interest to study such behavior, and rigid-body-like 
behavior, in the context of information.  In general, a rigid body is considered to be a 
solid body in which internal deformations can be neglected. But formal description of 
what constitutes a rigid body in a molecular system, which can be independent of the 
particular physics of the system of interest, is lacking. Nevertheless, the qualitative 
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description implies specific constraints on the conformational entropy and N-body 
information of the system. We can consider as an example a sphere of densely packed 
atoms. The coordinate of any atom in this sphere after a translation can be determined 
by measuring only one atom. Thus, for any atom i: 
 
 
H ptranslation x1,x2,…,xN( )⎡⎣ ⎤⎦ = H ptranslation xi( )⎡⎣ ⎤⎦   (1.154) 
As all atoms have the same translational entropy: 
 
 
H ptranslation x1,x2,…,xN( )⎡⎣ ⎤⎦ = H ptranslation xi( )⎡⎣ ⎤⎦ = IN ptranslation x1,x2,…,xN( )⎡⎣ ⎤⎦   (1.155) 
Thus, a system is maximally rigid in regard to translations if (1.155) is true. In the 
same sense, as the constituents atoms can be considered points in space, the coordinate 
of any atoms after a rotation can be determined, given the axis of rotation, by 
measuring only one atom. Thus, ignoring atoms that lie perfectly on the axis of 
rotation: 
 
 
H protation x1,x2,…,xN( )⎡⎣ ⎤⎦ = H protation xi( )⎡⎣ ⎤⎦ = IN protation x1,x2,…,xN( )⎡⎣ ⎤⎦   (1.156) 
If the rotations and translations are taken to be independent, the total entropy is then: 
 
 
H p x1,x2,…,xN( )⎡⎣ ⎤⎦ = IN p x1,x2,…,xN( )⎡⎣ ⎤⎦ = IN protation x1,x2,…,xN( )⎡⎣ ⎤⎦ + IN ptranslation x1,x2,…,xN( )⎡⎣ ⎤⎦  (1.157) 
Thus, an intuitive quantification of the rigid-body dynamics of a system, R, can be 
written as: 
 
 
R p x1,x2,…,xN( )⎡⎣ ⎤⎦ =
IN p x1,x2,…,xN( )⎡⎣ ⎤⎦
H p x1,x2,…,xN( )⎡⎣ ⎤⎦
  (1.158) 
However, R is not useful for a continuous distribution, in which the entropy is infinite 
for all non-Dirac delta distributions162, and the commonly used differential entropy 
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can be negative. Instead, it is useful to normalize to a strictly positive quantity that is 
also strictly greater than the N-body information and equal to the N-body information 
when the system is maximally rigid. One such quantity is the average 2-body 
information, and thus we can calculate the rigid-body fraction, RBF, as: 
 
 
RBF p x1,x2,…,xN( )⎡⎣ ⎤⎦ =
IN p x1,x2,…,xN( )⎡⎣ ⎤⎦
N2 −N
2 I2 p xi,x j( )⎡⎣ ⎤⎦j=1,i≠ j
N
∑
i=1
N
∑
  (1.159) 
However, the RBF can be problematic. Given a system composed of one rigid body, 
adding a single particle to the system that is independent of the existing rigid body 
results in a RBF of 0. In general, it would be useful to have a measure that could 
quantify rigid-body behavior in a system of multiple, possibly coupled, rigid bodies. 
To do this, one can consider the mutual information expansion of the entropy: 
 
 
H p x1,x2,…,xN( )⎡⎣ ⎤⎦ = H p xi( )⎡⎣ ⎤⎦
i=1
N
∑ + −1j−1 IjN
j
⎛
⎝
⎜
⎞
⎠
⎟
∑
j=2
N
∑
⎛
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  (1.160) 
where the sum over Ij is the sum of all j-body information terms.  Given that: 
 
 
IN p x1,x2,…,xN( )⎡⎣ ⎤⎦ ≤min IN−1( )   (1.161) 
then 
 
 
IN p x1,x2,…,xN( )⎡⎣ ⎤⎦ ≤
IN−1
N
N −1
⎛
⎝⎜
⎞
⎠⎟
∑ ≤ IN−2N
N − 2
⎛
⎝⎜
⎞
⎠⎟
∑ ≤…≤ I2N
2
⎛
⎝⎜
⎞
⎠⎟
∑   (1.162) 
Thus, the curve representing the average n-body information as a function of n is 
strictly decreasing. In fact, for a model system consisting of a finite one-dimensional 
lattice of one-dimensional normal distributions with unit variance and uniform 
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covariance between neighbors, we find that an approximately exponential decay of the 
average n-body information is expected for a range of covariances (see Figure 21). 
Additionally, adding heterogeneity by modifying some of the covariances did not 
change the decay (see Figure 21). 
 
Figure 21. Approximately exponential decay of the average n-body information 
in model 1-dimensional lattices of coupled 1-dimensional normal distributions. 
Covariance between neighbors are 0.7 (diamond), 0.8 (square), and 0.9 (circle, solid 
line). The dashed and dotted lines correspond to systems where the fourth and fifth 
distributions have greater covariance with their neighbors (0.95 and 0.99, 
respectively). All lines are parameterized as exponential decays using Eq. (1.163). 
Thus, in order to describe the average n-body information term as a function of n from 
2 to N, we can parameterize a function with the following exponential form: 
 In = Ae
− n−2( )
CO +B   (1.163) 
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By parameterizing the exponential function, we calculate the correlation order, CO, 
which describes the rate of decay of n-body correlations in the system. A CO of 1 
would indicate that the average nat (the unit of information when the natural logarithm 
is used) of n-body information is contributed by an n + 1 body correlation. In the 
model system described above, if the correlations between neighboring distributions 
are low, the exponential will decay quickly and have a low CO, and if the correlations 
between neighbors are high, the exponential decays slowly due to the emergence of 
higher correlations and have a high CO.  
Finally, we must address an issue regarding the normalization of the mutual 
information between multivariate continuous distributions through the lens of two 
rigid bodies. The generalized correlation coefficient, shown in (1.140), normalizes the 
mutual information between d-dimensional distributions by dividing the information 
by d. However, the mutual information is not expected to scale linearly with the 
additional of new dimensions. Consider two rigid bodies, each composed of some 
number of atoms. If they behave as perfectly rigid bodies, their translational entropy 
does not increase as new atoms are added to the rigid bodies, while their 
dimensionality clearly will. Thus, as the number of constituent atoms in the rigid 
bodies approaches infinity, the generalized correlation coefficient describing their 
translations will approach 0, even in the case where their translations are perfectly 
coupled. To remedy this, we developed a new quantification of the information shared 
between two multivariate distributions, which can be normalized similar to the 
generalized correlation coefficient. We begin with two multivariate distributions, X 
and Y. 
 
 
X = X1,X2,…,Xdx{ }
Y = Y1,Y2,…,Ydx{ }
  (1.164) 
	  118	  
We start by calculation the joint total correlation:  
 
 
TC p x1,x2,…,xdx ,y1,y2,…,ydx( )⎡⎣ ⎤⎦ = H p xi( )⎡⎣ ⎤⎦i=1
N
∑ + H p yi( )⎡⎣ ⎤⎦
i=1
N
∑ −H p x1,x2,…,xdx ,y1,y2,…,ydx( )⎡⎣ ⎤⎦  (1.165) 
However, this measure of information also includes information shared with X and 
within Y that is not shared between X and Y. Thus, we subtract out that excess 
information to result at the total intercorrelation:
 
 
TC p x,y( )⎡⎣ ⎤⎦ = TC p x1,x2,…,xdx ,y1,y2,…,ydx( )⎡⎣ ⎤⎦ − TC p x1,x2,…,xdx y1,y2,…,ydx( )⎡⎣ ⎤⎦ − TC p y1,y2,…,ydx x1,x2,…,xdx( )⎡⎣ ⎤⎦  
 (1.166) 
The total intercorrelation describes the total amount of information shared between 
two multivariate distributions through any n-body correlation that contains at least one 
dimension from both distributions, and equals the 2-body information between X and 
Y in the univariate case. Total intercorrelation is distinctly different from the (dx + 
dy)-body information as it counts the n-body information between dimensions of A 
and B that is not shared by all dimensions of both A and B.  
For illustration, we discuss a system of two atoms where the marginal entropy of each 
dimension of each atom has been standardized to H. If all dimensions share maximum 
information, then: 
 
 
max TCINTER p x,y( )⎡⎣ ⎤⎦( ) = max TC p x1,x2,…,xdx ,y1,y2,…,ydx( )⎡⎣ ⎤⎦( ) = dx + dy −1( )H   (1.167) 
Thus, the maximum total intercorrelation can be easily scaled to account for 
dimensionality. Since in the one-dimensional case, total intercorrelation is equivalent 
to 2-body information, we can write an intercorrelation coefficient that is analogous to 
the generalized correlation coefficient: 
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 rint er p x,y( )⎡⎣ ⎤⎦ = 1− e
− 2dx+dy−1( )TCINTER p x,y( )⎡⎣ ⎤⎦   (1.168) 
However, it should be noted that the total intercorrelation behaves differently from the 
mutual information in important ways. The total intercorrelation maximizes when X 
and Y are perfectly coupled rigid bodies, whereas the mutual information maximizes 
when X and Y have no rigid-body like behavior but are perfectly coupled to each 
other.  
Lastly, the domains involved in allostery, such as ligand binding sites, are generally 
composed of many residues. Thus, it is desirable to be able to differentiate between 
residues that are involved in information transmission with other sites (we will refer to 
these residues as “communicators” versus those that may be essential to the internal 
dynamics of its constituent site (we will refer to these residues as “stabilizers”). 
To identify residues that contribute significantly to information measures, we 
calculated the contribution of a variable x to an arbitrary information metric describing 
a set of variables X that contains x, which we will denote as I[f(X)], as: 
 Contribution I f X( )⎡⎣ ⎤⎦,x( ) =
I f X( )⎡⎣ ⎤⎦ − I f X x( )⎡⎣ ⎤⎦
I f X( )⎡⎣ ⎤⎦
  (1.169) 
Lastly, we described a method that can be used to identify residues that play a 
significant role as a channel. To identify the residues with high co-information (or 
mutual coordination information), we take advantage of an empirically observed 
relationship between the co-information and the co-information rank. We find that 
when plotting co-information against the co-information rank for an arbitrary pair of 
sites, the midsection contains a large linear region, surrounded with a large co-
information extreme on the left and a small co-information extreme on the right. To 
	  120	  
identify a cut-off for the high co-information extreme region, we calculate a linear fit 
to the middle residues (the exact number determined on a case-by-base basis) and 
calculate the root mean squared residual (RMSR) for the fit. We then project the fit 
across all residues, and define the residues with high co-information as those that have 
a residual of greater than 1 RMSR. An example distribution and the corresponding fit 
and cut-off are shown in Figure 22. This type of method has been used previously 163 
to identify residues that are important for function from multiple sequence alignments. 
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Figure 22. The typical co-information plot.  
The co-information for a given residue (the channel) with the INI (receiver) and S1 
(transmitter) is plotted against the co-information rank of that residue (black circles). 
The black line is the linear fit to the middle 200 residues and the blue line is the cut-
off for high co-information residues.   
	  122	  
2.3. Random Forest-Based Identification of Ligand-Specific Allosteric 
Modulation 
2.3.1. Motivation for Method 
While residues involved in function are often known from detailed biochemical and 
pharmacological analysis, their responses to ligand-specific allosteric modulation are 
hard to characterize experimentally outside of the use of structural method such as x-
ray crystallography. However, both the crystallization of specific ligand-protein 
complexes and the determination of high resolutions structures from these crystals are 
non-trivial undertakings. Even when structures are available, modulation that affects 
either the distribution or dynamics of the protein, such as the local flexibility of loops 
or the frequency of interactions, are difficult or impossible to quantify from single 
structures. To identify these differences, estimation of the ensemble through MD is 
commonly employed. 
2.3.2. Previous Work 
Many methods have been proposed to differentiate ensembles under different 
conditions. These methods sometimes utilize measures from probability theory and 
information theory, such as the Kullback-Leibler divergence164,165 and the related 
Jensen-Shannon divergence166,167, or methods from machine learning such as support 
vector machines168. While these methods are theoretically rigorous, it is beneficial to 
utilize a method that specifically analyzes characteristics of the protein that can be 
modulated experimentally through mutagenesis, such as pairwise interactions. The 
dimensionality of the pairwise interaction space can be very high and cannot be 
estimated using quasi-harmonic approximations of the distributions. However, it has 
been shown that rather simple statistical analysis of the differences in pairwise 
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interaction frequencies between simulations with and without allosteric modulators or 
mutations that have allosteric effects can reveal interactions that are likely to compose 
the allosteric interaction networks (AINs) that propagate long-distance conformation 
change134. Still, these statistical differences are not guaranteed to be statistical 
differences related to allosteric modulation; they may be statistical differences that 
would also appear if two MD simulations of the same system were run and neither 
reached the true equilibrium distribution, which is expected to be common even as we 
reach the micro- and millisecond times scales. Since the number of simulation is finite 
even when multiple simulations are performed, the proper reweighting procedure is 
required to ensure that an outlier simulations trapped in a low probability region of 
conformational space does not bias the entire analysis. 
This problem is further amplified when the goal is to identify class-specific statistical 
differences rather than ligand-specific differences. The naïve approach would be to 
combine the simulations of ligands of the same classes, and compare these 
agglomerated simulations. However, due to this implicit averaging, the naive approach 
is sensitive to mistaking ligand-specific interactions for class-specific interactions. For 
example, imagine that one wishes to compare the allosteric modulation of interaction 
frequencies by three ligands of class A to that of three ligand of class B. If an 
interaction is formed in two of the ligands in class A and none of class B, pooling the 
data for class A and class B ligands will result in a significant difference in the 
interaction frequency between class A and class B. However, as one ligand in class A 
does not allosterically induce that interaction, it cannot actually be a class-specific 
interaction. Thus, the problem must be divided into two steps: first, ligand-specific 
interaction frequencies within the classes must be identified and removed, and then the 
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remaining interaction frequencies can be compared between classes. To solve this 
two-step problem, we developed a two-step method utilizing random forests. 
2.3.3. 2-Step Random Forest Identification of Class-Specific Features 
We treat the problem of determining which interaction frequencies display class- or 
ligand-specific modulation as a classification problem, in which we would like 
determine which interactions are most useful in classifying which ligand or class of 
ligand is likely to be bound to a given protein structure. As interaction frequencies 
deal with binary variables, decision trees become a powerful tool for this classification 
problem.  
A decision tree is a tree-like graph in which each internal node denotes a splitting 
process that divides the given attribute by categories: each branch represents the 
categorical output of the preceding node, and each terminal leaf represents a class 
label. In order to classify a data point using a decision tree, one begins at the first 
internal node (called the root) and traverses the decision tree until a leaf is reached, 
which outputs the class prediction for that data point. While there are many methods 
for training decisions trees, most methods are known to be sensitive to over-fitting the 
training data. To overcome this over-fitting problem, random forest methods build an 
ensemble of decisions trees using different subsets of the training data, and then 
outputting a class prediction using the mode classification across all trees. Random 
forests have been shown to be less sensitive to over-fitting and outperform single 
decision trees.  
However, we are not primarily interested in classification per se. Instead, we would 
life to first identify interactions that are most important for the classification of 
structures by ligands of the same class. To do so, we perform random forest 
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classification and then calculate a normalized variant of the variable importance for 
each interaction. The variable importance describes the contribution of a given 
variable to a random forest, and is most often described by the mean decrease in 
accuracy across all trees in the random forest when a predictor variable in randomly 
permuted and the accuracy is re-calculated. The accuracy, A, is calculated as: 
 A d( ) = ncorrectntotal
  (1.170) 
where d is a set of data points, ncorrect is the number of correctly classified data points, 
and ntotal is the total number of data points.  
Thus, the mean decrease in accuracy for a variable x, <dA>x, is calculated as: 
 ΔA x =
Ai d( )−Ai dx( )
i=1
N
∑
N   (1.171) 
where Ai is the accuracy of a given decision tree, N is the number of decision trees in 
the random forest, and dx is the set of data points with variable x permuted. Another 
measure, the mean decrease in node impurity, is also used but is difficult to normalize 
across variable of differing number of categories. For this reason, we chose to use the 
mean decrease in accuracy to quantify the role of an interaction in predicting the 
ligand or class of ligand bound to a given structure.  
To normalize the decrease in accuracy, we use Cohen’s kappa, k.  
 κ = A −Aexp1−Aexp
  (1.172) 
where Aexp is the expected accuracy if data points were classified by random given the 
frequency of that class in the data set. The value of κ is 1 if classification is perfect, 
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and 0 if classification is no better then random assignment. Thus, we write a 
normalized variable importance as: 
 Δκx =
ΔA x
1−Aexp
  (1.173) 
To solve the first step of the problem, we first pool the trajectory data by class, and 
then we then build for  each class a random forest to classify the structures by the 
ligand, rank the interactions by Dk, and remove all interactions that exceed some 
threshold, which we will call k. After doing this for each class, we pool the classes 
together, remove their ligand labels, and classify the structures by class with the 
remaining interactions. All interactions with Dk > k are then deemed to be important 
for the classification of class but not ligand, and thus are likely to be signatures of 
hallucinogen-specific allosteric modulation.  
One difficulty is then choosing the cut-off for importance, k. The goal of the analysis 
is to find the interactions that best classify the ligand class and not the individual 
ligands. Thus, it seems reasonable that enough interactions should be removed such 
that, given the reduced set of interaction data, a random forest for predicting class 
outperforms random forests for predicting the ligands within class. To identify when 
class prediction outperforms ligand prediction, we calculate the ratio of the Cohen’s 
kappa for classification by ligand class over the average k for classification of ligands 
within each class: 
 α = κ class
κ ligand
  (1.174) 
While ideally α should exceed 1, it is not necessarily the case that the classification of 
structures by ligand class will be highly accurate. One could imagine that there exist 
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two active states of the receptor, one that results in hallucinogenic activity and one that 
mediates all other activities, hallucinogens may increase the probability of the 
hallucinogenic state more than the non-hallucinogenic ligands, but the resulting 
ensembles will still be mixtures of the two states and thus significantly overlapping. 
Thus, we test many values of k and choose the cut-off that maximized α.  
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3. Application to Membrane Protein Systems 
While the models and methods described above may be of interest to theoreticians, the 
merit of their development is determined by their ability to help us describe and 
understand real systems. Below, the use of several of these methods will be illustrated 
in the context of membrane transporters and GPCRs.  
3.1. Allostery in the Transport Mechanisms of LeuT 
Much of the content in this section has been adapted with permission from 110. 
The prototypical member of the family of neurotransmitter:sodium symporters (NSS), 
the bacterial transporter LeuT has been particularly well studied, and the results from 
many experimental and computational investigations suggest that transport is driven 
by a complex allosteric mechanism spanning the entire length of the transporter. From 
single molecule FRET (smFRET) experiments carried out on LeuT, a number of 
transport-related structural transitions were identified in the intracellular gate region 
that occludes the substrate from the cytoplasm169, and these were shown to be 
modulated by binding events at the extracellular end 84,170. Crystallographic studies 
have also revealed that a second binding site in the extracellular vestibule (termed S2) 
is the target of several transport inhibitors (including many of the psycho-active drugs 
acting on the cognate NSS neurotransmitter transporters) 73,171, and biochemical and 
computational evidence suggests that the release of substrate is allosterically 
connected to the binding of a second substrate in this site68,81,93. These results bring to 
light the cross talk between several allosterically coupled domains in the transport 
mechanism of NSS transporters, and suggest that modulation of these domains can 
both facilitate and hinder function. However, the smFRET and crystallographic data 
did not provide a basis for understanding which domains and interactions were crucial 
	  129	  
for the observed substrate-modulated dynamics. Thus, we proposed that the NbIT 
analysis method would be able to identify tentative channels and crucial interactions 
between the channel and substrates that mediate the allosteric modulation.  
Problematically, simulating the complete equilibrium distribution of LeuT, in any 
substrate or ion condition, is still unfeasible due to computational restrictions on the 
time scales of MD simulations. We reasoned that if the metastable states of two 
domains are coupled (e.g., if the population of the open and closed state of the 
intracellular gate, and/or the transitions between them, are coupled to the occupancy 
state of the substrate sites), their microstates were likely to also exhibit coupling (e.g., 
the fluctuations within the closed state of the intracellular gate would be coupled to the 
fluctuations within the bound state of the substrate site). It should be noted that while 
there is no theoretical basis that requires this to be true, it has been previosuly found 
that fluctuations around a single state can be indicative of dynamics that are relevant 
to function172. 
3.1.1. NbIT Identifies Allosteric Channels and Functional Residues in LeuT 
The application of the NbIT analysis to LeuT will be presented below. The section 
will be subdivided into two subsections. First, the results of the analysis performed in 
111 will be presented and discussed (text and figures have been adapted with 
permission). In the next subsection, unpublished results that are currently in 
preparation for submission will be presented, including follow-up computational work 
and experimental validation.  
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3.1.1.1. Methods 
3.1.1.1.1. Simulations 
Two separate trajectories of the same LeuT structure were analyzed with the NbIT 
method, denoted as LeuTPOPE/POPG and LeuTMNG-3. The LeuTPOPE/POPG trajectory is a 
simulation of the occluded LeuT structure75 (PDB ID 3GJD) bound to the two sodium 
ions and leucine, but with the octyl-glucoside (OG) detergent molecule removed, 
which has been described previously173. The LeuTMNG-3 trajectory is for the same 
LeuT structure simulated in lauryl maltose-neopentyl glycol (MNG-3), a detergent 
known for its excellent stabilization of transmembrane proteins, including LeuT, in 
micellar environments174,175. Both simulations were run at in an NPT ensemble under 
semi-isotropic pressure coupling conditions and at 310 K temperature using the 
CHARMM27 force field with CMAP corrections for proteins176 and CHARMM36 
lipid force field177 in NAMD 2.7178 using the Nose-Hoover Langevin piston algorithm 
and PME for electrostatic interactions. The trajectories used for the analysis are from 
the production phase and only include the segment of the simulations after the Cα 
RMSD had converged. The total lengths of the equilibrated trajectories were 148 ns 
for LeuTPOPE/POPG and 146 ns for LeuTMNG-3.  
3.1.1.1.2. Definition of functional residue clusters 
Mechanistic and structure-function studies of LeuT as a prototypical NSS transporter 
have identified specific residues and structural microdomains that have significant 
roles in functional mechanisms. These include the binding sites for substrate and ions 
identified in the crystal structures 65,73,75, as well as the intracellular gate and 
surrounding interaction network, which has been shown to be involved in the transport 
mechanism 169. We used these findings to define functional residue clusters (frc-s). 
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Specifically, we defined the S1-frc to include the substrate, leucine, and residues L25, 
G26, V105, Y108, F253, T254, S256, F259, S355, and I359. The NA1-frc includes the 
bound ion, leucine, and residues A22, N27, T254, and N286 of the Na1 binding site.  
The NA2-frc is composed of the second ion bound, and residues G20, V23, A351, 
T354, and S355 of the Na2 binding site. We defined the S2-frc as composed of L29, 
R30, Y107, I111, W114, F253, A319, F320, F324, L400, and D404, and the 
intracellular gate region as an “intracellular network of interactions”, INI-frc, 
composed of R5, I187, S267, Y268, Q361, and D369. The locations of these sites in 
the LeuT structure are presented in Figure 23. 
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Figure 23. The structure of LeuT.  
Top panels: The 3GJD crystal structure of LeuT from two perspectives. TMs are 
displayed as cyan cylinders connected by loops. Each frc-site is represented by an 
outer surface: S1 (grey), S2 (orange), INI (tan), Na1 (yellow) and Na2 (purple). 
Bottom left: The INI-frc; numbers refer to the residue identity. Bottom right: The S1-
frc (the leucine substrate is in grey, Na2 is added for reference). 
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3.1.1.1.3. Correcting for symmetric side chain conformations  
Some post-processing was required for the analysis by the NbIT method. In order to 
estimate entropy from MD simulations, the coordinate of each atom is tracked 
throughout the trajectory to create a distribution of Cartesian coordinates. For side 
chains that display symmetry (Phe, Tyr, the carboyxlate groups of unprotonated Glu 
and Asp), simple tracking of atoms based on their numbering in the structure file can 
make symmetric states appear non-symmetric. To account for this, we used a 
clustering algorithm to group states by dihedral angles, and then divide the states by 
symmetry. For Phe and Tyr, we defined the state of the ring by the dihedral angle 
formed by the Cα, Cβ, the benzyl carbon bound to Cβ, and a benzyl carbon para to 
that carbon. For Glu and Asp, the state of the carboxylate was defined as the dihedral 
angle formed by N, Cα, the carbonyl carbon, and a carboxylate oxygen. For each 
residue, the sin and cos of each angle was calculated in order to project the angles onto 
the unit circle. Finally, the projections were collected into two clusters using the k-
means clustering algorithm (implemented in R using the kmeans function in the stats 
package). If the angle between the centers of the two clusters was > 90°, the position 
of the fourth atom was rotated by 180° relative to the plane formed by the first three 
atoms (as listed above) in frames from the second cluster.  
3.1.1.1.4. Clustering 
The MD trajectories analyzed with NbIT for this illustration of the method include 
only the long segments in which the interaction between R5, D369, and S267, which is 
observed crystallographically, is maintained. From analysis of a large number of LeuT 
simulations in our lab, we became aware of long-lived rearrangements in the 
conformation of the INI. We determined first if there were distinct substates of the 
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INI, by using k-means clustering on the minimum distances between side chains in the 
INI. Indeed, this revealed the transition between two long-lived states in the two 
simulations used for the NbIT analysis. Specifically, in LeuTPOPE/POPG, the system 
transitioned after ~118 ns from the crystal structure configuration in which R5 
interacts with D369 and S267 in the INI, to a new configuration where R5 interacts 
with the surrounding water. In LeuTMNG-3, the equilibrated portion of the simulation 
begins with R5 interacting with the D369 and S267, but after ~25 ns there is a 
transient rearrangement event, leading to a state in which R5 breaks away from D369, 
followed by a return of the INI to its original state after ~20 ns. In order to isolate 
these states, MD simulation trajectories were clustered by the minimum distance 
between non-hydrogen side chain atoms of residues within the frc-s using the k-means 
clustering algorithm. Distance time series were smoothed over 1 ns windows to 
minimize thermal noise, and the best clustering was taken from 100 k-means runs. We 
performed the same clustering analysis using each frc individually, and found that not 
only did the INI have the most conformational variability (nearly an order of 
magnitude greater sum of square distance between frames in comparison to the other 
frc-s), but clustering into two states accounted for most of the variability (see Table 
S2). Furthermore, we determined the similarity between results of clustering by the 
conformation of a specific frc versus all frc-s, by calculating the overlap as: 
 
 
overlap = occludedfrc ∩ occludedalloccludedfrc ∪ occludedall
  (1.175) 
where occludedfrc corresponds to the set of frames in the occluded state when clustered 
by a given frc, whereas occludedall corresponds to the set when clustered by all frc-
s. We find that clustering by all residues in the frc-s of interest provided a near 
identical result to clustering specifically by the INI. These results indicate that the INI 
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rearrangement is the only significant rearrangement of a structural motif that takes 
place in the simulation trajectories.  As the interaction between R5, D369, and S267 is 
observed crystallographically, we focused the study herein on comparing only this 
state from both simulations, in trajectories of over 100 ns from each simulation. While 
it might be interesting eventually to study as well the minor states of the INI not 
observed crystallographically, in which the gate is broken, these were not sampled 
sufficiently in either trajectory and thus are not yet adequate for rigorous analysis. 
3.1.1.1.5. Entropy estimations 
In order to estimate the configurational entropy from the MD simulations, we first 
approximated the probability distributions of the atomic coordinates as a 3N-
dimensional multivariate normal distribution.  The probability density function of a 
multivariate normal distribution is: 
 
 
p !x( ) = e
−12
!x− !x( )TC−1 !x− !x( )
2π( )k C
  (1.176) 
where k is the rank of the covariance matrix. Covariance matrices were calculated 
using carma179. The entropy of the continuous multivariate normal distribution can be 
calculated analytically through the differential entropy: 
 
 
H p !x( )⎡⎣ ⎤⎦ =
1
2 log 2πe C( )   (1.177) 
It should be noted that while the multivariate normal distribution is the maximum 
entropy distribution given constraints on the mean and covariance matrix, it can be a 
very poor estimator of the entropy if the distribution is multi-modal, and while the 
multivariate normal approximation of the mutual information between two 
distributions has been claimed to define the lower bound on the true mutual 
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information, it has been shown to be untrue. Thus, care must be taken when using the 
multivariate approximation. However, calculating the configuration entropy through 
more rigorous means is computationally intensive and not reasonable in the case of 
calculating the entropy of different subsets of the space many times as is done when 
performing NbIT analysis.  
3.1.1.2. Results 
3.1.1.2.1. The Pairwise Mutual Information 
The analysis of pairwise mutual information for each of the functional residue clusters 
(frc-s) is summarized in Table 1. The calculated values show that the component 
residues in each of the frc-s exhibit coupled motions within the leucine-bound state 
studied here, as indicated by the mutual information that is greater than zero. Note, 
however, that it is difficult to compare the strength of coupling between two different 
sets of frc-s, because mutual information cannot be easily normalized from differential 
entropies calculated from multivariate normal distributions (see Section 2.2.3.	  N-­‐body	  Information	  Theory	  (NbIT)	  Analysis). Therefore, we will not discuss further below 
the coupling strength between sites until we discuss other measures of information that 
can be normalized. 
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Table 1. Mutual information between known function sites in LeuTPOPE/POPG. 
 S1  S2  Na1  Na2  Na1, 
Na2  
Na1, 
Na2, S1  
Na1, Na2, 
S1, S2  
INI  
S1  -328.1 
(0.5)  
23.4 
(0.6)  
9.3 (0.1)  7.1 (0.1)  13.2 
(0.2)  
X  X  12.9 
(0.3)  
S2  X  -356.3 
(0.7)  
14.9 
(0.3)  
7.5 (0.2)  21.6 
(0.6)  
33.0 
(1.0)  
X  15.1 
(0.4)  
Na1  X  X  -141.2 
(0.1)  
8.3 (0.1)  X  X  X  4.8 
(0.1)  
Na2  X  X  X  -112.9 
(0.1)  
X  X  X  4.0 
(0.1)  
Na1, Na2  X  X  X  X  -262.4 
(0.12  
X  X  8.4 
(0.3)  
Na1, Na2, 
S1  
X  X  X  X  X  -519.2 
(0.9)  
X  18.1 
(0.6)  
Na1, Na2, 
S1, S2  
X  X  X  X  X  X  -869.6 
(2.5)  
31.7 
(1.2)  
INI  X  X  X  X  X  X  X  -136.8 
(1.4)  
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Off-diagonal elements correspond to the mutual information between two given frc-s, 
where as the diagonal elements correspond to the entropy of a given frc. Units are in 
nats.  
3.1.1.2.2. The Communication Channel Coupling the S1-frc to the INI-frc utilizes 
TM6 
A central mechanistic question regarding the functional dynamics of transporters is 
how the binding of substrate can trigger the conformational reorganization leading to 
the intracellular-open state from which the substrate is eventually released. Because 
studies have shown that just the binding of Na+ and substrate cause measurable 
dynamic effects at the intracellular end of the LeuT molecule, even in the absence of 
transport 84,170, we sought to determine the information channel enabling this allosteric 
behavior. To this end, we performed co-information analysis to evaluate which 
residues played the role of channel in the information exchange between the substrate 
sites and the INI. Applying co-information analysis reveals that S1 and the INI are 
coupled through a set of residues consisting largely of residues from TM6b, TM8, and 
TM2 (see Figure 24).  
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Figure 24. TMs 2, 6b, and 8 form a co-information channel between S1 and the 
INI.  
Main: Residues found to have high co-information with S1 and the INI are colored by 
their calculated normalized co-information (NCo-I) values using the scale at the top 
right, where the Min and Max NCo-I refer to the minimum and maximum values 
among all possible residues. All other residues are represented in grey. Bottom right: 
A close up of the TM6b and TM8 interface. 
Co-information analysis also reveals a channel between S2 and the INI, which is 
similarly composed of residues from TM6b and TM8, in addition to residues from S1 
in the unstructured region between TM6a and TM6b (see Figure 25). 
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Figure 25. TMs 2, 6b, and 8 form a co-information channel between S2 and the 
INI. 
Main: Residues found to have high co-information with S2 and the INI are colored by 
their calculated normalized co-information (NCo-I) values using the scale at the top 
right, where the Min and Max NCo-I refer to the minimum and maximum values 
among all possible residues. All other residues are represented in grey. Bottom right: 
A close up of the TM6b and TM8 interface. 
Not all the residues in a particular frc contribute equally to the allosteric 
communication. In order to identify which residues within the substrate sites and the 
INI are essential for allosteric communication we identified the residues within these 
sites that made large contributions to the mutual information. Such residues contribute 
by coupling the sites directly to the channel, and by distributing the information 
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throughout the rest of their respective site. It is essential to note that the total sum of 
contribution from all residues does not necessarily sum to 100%. This occurs because 
just as the residues share information, they can also share their contribution to the 
mutual information, so the sum of the contribution will exceed 100%. This is also the 
case for other contribution measures, as described further below. 
We found that for the coupling between the S1-frc and the INI, it is residues I359,  
F259, F253 in the S1-frc that make the largest contributions (21.2% 18.8%, and 12.5% 
respectively), and in the INI the largest contribution is from residues Q361, R5, and 
Y268 (28.3%, 21.6%, and 21.3% respectively). These very specific identifications 
underscore the validity of the calculated communication channel, as they are 
consistent with results from previous work in which mutations of I359 and F259 were 
shown to modulate transport efficacy 180. Interestingly, we find that for the coupling 
between the S2-frc and the INI, residues R30, F324, and W114 make the largest 
contributions in S2 (20.1%, 12.9%, and 12.5%), and in the INI residues R5, I187, and 
Y268 make the largest contributions (27.1%, 23.3%, and 9.5% respectively). Because 
R30 is considered to form an extracellular gate with D404, the significant role we find 
for it here in the coupling of S2 and the INI underscores the strong relationship 
between the extracellular and intracellular gates. These results are summarized in 
Table 2A and Table 2B.  
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Table 2A. Specific residues highly contribute to mutual information between S1 
and the INI in LeuTPOPE/POPG. 
S1  Leu  L25  G26  V104  Y108  F253  
 10.5% 
(0.1%) 
9.9% 
(0.0%) 
6.4% 
(0.0%) 
8.4% 
(0.1%) 
11.8% 
(0.1%) 
12.5% 
(0.1%) 
 T254  S256  F259  S355  I359  Na1  
 8.8% 
(0.1%)  
9.3% 
(0.1%)  
18.8% 
(0.1%)  
7.7% 
(0.1%)  
21.2% 
(0.2%)  
3.0% 
(0.0%)  
INI  R5  I187  S267  Y268  Q361  D369  
 21.6% 
(0.3%)  
19.7% 
(0.4%)  
14.6% 
(0.1%)  
21.3% 
(0.1%)  
28.3% 
(0.3%)  
15.6% 
(0.1%)  
The contribution of specific residues in S1 (top) and the INI (bottom) to the 
communication between S1 and the INI (top 3 in each site are bold). 
Table 2B. Specific residues highly contribute to mutual information between 
S2and the INI in LeuTPOPE/POPG.  
S2  L29  R30  Y107  I111  W114  F253  
 8.8% 
(0.6%)  
20.1% 
(0.0%)  
9.9% 
(0.1%)  
7.5% 
(0.1%)  
12.5% 
(0.1%)  
10.6% 
(0.1%)  
 A319  F320  F324  L400  D404   
 6.1% 
(0.1%)  
10.2% 
(0.1%)  
12.9% 
(0.1%)  
9.1% 
(0.1%)  
8.6% 
(0.1%)  
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INI  R5  I187  S267  Y268  Q361  D369  
 27.1% 
(0.3%)  
23.3% 
(0.5%)  
14.6% 
(0.2%)  
19.5% 
(0.1%)  
17.3% 
(0.2%)  
18.2% 
(0.2%)  
The contribution of specific residues in S2 (top) and the INI (bottom) to the 
communication between S2 and the INI (top 3 in each site are bold). 
3.1.1.2.3. The Coordination within frc-s is Performed by Known Functional Residues 
We hypothesized that that the proper fold and specific local function of a given frc, 
such as substrate binding, are maintained through short-distance allosteric couplings 
underlying collective behavior among the residues in the clusters. We probed this by 
calculating the total correlation (TC) for each frc to obtain a measure of the total 
amount of information shared by a set of size N through any type of correlation from 2 
to N-body.  We then calculated the contribution of a given residue in the frc to this TC. 
With this approach, we find that in the INI, the three largest contributors are Y268 
(60.7%), S267 (59.0%) and R5 (42.7%). This is consistent with their central location 
in the INI topology and with previous reports that mutation of the highly conserved 
Y268 and R5 to alanine has a strong effect on the structure and dynamics of the 
intracellular gate 84,169. In the S1-frc, the largest contributions to the TC were 
calculated to come from T254 (40.3%), the leucine substrate (38.9%), and F253 
(38.9%). The bound Leu is expected to contribute strongly, as seen here, because it 
interacts with all other residues in S1. Furthermore, as mutation of F253 has been 
shown to greatly reduce binding in S169,170, it is possible that its role is not only to 
stabilize Leu binding through direct interaction, but also to stabilize the site as a whole 
by coordinating the rest of the S1 residues.  
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In the other frc-s we also found a small number of specific high contributions. Thus, in 
the Na1 site the largest contributions to the total correlation are made by the Na1 
sodium ion (61.7%), T254 (60.1%), and by leucine (58.4%).  Interestingly, in the Na2 
site, T354 and S355 contribute significantly more (70.9% and 66.4%, respectively) 
than the Na+ ion (52.1%). Finally, in S2, residues F320, A319, and R30 are found to 
make the largest contributions of 39.6%, 33.0%, and 31.1%, respectively. These 
results are summarized in Table 3.  
Table 3. The contribution of specific residues to the total correlation of their sites 
in LeuTPOPE/POPG. 
S1  Leu  L25  G26  V104  Y108  F253  
 38.9% 
(0.2%) 
36.2% 
(0.2%) 
32.3% 
(0.3%) 
13.2% 
(0.1%) 
23.3% 
(0.1%) 
38.9% 
(0.2%) 
 T254  S256  F259  S355  I359  Na1  
 40.3% 
(0.3%) 
29.1% 
(0.2%) 
20.1% 
(0.2%) 
13.6% 
(0.2%) 
12.1% 
(0.1%) 
20.2% 
(0.2%) 
S2  L29  R30  Y107  I111  W114  F253  
 25.6% 
(0.1%) 
31.1% 
(0.2%) 
17.4% 
(0.1%) 
17.4% 
(0.1%) 
18.5% 
(0.1%) 
10.9% 
(0.0%) 
 A319  F320  F324  L400  D404   
 33.0% 
(0.3%) 
39.6% 
(0.3%) 
20.9% 
(0.1%) 
14.0% 
(0.1%) 
15.0% 
(0.1%) 
 
Na1  Na1  A22  N27  T254  N286  Leu  
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 61.7% 
(0.3%) 
49.5% 
(0.2%) 
50.0% 
(0.2%) 
60.1% 
(0.2%) 
36.3% 
(0.2%) 
58.4% 
(0.2%) 
Na2  Na2  G20  V23  A351  T354  S355  
 52.1% 
(0.2%) 
37.6% 
(0.2%)  
40.1% 
(0.2%)  
38.6% 
(0.2%)  
70.9% 
(0.1%) 
66.4% 
(0.1%) 
INI  R5  I187  S267  Y268  Q361  D369  
 42.7% 
(0.4%)  
34.8% 
(0.8%)  
59.0% 
(0.6%)  
60.7% 
(0.4%)  
23.8% 
(0.4%)  
28.8% 
(0.4%)  
For each frc, the contribution of each residue to the total correlation is presented. The 
top 3 residues in each site are shown in bold. 
3.1.1.2.4. Both the S1-frc and the S2-frc Coordinate Multi-Body Collective Motions in 
the INI 
Key findings from smFRET experiments investigating the allosteric modulation of 
intracellular gating in LeuT 84 were that conformational changes in the intracellular 
gates require collective motions resulting in large spatial displacements, and that these 
motions are modulated (in some undetermined way) by the state of the substrate 
binding sites, S1 and S2 170. In order to investigate the role of these substrate binding 
sites in the collective dynamics within the INI-frc, we calculated how much each of 
the two binding sites contributed to the total correlation of INI. This contribution, 
termed here coordination information (CI), describes the amount of total correlation in 
a set of variables (the “coordinated set”, here the INI-frc) that is shared with a variable 
(or multivariate distribution) that is not included in the coordinated set (“the 
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coordinator”, here the S1 or S2 frc-s). When calculated in this manner, CI describes 
the contribution of a site to all possible n-body correlations within another. Here we 
used as the descriptor the normalized coordination information (NCI), in which the 
coordination information is normalized to the total correlation within the coordinated 
site. It should be noted that coordinators are not all coordination channels. 
Coordinators can be coupled to coordination channels, and thus perturbation to the 
coordinator leads to a perturbation in the coordinated set. 
As summarized in Table 4, the NCI calculated for S1 and S2 show that they both 
coordinate the INI, with values of 19.1% for S1, and 21.2% for S2. The Na1 and Na2 
sites coordinate the INI only weakly (NCI = 9.0% and 6.9%, respectively), and their 
combined NCI in coordinating the INI is 11.1%. The coordination of INI by the 
combination of S1, S2, and the Na1 and Na2 frc-s is 27.1%, indicating that just under 
a third of all the correlated motions in the INI are related to these sites. The 
coordination exerted by INI on the binding sites was also calculated, because 
coordination information is not symmetric. We find that while S1 and S2 coordinate 
the INI strongly, the INI coordinates the two only moderately (NCI = 12.0% and 
7.4%, respectively). Interestingly, in the MD trajectory we analyzed, the coordination 
by INI of the Na1 (NCI = 14.2%) and Na2 (NCI = 10.5%) sites is stronger than in the 
opposite direction. These results, along with results for all comparisons of sites, are 
summarized in Table 4.   
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Table 4. Normalized Coordination Information between sites in LeuTPOPE/POPG. 
 S1  S2  Na1  Na2  Na1, Na2  Na1, Na2, S1  Na1, Na2, S1, 
S2  
INI  
S1  30.6 (0.2)  23.8% 
(0.5%)  
27.5% 
(0.4%)  
17.3% 
(0.3%)  
31.0% 
(0.5%)  
X  X  12.0% 
(0.4%)  
S2  14.2% 
(0.4%)  
33.1 
(0.4)  
8.2% 
(0.2%)  
4.5% 
(0.2%)  
8.9% 
(0.3%)  
15.0% 
(0.5%)  
X  7.4% 
(0.3%)  
Na1  51.5% 
(0.5%)  
44.2% 
(0.5%)  
9.2 
(0.1)  
39.1% 
(0.3%)  
X  X  X  14.2% 
(0.5%)  
Na2  40.1% 
(0.4%)  
16.7% 
(0.3%)  
32.4% 
(0.3%)  
12.04 
(0.1)  
X  X  X  10.5% 
(0.3%)  
Na1, Na2  32.1% 
(0.3%)  
23.3% 
(0.4%)  
X  X  29.8 (0.2)  X  X  10.1% 
(0.3%)  
Na1, Na2, 
S1  
X  16.3% 
(0.5%)  
X  X  X  67.2 (0.6)  X  8.8% 
(0.3%)  
Na1, Na2, 
S1, S2  
X  X  X  X  X  X  132.9 (2.0)  6.2% 
(0.4%)  
INI  19.1% 
(0.6%)  
21.2% 
(0.7%)  
9.0% 
(0.3%)  
6.9% 
(0.3%)  
11.1% 
(0.4%)  
20.5% 
(0.7%)  
27.1% (1.2%)  14.3 
(0.1)  
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For each pair of frc-s, the normalized coordination information is presented, with 
residues on the top (columns) acting as the coordinator and residues on the left (rows) 
being coordinated. On the diagonal, the total correlation of the site is shown in bold. 
To estimate the importance of these coordination values for the allosteric mechanism, 
we performed control calculations of the normalized coordination information for S1 
and S2, with several other intracellular sites not known for their functional roles, 
including specific helices, loops, and interfaces between them. In all cases, S1 and S2 
coordination of any of these control sites was half (or much less) that of the INI (see 
Table 5). 
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Table 5. Coordination of control regions by S1 and S2 in LeuTPOPE/POPG and 
LeuTMNG-3. 
 
The coordination of each control region by S1 and S2 are presented with the standard 
error of the mean in parenthesis, estimated using moving block bootstrapping with 50 
realizations.  
Given the importance of the INI in the function of the transporter, we also determined 
which individual residues make the largest contributions to coordination of the INI. 
For each residue in the S1-frc and S2-frc residue we calculated the contribution of the 
residue to the particular frc coordination of the INI, as well as the contribution of INI 
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residues to receiving that coordination, using Equation (S5). Results summarized in 
Table 6 show that for coordination of the INI-frc by S1, the top 3 coordinators are 
F259 (contribution = 69.6%), S256 (contribution = 34.9%), and I359 (contribution = 
34.6%), and the top 3 receivers are R5 (contribution = 67.8%), I187 (contribution = 
63.8%), and S267 (contribution = 59.9%). For coordination by S2, the top 3 
coordinators are R30 (contribution = 54.7%), F253 (contribution = 28.7%), and F324 
(contribution = 24.0%), and the top 3 receivers are R5 (contribution = 80.8%), I187 
(contribution = 71.0%), and D369 (contribution = 58.1%).  This underscores the 
important role of INI residues R5, I187, and S267 in the coordination of the INI-frc by 
the known allosteric substrate sites. 
Table 6A. Specific residues highly contribute to coordination of the INI by S1 in 
LeuTPOPE/POPG. 
S1  Leu  L25  G26  V104  Y108  F253  
24.5% 
(0.1%)  
22.8% 
(0.2%)  
21.9% 
(0.2%)  
18.8% 
(0.2%)  
13.9% 
(0.1%)  
31.0% 
(0.2%)  
 T254  S256  F259  S355  I359  Na1  
27.3% 
(0.2%)  
33.6% 
(0.3%)  
67.6% 
(0.2%)  
13.3% 
(0.2%)  
33.2% 
(0.4%)  
16.6% 
(0.1%)  
INI  R5  I187  S267  Y268  Q361  D369  
66.1% 
(0.3%)  
63.1% 
(0.2%)  
58.7% 
(0.1%)  
57.3% 
(0.2%)  
57.2% 
(0.4%)  
48.1% 
(0.3%)  
The contribution of specific residues in the S1-frc (top) and the INI-frc (bottom) to the 
coordination of the INI-frc by the S1-frc (top 3 in each site are bold). 
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Table 6B. Specific residues highly contribute to coordination of the INI by S2 in 
LeuTPOPE/POPG.  
S2  L29  R30  Y107  I111  W114  F253  
20.1% 
(0.2%)  
53.8% 
(0.5%)  
10.6% 
(0.2%)  
9.0% 
(0.3%)  
14.6% 
(0.2%)  
28.0% 
(0.2%)  
 A319  F320  F324  L400  D404   
10.7% 
(0.0%)  
11.4% 
(0.1%)  
23.2% 
(0.1%)  
16.2% 
(0.1%)  
18.8% 
(0.1%)  
 
INI  R5  I187  S267  Y268  Q361  D369  
78.3% 
(0.2%)  
69.0% 
(0.2%)  
48.5% 
(0.2%)  
42.5% 
(0.3%)  
40.0% 
(0.3%)  
57.6% 
(0.4%)  
The contribution of specific residues in the S2-frc (top) and the INI-frc (bottom) to the 
coordination of the INI-frc by the S2-frc (top 3 in each site are bold). 
3.1.1.2.5. The Coordination Channel Mediating the INI-frc Coordination by the 
Substrate frc-s is Through TM6b 
Because TM6b emerged as the major channel for communication between S1 and the 
INI, we investigated whether it was also the major channel for the CI between the 
substrate sites and the INI. We calculated the mutual coordination information (MCI), 
which described how much of the coordination information is shared between two 
coordinators that are coordinating the same set, and then normalized to the 
coordination information of the coordinator of interest (NMCI). Using this analysis, 
we identified residues in the high NMCI region using the same criteria described for 
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co-information. The results identify a coordination channel that is nearly identical to 
the channel revealed by the co-information analysis, with a significantly larger signal 
in TM6b than that calculated with co-information analysis (see Figure 26).  
 
Figure 26. TMs 2, 6b, and 8 form a coordination channel between S1 and the INI. 
Main: Residues found to have high mutual coordination information with S1 and the 
INI are colored by their calculated normalized mutual coordination information 
(NMCI) values using the scale at the top right, where the Min and Max NMCI refer to 
the minimum and maximum values among all possible residues. All other residues are 
represented in grey. Bottom right: A close up of the TM6b and TM8 interface. 
interface.  
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We are able to identify a similar coordination channel for S2 (see Figure 27). These 
results indicate that TM6b is the major channel for the coordination of the INI by S1 
and S2. 
 
Figure 27. TMs 2, 6b, and 8 form a coordination channel between S2 and the INI 
in LeuTPOPE/POPG.  
Main: Residues found to have high mutual coordination information with S2 and the 
INI are colored by their calculated normalized mutual coordination information 
(NCMI) values using the scale at the top right, where the Min and Max NCMI refer to 
the minimum and maximum values among all possible residues. All other residues are 
represented in grey. Bottom right: A close up of the TM6b and TM8 interface. 
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3.1.1.3. Discussion 
Taking advantage of the information about specific functional motifs for the allosteric 
transporter LeuT, the illustration of the new NbIT analysis method brings to light how 
it identifies the details of allosteric couplings, and can quantify them at a previously 
unattained level of detail. Moreover, the choice of LeuT for this illustration of NbIT 
allowed us not only to start from well-defined frc-s, but also to compare the results 
and the inferences from NbIT analysis to known mechanistic elements in the allosteric 
process underlying LeuT function. Indeed, the allosteric pathway between the known 
ligand (ions, substrate) binding sites and previously proposed functional elements such 
as the intracellular gate (in INI), were identified by the NbIT analysis as the channels 
that propagate these couplings. This agreement with previous mechanistic insights is 
important because computational approaches, and in particular the type of MD 
simulations utilized here as well, have been used successfully to study the dynamics of 
transporter molecules and to infer on residues and motifs that play essential roles in 
the allosteric mechanisms81,181–183, By taking advantage of this kind of data, the novel 
NbIT analysis provides the first rigorous method for the identification of specific 
channels by which information is transmitted between functional sites of an allosteric 
molecular system. Key observations from the present application of NbIT analysis are 
discussed below to stress the specific molecular detail of the results, and to indicate 
the predictive power that this new method can bring to the many other allosteric 
protein systems for which the type of information available for LeuT is currently 
lacking.  
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3.1.1.3.1. Allosteric Coordination of the INI by S1 and S2 
The CI calculations were essential in revealing that the S1 and S2 sites coordinate the 
internal dynamics of the INI (see Table 4). The allosteric modulation of the 
intracellular gate considered on the single molecule macro scale has been noted 
previously in the dynamic changes revealed by smFRET experiments with LeuT in 
detergent; this study showed how the allosteric connection enabling modulation at the 
micro scale is effectuated. Coordination information as calculated here connects the 
collective coordination of the INI domain to the individual components (specific 
residues) and interactions (within, and outside the frc to which they belong) that 
underlie it. This provides insight at unprecedented detail about the elaborate 
coordination in the allosteric mechanism underlying ligand-induced opening of the 
gate. An intriguing observation in view of the ongoing controversy surrounding the 
role of the S2 binding site 68,75–78,81,93,184 is that the S2-frc coordinates the INI through 
a channel that includes the S1 site. The coordination found here, of the INI by the apo 
S2 site (the MD trajectories analyzed here did not include substrate bound in S2) may 
explain why mutations to the S2 site have been shown to affect intracellular gating 
dynamics 84. Although they demonstrate the ability of the S2-frc to coordinate the 
intracellular gate, the present results cannot inform about the role of substrate binding 
in S2 in the transport process, since this was not covered in the MD simulation. 
3.1.1.3.2. Propagation of Information between S1, S2, and the INI Requires TM6b 
The channel that propagates the coordination of the INI by S1 and S2 was found here 
to consist largely of residues in TM6b (see Figure 26 and Figure 27). Indeed, several 
residues in the S1 site and the INI are part of the highly conserved TM6, and its 
intracellular end, TM6b, was shown to undergo a large rotation of 17° in a recent 
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crystal structure of a LeuT mutant stabilized in what is believed to be an apo 
intracellular-open state 185; TM1a and TM8 also contain many residues from S1 and 
the INI.  
Notably, while this work was originally in preparation, a set of LeuT mutants have 
been described that were constructed to resemble the human serotonin transporter 186, 
and all constructs containing a mutation of the TM6b residue Y265 to F, were found to 
lack transport activity despite retaining high affinity inhibitor binding. This indicates a 
possible role of TM6b in function, and we interpret the observed rotation of TM6b and 
the effect of the Y265F mutation as support for their role in propagating information 
from the substrate site to the intracellular gate during the transition between LeuT 
states. The fact that the role of TM6b became evident from the NbIT analysis of the 
S1-occupied occluded state supports its role as an information conduit from the 
substrate sites to the intracellular gate.  
3.1.1.3.3. The Intramolecular Allosteric Mechanism Involves a Subset of Residues 
Known to Have Functional Roles 
With NbIT analysis, we identified specific residues that play a role in allosteric 
connections related to function, and were able to discern different contributions (i.e., 
“stabilizers” and “communicators”). In the S1-frc we find that while the bound leucine 
substrate, F253, and T254 coordinate the binding site’s internal correlations (hence 
acting as stabilizers), residues F259, S256, and Q359 contribute to the coupling 
between S1 and the INI (Table 5A) and belong to “communicators”, which are 
involved in between-site allosteric communication. We know of no previous 
computational method that offered such functionally specific discrimination. 
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The identification of functional roles for specific residues in the allosteric 
communication revealed further details of their mechanistic involvement: 
3.1.1.3.3.1. F259 
Our analysis predicted that F259 interactions may have a significant effect on 
transport. Earlier crystallographic studies had indicates that F259 may be involved in 
the diversity of transport phenotypes produced by various LeuT substrates 110. Three 
basic modes of interaction have been observed: (i)-in crystal structures of LeuT in 
complex with leucine, methionine, or p-flurophenylalanine, the hydrophobic side 
chains interact with F259; (ii)-in LeuT structures with alanine or glycine, this 
interaction is lost, leading to a 30° rotation of the F259 side chain; (iii)-in the structure 
bound to tryptophan, the indole ring makes a ring-ring contact with the F259 side 
chain. The three distinct modes of interaction observed for F259 correlate with distinct 
transport phenotypes. Thus, although the overall binding modes could appear nearly 
identical, the transport efficiencies differ, with alanine being transported with highest 
efficiency (kcat/Km); leucine, methionine, and p-flurophenylalanine displaying low 
efficiency, and tryptophan acting as an inhibitor. While the efficiency for glycine is 
even lower than for the low efficiency amino acids mentioned above, the difference 
may in fact be due to the very low affinity of Gly for LeuT which may not allow it to 
remain bound to the transporter long enough to initiate transport (no kon or koff values 
have been reported). Together, these structure/function relations suggest that substrate 
interactions with F259 may lead to different effects on transport. Our analysis 
predicted a specific participation in the allosteric mechanism. We suggest that because 
alanine does not interact with F259 and induces a change in the rotameric state of 
F259 relative to that observed for the less efficiently transported substrates, F259 plays 
an inhibitory role by allosterically blocking transport. Clarification of the specific role 
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that this type of allosteric modulation plays in the transport cycle with the NbIT 
method must await a complete trajectory of the transition among the different states, 
but the insights gained in this study offer an intriguing avenue for future 
experimentation. 
3.1.1.3.3.2. Y268, S267, R5, and I187 – stabilizers and communicators in the INI 
We find that Y268 R5, and S267 all play the role of both strong stabilizers and 
communicators in the INI. Both R5 and Y268 are known to be involved in function, 
with mutation of either residue to alanine resulting in disruption of the intracellular 
gate 84,169, characterized by an increased “open” (intracellular gate) population 
observed in smFRET experiments of the intracellular gate. However, the R5A 
mutation has also been shown to cause increased transitions between the “open” and 
“closed” (intracellular gate) state in the presence of leucine 84. Considered together, 
these experimental findings indicate that mutation of R5 can affect the allosterically 
modulated gating dynamics; in agreement, R5 is predicted to be the strongest 
coordinator within the INI. The result that Y268, S267, and R5 all play the role of 
both coordinator and stabilizer is especially noteworthy because one would expect 
that residues that are essential to the stability of the gate would need to be modulated 
in order to initiate large collective conformational changes, such as the opening of the 
gate. That such residues are also communicators substantiates the allosteric 
modulation of the conformational change that opens the gate. Indeed, these residues 
are highly conserved in NSS transporters71, and our finding leads to the prediction that 
disruption of interactions between S267 and its surrounding network will strongly 
affect transport. Future experiments should be able to better define the role of S267 in 
the transport function based on this testable hypothesis. In addition, we find that while 
I187 has a minor stabilizer role in the INI, it plays a significant role as a 
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communicator. This leads to the mechanistic prediction that mutation of I187 may lead 
to disruption of allosteric modulation without disrupting the structure of the 
intracellular gate.  
3.1.1.2. Related Work  
Another quantitative computational approach was used to investigate allosteric 
couplings in LeuT from MD simulation trajectories, utilizing a comparative analysis 
of the results from a large set of simulations of the transporter and mutant constructs 
(Y268A/R5A/D369A) in complexes with various combinations of ions (Na+/Li+) and 
substrates (no substrate/leucine/alanine)187. The MD simulation of the Na+-bound, 
substrate free state of LeuT was used as a reference relative to which the various 
trajectories for different ion binding states and mutations were considered as 
perturbations. To follow the manner in which the “perturbations” affected the 
allosteric coupling in a detailed structural context, the comparative analysis was 
formulated in terms of the interaction frequencies between residue pairs observed in 
the compared trajectories. These interaction frequencies were used to build a network, 
termed “allosteric interaction network” (AIN), that contains the conformational 
changes produced by each of the “perturbations”. 
A key finding of this analysis of the interactions involved in the conformational 
changes is the consistency of the AIN in the various constructs. Thus, the 
perturbations - whether induced by ion, substrate, or mutation - led to changes in a 
core interaction network. This network, the AIN, surrounds S1 substrate binding site 
and spreads out to the intracellular and extracellular domains. The large changes in 
this core interaction network were observed in the unwound region of TM6 and the 
central region of TM10. Notably, the analysis predicted that the Y268A mutation at 
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the intracellular end of the LeuT transporter would perturb the Na+ binding sites, 
through a propagation of changes involving TM6b, TM8, and F259 in particular. The 
excellent agreement of these results with the findings from the NbIT analysis111 
supports the involvement of these structural elements in the coupling between binding 
sites and the intracellular gate region. Indeed, the associated experiments reported in 
this study187 found that the Y268A mutation disrupted Na+ binding in the distal 
binding site, and that due to the cooperative binding of Na+ and substrate, it also 
disrupted substrate transport in a clear coupling of distal structural motifs. 
3.1.2. Additional Computational and Experimental Studies  
We hypothesized that the role of F259 in the substrate-specific allosteric modulation 
of intracellular gating dynamics could be investigated by a systematic study of how 
the interaction between F259 and substrate affected F259 dynamics (using MD 
simulations) and the corresponding allosteric modulation of intracellular gating (using 
smFRET). Because it is difficult to modify the interaction between F259 and the 
substrate from the side of F259 in a semi-continuous fashion by modifying F259, we 
modify the interaction by changing the substrate instrad. We chose to study the 
substrates leucine, valine, alanine, and glycine, which maintains the interaction as a 
van der Waals interaction but is expected to reduce the interaction strength as the side 
chain is shortened and eventually removed completely. The results of this study will 
be detailed below. 
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3.1.2.1. Methods  
3.1.2.1.1. Computational Methods  
We constructed models of LeuT bound to leucine, valine, alanine, and glycine by 
starting from the PDB crystal structure of LeuT bound to leucine and using the 
Mutator plug-in within VMD to mutate the leucine substrate to the corresponding 
amino acid of choice. The simulations were constructed as described in Section 3.1.1.1.1.	  Simulations, but with reduced box size such that the total number of atoms 
was approximately ~120,000. This was required to run on the Anton supercomputer at 
the Pittsburgh Supercomputing Centers, which limits system size. After an initial 
minimization and equilibration as described in Section 3.1.1.1.1.	  Simulations, the 
systems were subjected to microsecond-scale MD simulations on Anton, a special-
purpose supercomputer machine188. These production runs implemented the same set 
of CHARMM36 force-field parameters and were carried out in the NPT ensemble 
under semi-isotropic pressure coupling conditions (using the Multigrator scheme that 
employs the Martyna-Tuckerman-Klein (MTK) barostat189 and the Nosé-Hoover 
thermostat190), at 310 K temperature, with 2 fs time-step, and using PME for 
electrostatic interactions. All the other run parameters were derived from the Anton 
guesser scripts based on the system chemistry 62. 
A mutant construct, F259W bound to glycine, was also constructed from a 
representative from of the glycine-bound construct in which F259 was in the 
perpendicular state and simulated using the same protocol for 3 microseconds. 
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3.1.2.1.2. Experimental Methods  
All experiments were performed in the laboratory of Scott Blanchard by Daniel Terry. 
3.1.2.1.2.1. TIRF single-molecule fluorescence imaging of LeuT 
Microfluidic chambers passivated with polyethylene glycol (PEG) and a small 
percentage of biotin-PEG191 were incubated for 5 min with 0.8 µM streptavidin 
(Invitrogen), followed by 4 nM biotin-tris-NTA-Ni2+ 192 in T50 buffer (50 mM KCl, 
10 mM Tris-acetate, pH 7.5). LD550/LD650-labeled, His-tagged LeuT molecules 
were immobilized via the His-tag:Ni2+ interaction by incubating for 2 min at ~4 nM 
concentration. Subsequent imaging experiments were conducted in imaging buffer 
containing 50 mM Tris/Mes (pH 7.5), 10% glycerol, 0.05% (w/v) DDM, 1 mM β-
mercaptoethanol and 200 mM total salt (KCl and NaCl, as specified). An oxygen 
scavenging system consisting of 0.1% w/v glucose, 0.2 units/mL glucose oxidase 
(Sigma), and 1.8 units/µL catalase (Sigma) was added to minimize photobleaching. 
Both enzymes were purified by gel filtration prior to use. Microfluidic chambers were 
reused up to five times by eluting the protein from the surface with 0.3 M imidazole in 
imaging buffer. 
Single-molecule FRET imaging of LeuT dynamics was performed at 25 °C using a 
custom-built prism-based total internal reflection (TIR) microscope, as previously 
described84,85,193. Surface-bound LD550 fluorophores were excited by the evanescent 
wave generated by TIR of an Opus 532 nm solid state laser (Laser Quantum). 
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Scattered excitation light was removed by a ET555lp filter (Chroma) between the 
objective and the MultiCam. Synchronization was ensured with an external pulse 
generator and verified with an oscilloscope. Data were acquired with 2x2 hardware 
binning using custom software implemented in LabView (National Instruments). 
Unless otherwise noted, data were recorded at a rate of 10 s-1 (100 ms time resolution). 
3.1.2.1.2.2. Analysis of smFRET data 
Analysis of single-molecule fluorescence data was performed in MATLAB {Juette 
2016, Nature Methods}. Single-molecule fluorescence traces were extracted from 
wide-field movies and corrected for background, spectral crosstalk, and unequal 
apparent brightness194. Each FRET trajectory was calculated as EFRET = IA/(IA+ID), 
where IA and ID are the acceptor and donor fluorescence intensities at each frame, 
respectively. Traces were selected for further analysis according to the following 
criteria: (1) single-step photobleaching, (2) signal to background noise ratio > 8, (3) 
less than four donor blinking events, and (4) FRET efficiency above baseline levels 
(0.15) for at least 100 frames. Figures were made with Origin software (OriginLab). 
To quantify dwell-times in each state, we idealized the smFRET trajectories using the 
segmental K-means algorithm in QuB195 with models containing three non-zero FRET 
states. The model FRET values (0.0, 0.52, 0.65, and 0.82) were obtained by fitting 
FRET histograms to a sum of three Gaussian functions in Origin (OriginLab). 
3.1.2.2. Results  
We investigated the nature of the F259-substrate interaction in each of the wild-type 
trajectories. The F259 side chain can undergo a rotation, which we monitored by 
calculating the dihedral angle formed by the Cα, Cβ, Cγ, and CD1 (benzyl carbon 
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ortho in respect to the Cβ).  We found that in the WT:Leu trajectory, F259 rotation is 
constricted and only two rotation events can be observed (see Figure 28, top left), 
between symmetric states of the phenyl ring at approximately 80-110° and -80-110°, 
which we will call the “perpendicular state”, to reflect the orientation relative to the 
side chain of the substrate. In the WT:Val trajectory, the rotation between thee two 
symmetric perpendicular states becomes more frequent (see Figure 28, bottom left). 
However, in the WT:Ala and WT:Gly simulations, two new states (symmetric to each 
other at approximately 90° from the ) appear with high frequency (see Figure 28, 
right). We call these symmetric states the “parallel states”.  
 
Figure 28. The F259-substrate interaction in various substrate-bound complexes. 
In each system, the starting state of the F259-substrate interaction is shown with the 
protein backbone shown in cyan cartoon and the substrate and side chain in licorice 
representation (carbon in cyan, oxygen in red, and nitrogen in blue). The dynamics of 
the dihedral angle formed by the CA-CB-CG-CD1 atoms over the course of each 3 
microsecond simulation is shown to the right. Top left: LeuT:Leu. Bottom left: 
LeuT:Val. Top right: LeuT:Ala. Bottom right: LeuT:Gly. 
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We hypothesized that the ligand-specific smFRET behavior previously observed for 
Leu and Ala was related to their ligand-specific modulation of F259, and thus 
predicted that Val’s effect on intracellular smFRET would resemble that of Leu, and 
that Gly’s effect would resemble that of Ala. The corresponding smFRET 
experiments, performed by Daniel Terry in the Blanchard lab, are presented in Figure 29 
and Figure 30. Due to improved experimental methodology, three states could be 
resolved in the smFRET data. In accordance with our predictions, Leu and Val both 
stabilize the high FRET state (see Figure 29), indicating they induce intracellular 
closing. Additionally, Ala and Gly both stabilize the mid FRET state (see Figure 29) and 
increase the frequency of transitions (see Figure 30). This data suggest that ligand-
specific modulation of the F259 is correlated with ligand-specific modulation of 
smFRET distributions and dynamics. However, the data does not necessarily suggest a 
causal relationship. 
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Figure 29. 3-State smFRET distributions as a function of substrate concentration. 
The idealized population of each state (low FRET in green, mid FRET in red, and high 
FRET in blue) is shown as a function of substrate concentration for Leu, Val, Ala, and 
Gly. 
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Figure 30. Transition density as a function of substrate concentration.  
The transition density, represented as the number of events in which the FRET 
transitions from a given initial value (x-axis) to a given final value (y-axis), as a 
function of substrate concentration for Leu, Val, Ala, and Gly. 
These results are supported by a recent report of results from fluorescence quenching 
experiments that indicate that substrate binding in S1 induces conformational changes 
at the intracellular end of the transporter196, and that lead to reduced transport. In these 
experiments, TM5, which undergoes a conformational change during inward 
opening72,197, was labeled with a fluorescence tag and the quenching of the 
fluorescence by the water-soluble reagent potassium iodide was measured in response 
to ions, substrates, and inhibitors. Substrate binding was found to induce quenching of 
fluorescence (indicating increased accessibility of the fluorophore), but when 
measured across a panel of substrates with varying transport efficacy, the magnitude 
of maximal quenching was inversely correlated with transport efficacy (the correlation 
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between the quenching rate constant and transport efficacy was 0.985). This was taken 
to indicate that while substrate binding may induce transport dynamics, poorly 
transported substrates like leucine might actually prevent this induction of dynamics 
by stabilizing either an inward closed state, or a rate-limiting intermediate in the 
inward opening process. 
Based on these observations, we hypothesized that it would be possible to decrease the 
occupancy of the inward closed state and increase the rate of transitions if F259 could 
be locked into a parallel state. To investigate this possiblity, we constructed an F259W 
mutant bound to Gly, and simulated the new system to determine if this mutant would 
exclusively sample states in which the tryptophan ring was in a perpendicular state (as 
it would not fit in the site with the rings in the parallel orientation). Our simulations 
revealed that over the course of the 3-microsecond trajectory, the F259W side chain 
did not rotate, suggesting that the mutant was constrained to the perpendicular state 
(see Figure 31). As F259 is a W in the glycine transporter GlyT, we hypothesized that 
the mutant would be folded and able to transport glycine. However, we did not expect 
binding or transport of Leu, Val, or Ala as the presence of the bulky F259W side chain 
would likely produce a steric clash with the substrate side chain. 
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Figure 31. F259W:Gly is locked in a parallel state.  
The F259W-glycine interaction is shown with the protein backbone shown in cyan 
cartoon and the substrate and side chain in licorice representation (carbon in cyan, 
oxygen in red, and nitrogen in blue). The dynamics of the dihedral angle formed by 
the CA-CB-CG-CD1 atoms over the course of the 3 microsecond simulation is shown 
to the right.  
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In related smFRET experiments with the F259W mutant, the apo state was found to 
exhibit an increased occupancy of the inward open state (see Figure 32) and the 
dynamics were also increased to levels greater than were previously seen when 
induced by alanine (see Figure 33), supporting our hypothesis that the parallel state of 
the F259 allosterically induces inward opening, whereas the perpendicular state of 
F259 allosterically induces inward closing. 
 
Figure 32. 3-State smFRET distributions for F259W as a function of substrate 
concentration.  
The idealized population of each state (low FRET in green, mid FRET in red, and high 
FRET in blue) is shown as a function of substrate concentration for Leu, Ala, and Gly. 
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Figure 33. Transition density of F259W as a function of substrate concentration. 
The transition density, represented as the number of events in which the FRET 
transitions from a given initial value (x-axis) to a given final value (y-axis), as a 
function of substrate concentration for Leu, Ala, and Gly. 
However, the effect of substrates on F259W smFRET also revealed some unexpected 
behavior. Whereas in the wild-type transporter the allosteric effect of Gly is similar to 
that of Ala, in the F259W mutant the allosteric effect of Gly is similar to that of Leu 
on the wild-type transporter (see Figure 32 and Figure 33). As the F259W side chain 
and glycine Cα are in close proximity, this may indicate that any constriction of the 
dynamics of TM6b through interaction with the substrate can lead to inward closing 
and reduced dynamics, even if the ring can be in the parallel state. Secondly, Leu and 
Ala still have an allosteric effect on intracellular dynamics, even though they are not 
expected to be able to bind in S1 in the F259W mutant, which makes the S1 pocket 
very crowded. In F259W, the Leu allosteric effect is similar to the allosteric effect of 
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Ala on the wild-type transporter. As F259W should not be able to bind Leu in S1, 
these results may indicate that the Ala/Gly allosteric effect on the wild-type 
transporter is actually mediated by binding in the S2 site. Previously, it was shown 
that L400S and F253A both blocked Ala's induction of dynamics85. While the F253A 
mutant does inhibit the Ala effect, the inhibition may be due to allosteric coupling 
between S2 and S1 rather than S1-mediated allostery.  
3.1.1.1.5.3. Discussion 
These results lead us to hypothesize that the smFRET data present two separate 
ligand-mediated allosteric effects. We propose that allosterically induced intracellular 
closure, as seen for Leu and Val, is mediated by substrate binding in S1 through the 
stabilization of the F259 perpendicular state. However, the allosterically induced 
intracellular dynamics, as seen for Ala and Gly, is mediated by S2 binding. This 
hypothesis can explain both the wild-type LeuT and F259W mutant results. In wild-
type LeuT, Leu interacts with F259 strongly, leading to an S1-dominated phenotype, 
whereas Ala and Gly do not interact with F259 strongly, leading to S2-dominated 
phenotypes. However, in F259W, Leu and Ala both do not bind to S1, leading to S2-
dominated phenotypes, whereas Gly binds to S1 and interacts with F259W, leading to 
an S1-dominated phenotype.  
To test this hypothesis, it is necessary to confirm the binding stoichiometry in the 
F259W mutant, as the above described proposal necessitates 1:1 F259W:Leu binding, 
1:1 F259W:Ala binding, and 1:2 F259W:Gly binding. Estimating the likely 
stoichiometry of binding using MD poses some difficulties, as the binding free 
energies that can be calculated using techniques like free energy perturbation198 are 
sensitive to the conformations of both the protein and the ligand. However, as future 
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work, these calculations will be performed in parallel to stoichiometry experiments. 
Furthermore, to confirm that the Leu and Ala allosteric effect on F259W is S2-
mediated, it is necessary to perform the same smFRET experiments on an F259W/S2 
double mutant, such as F259W/L400S.  
In the future, it will be necessary to decompose the S2-mediate allosteric modulation 
of intracellular gating in a similar way as to S1-mediated allosteric modulation was 
decomposed in the work presented here. While our original analysis suggested 
residues that were important for communication, the channel was expected to be 
composed of S1 and TM6b. This suggests a complex mechanism in which S2 
somehow modulates the conformation of S1, and potentially F259, to induce 
dynamics. By further investigating the S2-mediated allosteric induction of transport-
relevant dynamics, the role of this secondary site in physiological transport may 
become clearer. 
3.2. Allostery in the Transport Mechanisms of DAT 
Much of the content in this section has been adapted with permission from 199. 
As mentioned in Section 1.1.2.2. Membrane Transporters, much of the evidence for 
allosteric modulation in LeuT is mirrored by similar experiments in DAT and other 
sMATs. However, the N-terminal domains of sMATs are much longer than that of 
LeuT and are likely to be composed of significant structured segments200. These 
segments have been implicated in key mechanistic elements of NSS function including 
regulatory phosphorylation201–206, and the actions of psychostimulants201,202,207–210. 
Indeed, the involvement of the N-terminal domain (N-term) in amphetamine (AMPH)-
induced reverse transport (efflux) of the substrate has been well documented for 
different neurotransmitter transporters201,207,208,211–214. In hDAT, specifically, the 
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AMPH-induced efflux has been shown to be modulated by the first (distal) 22 residues 
in the hDAT N-term210, their electrostatic interactions with highly charged 
phosphatidylinositol 4,5-biphosphate (PIP2) lipids215, and by phosophorylation of this 
region at one or multiple Ser residues201.  
In order to investigate the potential role of the N-term as an allosteric modulator one 
of more components of the transport process, we performed extensive ( > 14 
microseconds  in total time) unbiased MD simulations of an hDAT homology model 
in a physiologically relevant lipid membrane environment, and used analysis tools 
based on NbIT to understand the allosteric coupling between the N-term and other 
functional domains.  
3.2.1. The role of allostery in spontaneous inward opening of hDAT 
As the work described in this section has been previously published199, only an 
abbreviated version of the Methods and Results, focusing on the application of NbIT, 
will be presented below. 
3.2.1.1. Methods 
Several molecular models of the full-length hDAT (residues 1-620) were prepared for 
all-atom MD simulations in explicit lipid membrane and water environment. Briefly, 
we used Modeler 9v10216 and a previously published sequence alignment of the NSS-
family proteins217 to first construct homology models for the transmembrane (TM) 
part of the hDAT (contained in residues 57-590) based on either recently released 
structure of the dDAT (PDB code:4M48)218, or on the high resolution outward-open 
X-ray structure of the bacterial member of the NSS-family, LeuT (PDB code:3TT1)72. 
The models included the substrate, dopamine (DA), positioned in the central binding 
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S1 site, two Na+ ions, positioned equivalently to those in the LeuT crystal structure, 
and a Cl- ion coordinated by residues Asn82, Tyr102, Ser321, and Asn353 of hDAT, 
based on the chloride binding site described previously219,220. 
As described earlier200, the 3D folds of the structurally unknown N- and C-terminal 
domains of the hDAT (fragments 1-57 and 591-620, respectively, that lack sequence 
homology to proteins of known fold) were generated using Rosetta-based ab initio 
structure prediction algorithms. Briefly, different fragments of the termini were 
subjected to the Rosetta ab initio fold prediction routine and for each construct, the 
predicted structures were clustered under various residue exclusion conditions. 
Clusters containing the majority of structures were identified. The conformations in 
the top clusters were evaluated with the RMSDTT iterative fitting algorithm to find 
regions with the highest structural conservation within each cluster, and the folds with 
the lowest scores (from the Rosetta energy function) in each cluster were selected.  
The predicted structures for the N- and C-termini were docked onto the two models of 
the hDAT TM bundle described above to complete the full-length hDAT models 
based on dDAT and LeuT (referred to throughout as hDATdDAT and hDAT3TT1, 
respectively). For the hDAT3TT1 model, two alternative docking poses were 
considered, resulting in two starting conformations in which the relative positioning of 
the two termini were different. For the hDATdDAT model only one docking pose was 
considered in which the positioning of the C-terminus closely followed that in the 
dDAT X-ray structure, and the N-terminus was docked so as not to contact any residue 
in the TM bundle. 
hDATdDAT and hDAT3TT1 models were immersed into a pre-equilibrated membrane 
containing an asymmetric lipid distribution of 451 lipids between the two leaflets so as 
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to resemble a lipid composition of neuronal cell plasma membranes221: 
100:40:32:27:29 mixture of POPE/POPC/PIP2/POPS/Cholesterol on the intracellular 
leaflet, and 176:29:18 mixture of POPC/DPPC/Cholesterol on the extracellular leaflet. 
For each transporter-embedded membrane patch, lipids overlapping with the protein 
were removed. After solvating with TIP3P water, the transporter-membrane 
complexes were neutralized with either K+Cl- or Na+Cl- salt, resulting in a final atom 
count of ~150,000.  
Simulations of the hDATdDAT and hDAT3TT1 constructs in the corresponding 
membrane environments were carried out with NAMD software version 2.9178. During 
this stage, the backbone of the protein was first fixed and then harmonically 
constrained. The solvent was initially prevented from entering the lipid-water 
interface. The constraints on the protein backbone were released gradually in three 
steps of 300 ps each, changing the force constants from 1, to 0.5, and 0.1 kcal/ (mol 
Å2), respectively. This step was followed by relatively short (50-100ns) unbiased MD 
simulations performed with 2fs integration time-step and under the NPT ensemble (at 
T=310K), using the Particle-Mesh-Ewald (PME) method for electrostatics and the 
Nose-Hoover Langevin piston to control the target 1atm pressure, with Langevin 
piston period and decay parameters set to 100 fs and 50fs, respectively. 
After this equilibration phase, long, microsecond-scale unbiased MD simulations were 
initiated on the Acellera GPU cluster that runs the specialized MD simulation software 
ACEMD222. ACEMD allows computations with standard CHARMM force fields and 
for all the runs (including the equilibration phases with the NAMD described above) 
we used the all-atom CHARMM27 force field for proteins with CMAP corrections176, 
the CHARMM36 force field for lipids177, the TIP3P water model, and the CHARMM-
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compatible force-field parameter set for PIP2 lipids223. The simulations with ACEMD 
implemented the PME method for electrostatic calculations, and were carried out with 
4 fs integration time-step. The computations were conducted under the NVT ensemble 
(at T=310K), using the Langevin Thermostat with Langevin Damping Factor set to 
0.1.  
The temporal correlation between time-dependent variables extracted from the MD 
simulations was quantified by calculating the Pearson correlation coefficients between 
the pairs of variables. To cluster the dynamic quantities based on the strength of 
temporal correlations between them, we then performed agglomerative mutual-
hierarchical clustering224 on the matrix of correlation coefficients, using the mutual 
information as the distance criterion. The linear approximation of the mutual 
information was calculated, and corrected for dimensionality using the generalized 
correlation coefficient156. Briefly, the clustering algorithm first assigns each variable 
to its own branch, and then calculates the pairwise generalized correlation coefficient 
between all branches. Two branches with the highest correlation are then merged, and 
the generalized correlation coefficient between the new branch and all other branches 
are recalculated. The algorithm continues until all variables are members of the same 
branch. In our application here, the dendrogram (tree) is built from the small number 
of medium-sized clusters consisting of highly correlated variables. The moderately 
correlated clusters are then merged into one large cluster. Finally, the tree is completed 
with the remaining small clusters that are weakly correlated to both each other and the 
large cluster.   
In order to quantitatively identify when medium-sized clusters of interest were 
merged, we used the Fowlkes-Mallows Index (FMI)225 as a measure of similarity 
between the different clustering before and after each merger. The FMI is defined as: 
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In the above, n is the number of objects being clustered and M is a matrix with rows 
equal to the number of clusters in the pre-merger clustering, columns equal to the 
number of clusters in the post-merger clustering, and elements mij equaling the number 
of common members in cluster i of the pre-merger clustering and cluster j of the post-
merger clustering. The FMI ranges from 0 to 1, with low values indicating merger of 
similarly sized clusters that significantly change the clustering, and high values 
describing mergers that do not change the overall clustering, such as the joining of 
small clusters (compared to other existing clusters) to each other or to a larger cluster. 
Therefore, the mergers of the medium-sized clusters will have relatively low FMI, 
whereas the mergers of small clusters to the large cluster (as is observed at the end of 
the clustering) will have a high FMI.  
3.2.1.2. Results 
In this section, results that do not pertain to the NbIT method will be described briefly 
and can be found in greater detail in the published manuscript199.  
By measuring several variables that are believed to be associated with conformational 
differencing between gating states of the transporter, we found that spontaneous 
inward-opening occurred in several simulations. Figure 34 shows the count of water 
molecules inside the EC and IC vestibules during the hDATdDAT simulation, which 
indicates a rapid transitioning of the transporter from the initially outward-open state 
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to the occluded state by the loss of hydration in the EC vestibule and increase in water 
count in the IC vestibule (see Figure 34).  
 
Figure 34. Spontaneous inward opening of hDAT.  
(A) Snapshots of the hDAT TM bundle (gray cartoon) in the hDATdDAT trajectory at 
0.13 and 1.3 µs time-points. Red and blue spheres represent oxygen atoms of the water 
molecules in the IC and EC vestibules, respectively (see Methods for description of 
the water count algorithm). The substrate, DA, is shown in van der Waals rendering. 
The TM1a segment is labeled. (B) Time evolution of the number of water molecules 
in the IC (red) and EC (blue) vestibules in the hDAT/dDAT simulation. The green 
arrows denote time-points at which the snapshots in panel A were taken. 
Distance measurements between various IC regions of the transporter (see Figure 
35A-C), reveal large-scale concerted motions of the intracellular TM1a, TM6b, and 
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TM9 segments during the subsequent trajectory interval (~0.2-0.6 µs), whereby 
TM1a-TM6b, TM1a-TM9, and TM6b-TM9 distances increase by ~4.5Å, 8Å, and 5Å, 
respectively. As a result, the TM1a and TM9 segments swing away from the TM 
bundle (see Figure 35F-G) and the IC vestibule opens, allowing the large influx of 
water molecules (see red trace in Figure 34B).   
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Figure 35. Time evolution in the hDATdDAT simulation of Cβ-Cβ distances 
between residues in various TM segments.  
(A) I67 (in TM1a) and L447 (in TM9); (B) I67 (in TM1a) and S333 (in TM6b); (C) 
S333 (in TM6b) and L447 (in TM9); (D) E307 (in TM6a) and F171 (in TM3); and (E) 
F171 (in TM3) and K92 (in TM1b). Panels F and G depict conformations of the hDAT 
TM bundle (silver) in the initial and final frames of the trajectory. The IC and EC 
segments from panels A–E are labeled and colored in yellow. Blue arrows in panel F 
indicate the direction of movement of the different regions in the transition from F to 
G. Collective motions of TM1b and TM6a segments are highlighted by a red dotted 
oval. 
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Collectively, the data indicate that the hDATdDAT simulation captures the event of the 
inward-opening in hDAT, which follows dynamic trends which are consonant with the 
DEER distance measurements226 in LeuT where TM1a, NT (the fragment of the N-
terminus adjacent to TM1a), TM6b, and TM7a segments undergo the most substantial 
ion- or ligand-dependent movements at the IC side. Computational explorations of 
dynamics of LeuT68,82, DAT227, and SERT228 showed that the isomerization to the 
inward-open state induces a destabilization of the ion in Na2. Consistent with these 
findings, we observe that the transition to the inward-open state in our simulations is 
accompanied by the spontaneous release of the Na+ ion from the Na2 site. 
We note that a similar isomerization event was detected in the two 4 µs long control 
simulations initiated from the hDAT3TT1 model. Importantly, we found that the inward 
opening in these simulations followed dynamic trends largely similar to those 
observed in hDATdDAT.  
We additionally found that PIP2 lipids mediated an interaction between the N-term and 
ICL4, which appears to be related to the intracellular opening.  To establish the 
relation between the PIP2-mediated association of the N-term with ICL4, and the 
sequence of rearrangements leading to the inward-opening transition, we clustered the 
time-dependent variable describing PIP2-mediated N-term/ICL4 contacts with the 
several other dynamics measurements. To determine the temporal relationship 
between the structural motifs that underlie the isomerization event in the hDAT and 
the PIP2-controled N-term/ICL4 dynamics we identified the dominant clusters using 
the FMI measure described in Methods above. The resulting dendrogram is shown in 
Figure 36. 
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Figure 36. Mutual information dendrogram of several measures of hDAT 
structure.  
The dendrogram shows a merger of two clusters (variables and limbs shown in red and 
blue) and a connection of the resulting large cluster to smaller branches of the tree (in 
black). The variables in black are weakly correlated with those belonging to the 
colored clusters; as assessed by the Fowlkes–Mallows Index, the variables in black do 
not affect the clustering significantly. 
The dendrogram shows a large cluster of highly correlated variables (rendered in red) 
consisting of distance changes on the IC and EC sides of the transporter. The cluster 
identifies strong temporal correlations between the dynamics of the 
TM1a/TM6b/ICL4/TM9 segments on the IC end, and the distance changes related to 
the movements of TM1b/TM6a regions on the EC vestibule combined with the 
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movement of the ECL4b region with respect to TM1b (involving residues W84, F387, 
and F391). Connected to this limb of the dendrogram is another large branch (shown 
in blue in Figure 36), which consists mostly of additional dynamic variables that 
describe the opening of the IC vestibule during the isomerization. This branch also 
contains the PIP2-mediated N-term/ICL4 contacts (“NT/ICL4 cont.” in Figure 36), as 
well as the dynamics of the Na2 ion.  
Clustering analysis on the same quantities extracted from hDAT3TT1Run1 and 
hDAT3TT1Run2 trajectories again revealed merger of two clusters (in red and blue 
colors) containing various IC and EC structural motifs that describe inward-opening of 
the transporter (most prominently, dynamics in TM1a/TM6b/ICL4/TM9 segments), 
movement of the Na2 ion, the extent of PIP2-mediated N-term/ICL4 contacts, and the 
dynamics of the ECL4b. Together, the clustering analysis quantitatively establishes 
coupling between the PIP2-mediated N-term/ICL4 association and the structural 
hallmarks related to the inward-opening transition in the hDAT.  
The prominent role played by the ICL4 region in the inward opening transition 
prompted a deeper analysis of the manner in which dynamics in the ICL4 propagates 
to the functional sites of the transporter. To this end we quantified in the simulated 
trajectories the total intercorrelation between the ICL4 segment and (i)-the residues 
that line ion binding Na1 and Na2 sites, and (ii)- the residues in the primary S1 and the 
presumed secondary S2 substrate binding sites in hDAT.  
The time evolution of the total intercorrelation coefficient (rINTER), used to quantify 
the extent of coupling between the collective motions of the ICL4 region and various 
functional sites, was calculated from the hDATdDAT, hDAT3TT1Run1, and 
hDAT3TT1Run2 trajectories and is shown in Figure 37.  
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Figure 37. Total intercorrelation coefficient between the residues in ICL4 and in 
different functional sites of the hDAT.  
Substrate binding S1 and S2 sites (green and red, respectively); Na+ ion binding sites 
Na1 and Na2 (blue and black, respectively). The intercorrelation coefficients are 
shown separately for simulations Run1 (A), Run2 (B), and hDATdDAT (C) and were 
obtained as averages over 500 ns time intervals by sliding the analysis windows by 50 
ns.  
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Figure 37 reveals strong coupling (large rINTER values) between the dynamics within 
the ICL4 segment and that in the functional sites of the transporter in the initial stages 
of the hDATdDAT, hDAT3TT1Run1, and hDAT3TT1Run2 simulations. The reduction in 
coupling that occurs within the first ~0.5µs could be due to collective relaxation 
dynamics from the starting outward-open model towards the occluded state in these 
systems. However, since the initial 0.5 µs interval coincides in time with the inward 
opening in these simulations (see above), the results may also indicate that the 
isomerization event is preceded by highly coupled motions in the ICL4 and the 
functional regions. In fact, the same analysis performed on trajectories in which PIP2 
was not a component of the membrane (dDATΔPIP and Run2ΔPIPa trajectories), for 
which the initial protein models where the same as in hDATdDAT and hDAT3TT1Run2 
simulations, respectively, but in which the hDAT did not transition to the inward-open 
state, revealed rINTER values equivalent to the late time values of hDATdDAT, 
hDAT3TT1Run1, and hDAT3TT1Run2. This leads to the inference that the high 
correlations measured in the trajectories collected in PIP2-enriched membranes are 
indeed related to the transition to the inward-open state observed in these systems.  
Figure 37 also shows that after the initial decrease in the correlations, the coupling 
between the ICL4 and some of the functional sites rises again in the hDATdDAT, 
hDAT3TT1Run1, and hDAT3TT1Run2 systems. Especially notable is the higher value of 
rINTER for the S2 site (red traces in Figure 37). The S2 site in hDAT includes residues 
W84, P387, and F391, which are involved in the conformational rearrangements 
accompanying the inward opening (i.e., the specific motion in ECL4b results in 
pulling F391 towards W84 while P387 moves away from W84). Thus, we find that the 
observed strong correlations between the ICL4 and the S2 site is primarily due to 
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highly coupled motions in the ICL4 segment and the S2 residues from the ECL4b 
loop, adjacent to P387, that participate in the described pulling motion.  
The timing of the increase in correlations shown in Figure 37coincides with the event 
of Na+ release from the Na2 site (at ~0.75, 1.25, and 1.0 µs time-points in the 3 
simulations hDATdDAT, hDAT3TT1Run1, and hDAT3TT1Run2 systems, respectively). 
After the release is complete, we observe a slow relaxation of the correlations (see 
hDAT3TT1Run2 in Figure 37), with the coupling between ICL4 and the S2 site 
remaining the highest among all the correlations considered. Collectively, the NbIT 
analysis demonstrates and quantifies the allosteric coupling between the ICL4 and the 
functional sites during the PIP2-mediated inward-opening of the hDAT, and identifies 
the S2 site as the region with the strongest coupling to the ICL4, suggesting that this 
distant communication is mechanistically important for the inward-opening transition. 
3.2.1.3. Discussion 
The analysis of the >14 µs unbiased atomistic MD trajectories of a full-length model 
of the hDAT in lipid membranes presented here addresses, to our knowledge for the 
first time, the mechanistic involvement of the N-terminal region of the hDAT in the 
functionally relevant conformational transitions of the transporter involved in the 
inward-opening of the hDAT. The results show that the conformational isomerization 
triggered by the strong tendency of the N-term to associate with the ICL4 segment 
through PIP2-mediated electrostatic interactions. The mechanistic consequences of the 
PIP2-mediated N-term/ICL4 association that emerge from this analysis are the 
disruption of a conserved IC network of ionic interactions, which triggers the inward-
opening by destabilizing the IC network of ionic interactions, and the associated 
release of the Na+ ion from the Na2 site causes destabilization of the substrate DA in 
	  188	  
the primary S1 site. The consequences of these interactions for the functional 
mechanism of the transporter are underscored by our findings showing that inward 
opening is accompanied by concomitant movements in the EC vestibule, and that 
isomerization to the inward-facing state in hDAT results in the release of the Na+ ion 
from the Na2 site, and the destabilization of the substrate (DA) in the S1 site.  
Our analysis using NbIT found that the collective motions triggered by the N-
term/ICL4 association on the intracellular side are strongly coupled to collective 
motions in the extracellular vestibule and in the substrate and ion binding sites. 
Further substantiating the mechanistic importance of the PIP2-mediated N-term/ICL4 
interactions, is the clear identification from the mutual information clustering (MIC) 
results of their effect on the intracellular side. This substantiates the allosteric coupling 
of these N-term/ICL4 interactions to the functional sites in hDAT involved in inward-
opening dynamics. Thus, the MIC revealed a strongly coupled helical bundle 
(composed of TM1a, TM6b, and TM9) in the intracellular side that was highly 
correlated to the N-term/ICL4 association, suggesting how the N-term can modulate 
the stability of this bundle and thus modulate intracellular gating. In combination, 
these results identify the N-terminus as an important allosteric modulator of the 
functional inward-opening and ion/substrate release in hDAT. 
3.3. The D2 Dopamine Receptor 
3.3.1 The asymmetric D2 receptor homodimeric signaling complex as an 
illustration of AIM-based analysis of allosteric coupling mechanisms 
The D2 dopamine receptor is know to signal as both a monomer and a homodimer, but 
a novel experimental construct developed in the Javitch lab 229 was required to make 
possible the characterization of the dimer as a signaling unit. The results demonstrated 
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experimentally that rather than signaling through each monomer independently, the 
D2R homodimer signals through a single protomer at a time (the signaling protomer 
will be referred to as “protomer A”). Furthermore, the results indicate that the function 
of the protomers is characterized by negative cooperativity: the stabilization of the on 
state of the non-signaling monomer (“protomer B”) by agonist biding decreases 
signaling by protomer A, whereas the stabilization of the off state of protomer B by the 
binding of an inverse agonist increases signaling by protomer A. Lastly, it is shown in 
229 that perturbations known to completely disrupt activation in the monomer, 
including (i)-ablation of ligand binding, (ii)-removal of intracellular loop 3 (IL3), and 
(iii)-mutations to (a)-intracellular loop 2 (ICL2), (b)-the conserved DRY motif, and 
(c)-the conserved NPxxY motif –  all disrupt activation in the homodimer when 
applied to protomer A. Unexpectedly, however, the perturbations in (iii) also disrupt 
activation when applied to protomer B.  
To explain the experimental results in a structural context, a molecular model of the 
homodimer complex with the G protein that senses the activation of the receptor was 
constructed in 229 using the active state crystal structure of another GPCR, rhodopsin, 
bound to its G protein, transducin. In this molecular model the interface of the 
homodimer involves the 4th transmembrane segment (TM4), and the G protein 
interacts with the signaling protomer A through IL3, IL2, and helix 8 (H8), while 
protomer B interacts through its IL2 and H8 (see Figure 38). We used AIMs as 
described below to explore the feasibility of the allosteric properties proposed for this 
structural model.  
Based on the experimental measurements of activation, an AIM representing the 
homodimer was constructed starting with a model for a signaling monomer (monomer 
A) and a G protein that can bind this monomer and become activated. Since the 
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experiments had shown229 that mutations in IL2, the DRY motif, and the NPxxY motif 
has identical phenotypes with regard to G protein binding, we represented all three as 
a single structural component termed conserved binding motifs (CBMs), due to their 
role in G protein activation by the GPCR230–234.  In the AIM constructed accordingly 
(see Figure 38A), the signaling monomer is composed of the following structural 
components: a ligand that can bind and unbind, a transmembrane domain, and two 
intracellular regions (IL3 and the CBMs); the G protein is composed of a structural 
component that can bind and unbind the signaling monomer, and one that can be 
activated. The conformational energies of the components of each protomer were 
chosen to prefer the off state ( u
conf = 1 ), and the interaction energies between all 
components were negative such that they preferred to be in the same state ( u
int = −1 ). 
We find that this coarse grained model responds as expected to agonists, antagonists, 
and inverse agonists (see Figure 38B). To create a homodimer with negative 
cooperativity, we then added to the AIM a negative interaction between the one 
monomer that can bind G protein (which is now protomer A) and one that cannot 
(protomer B), represented as a positive interaction energy between their 
transmembrane domains (see Figure 38C). We then calculated the allosteric efficacy 
for the homodimer when promoter A was bound to agonist and protomer B was 
simultaneously bound to either an agonist, an antagonist, or an inverse agonist.  This 
model reproduces the observed negative cooperativity (see Figure 38D). 
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Figure 38. Analysis of the AIM for a well-characterized asymmetric D2 
homodimer of the dopamine D2 receptor (D2R). 
(A): The D2R monomer AIM. (B): The effective interaction energy calculated for the 
D2R monomer AIM is presented for ligands that are agonists, antagonists, and inverse 
agonists, and also for the mutation of either IL3 or the conserved binding motifs 
(CBMs). (C): A molecular model of the homodimer obtained as described in the text, 
is shown with each AIM domain labeled in white on the structural representation. 
Protomer A is in blue, protomer B is in orange, and the G protein is in red. (D): The 
effective interaction energy for the D2R homodimer AIM is presented for different 
combinations of the states of protomer A (indicated by A in the top row) and those of 
protomer B in the dimer (B, bottom row).  
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To explore the effects of removing IL3 and introducing the CBM mutations, we 
constructed AIMs with the perturbations modeled as either i) stabilizing the off state of 
the mutated structural component, ii) stabilizing its on state, or iii) reducing the 
interaction energy between the structural component and the G protein to 0. Modeling 
the two perturbations in protomer A by imposing (i) or (iii), reduced activation as 
expected. However, stabilizing the off state of IL3 in protomer B increases activation 
in our model when it should have no effect, indicating that treating the IL3 mutation 
such that it eliminates interaction between IL3 and the G protein is a better model. On 
the other hand, treating the CBM perturbation in protomer B as stabilizing the off state 
leads to more activation, so that the effect of the mutation cannot be explained without 
an interaction between the CBM in protomer B and the G protein. To reconcile these 
effects in the model, we assumed that protomer B and the G protein bind in a state-
independent way (the G protein’s state independent binding is represented by  
uG binding
conf
 
in the AIM), and modeled the CBM mutation effect as further decreasing state-
independent binding. We find that if  
uG binding
conf
 is increased from 1 to 2, allosteric efficacy 
is reduced (see Figure 38D). The finding that state-independent interactions between 
the G protein and CBMs on both protomer A and protomer B are required for 
activation is in full agreement with the structural model of the dimer as presented229, in 
which not only protomer A, but also ICL2 and H8 from protomer B interact with the G 
protein directly. As this structural information was not used in the construction of the 
AIMs, the prediction from the allosteric model underscores the ability of the AIMs-
based approach in this illustration to connect the representation of allostery with the 
structural context of the modeled biomolecular systems. 
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3.4. 5-HT2AR 
Of the fifteen different receptors activated by the neurotransmitter serotonin, the 5-
HT2A subtype is of great interest not only because it plays a crucial role in cognitive 
processing but also because it is the target of a large number of medications including 
antidepressants and antipsychotics235–237. Remarkably, several 5-HT2A agonists, such 
as LSD28, are known to display hallucinogenic properties. Indeed, a large body of 
evidence indicates that the common target of all hallucinogens is the 5-HT2A receptor 
(5-HT2AR)28,235,237.  
Given that 5-HT2AR agonists and partial agonists can exhibit hallucinogenic properties 
or not by activating the same receptor, indicates a strong functional selectivity. 
Functional selectivity by hallucinogenic ligands (HLs) and non-hallucinogenic ligands 
(NHLs) at the level of PLC and PLA signaling pathway activation has been observed 
pharmacologically at 5-HT2AR and 5-HT2CR238,239,240,241. Furthermore, it has been 
observed that in a transgenic mouse model with humanized HT2AR, hallucinogenic 5-
HT2AR agonists induce a gene expression profile distinct from that elicited by non-
hallucinogenic 5-HT2AR agonists242,235.  In addition, recent computational work by our 
lab investigated the activation of the 5-HT2A serotonin receptor by endogenous, 
hallucinogenic, and non-hallucinogenic ligands using Molecular Dynamics (MD) 
simulations of homology models of 5-HT2AR233. This work indicated that these 
ligands can induce very different structures and dynamics in known functional micro 
domains similar findings were reported by others for the β2AR adrenergic receptor 
using computational243 and experimental techniques244,245. Lastly, very recently, 
structures of 5-HT1BR and 5-HT2BR bound to the agonist ergoline were solved using 
x-ray crystallography246,247. Ergoline displays no β-arrestin bias in 5-HT1BR while 
showing substantial bias in 5-HT2BR. While nearly all known activation motifs were in 
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their “active-like” conformation in both structures, the conserved PIF motif displayed 
an “inactive-like” conformation in the 5-HT2BR:ergoline structure, providing the first 
structural evidence that allosteric modulation of known functional microdomains may 
contribute to functional selectivity. These results support the role of specific structural 
components in activation and inactivation and also indicate that ligands induce distinct 
conformational ensembles that may be responsible for functional selectivity. 
3.4.1 Identification of Hallucinogen-Specific Allosteric Modulation of 5-HT2AR  
The Methods and Results described in this section are an abbreviated adaptation of 
previously published results131,248, adapted with permission. This will be followed 
below by a more complete description of new analysis of these trajectories, which is 
currently in preparation.  
The remarkable functional selectivity of HL compounds on 5-HT2AR235,249–251, 
included in the ample literature on the experimentally determined properties of the 
receptor and of structure-activity relations for its ligands28, prompted us to investigate 
structural and dynamical elements associated with the functional selectivity of the HL 
and cognate NHL 5-HT2AR agonists235. To cover a chemically distinct ligand space, 
we selected 5-HT2AR complexes with the four agonists (i-iv) described below for 
extensive unbiased all-atom MD simulations. We chose two HL compounds: (i)- the 
hallucinogenic substituted amphetamine, 2,5-dimethoxy-4-iodoamphetamine (DOI), 
and (ii)- the prototypical hallucinogen L-lysergic acid diethylamide (LSD). DOI has a 
relatively small and flexible chemical structure, whereas LSD is representative of the 
larger and more rigid chemical family of ergots. We also selected two cognate NHL 
compounds: (iii)- the endogenous 5-HT2AR ligand serotonin (5-HT), and (iv)- the 
partial agonist R-lisuride (LIS) that belongs to the same chemical family as LSD but 
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has a very different pharmacological fingerprint with regards to perceptional and 
cognitional phenotypes235. These ligands are shown in Figure 39.  
 
 
Figure 39. Schematic representation of the MD simulations and different ligands.  
(A) The structures of the four ligand agonists involved in this study, two hallucinogens 
(LSD and DOI) and two non-hallucinogens (5-HT and LIS), are depicted. For 
comparison the structure of ergotamine is also depicted. Ergotamine is one of the 
ligands co-crystallized with the closely related serotonin receptors, 5-HT1BR, and 5-
HT2BR. (B) Starting from the same 5-HT2AR structure, five different simulations were 
carried out. Although the production phase consists of 1000 ns, during the analysis 
just the second half, from 500 ns to 1000 ns, was considered. The midpoint of the 
simulations is indicated with black dots. Previously, a short segment of the two of the 
simulations (5-HT and LSD) were included as part of a study from our group233. These 
segments range from the starting point until the point indicated by an open circle in 
each of the simulations, ~175 ns for 5-HT and ~250 ns for LSD. 
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All four ligands have been extensively characterized with diverse biophysical and 
physiological techniques in vitro and in vivo with respect to serotonergic signaling 
efficacy across several downstream pathways and hallucinogenic phenotypes235.  
3.4.1.1. Methods 
Microsecond unbiased all-atom MD simulations were carried out in the membrane-
embedded 5-HT2AR in the unbound form (APO) and in complex with four different 
agonists: 5-HT, LSD, DOI and LIS. For two of the systems described here (5-
HT2AR/5-HT) and (5-HT2AR/LSD), shorter segments of the simulations (relative to the 
extent of the trajectories presented in this work) were part of a previous study from our 
group233. As a control, MD simulations of two closely related 1B (5-HT1BR) and 2B 
(5-HT2BR) human serotonin receptors in complex with the 5-HT ligand were carried 
out (100 ns each). All analyses were performed on the second half of the trajectories. 
3.4.1.1.2.  5-HT2AR structure complexes.  
The different systems were constructed as described previously233. Briefly, the 5-
HT2AR model was created with homology modeling using as templates, the high-
resolution X-ray crystal structures of the β2 adrenergic receptor (PDB accession code, 
2RH1) and bovine rhodopsin (PDB accession code, 1U19)252. The crystal structures of 
two closely related human serotonin receptors, the 1B (5-HT1BR) and 2B (5-HT2BR) 
receptors, were solved after the MD simulations presented here were collected246,253 
and thus, they were not considered as template for the 5-HT2AR structure, but were 
used for validation and controls. The resulting 5-HT2AR structure is comprised of the 
segment S67 to K400 (a 28-residue segment in the long ICL3, the first 66 N-terminal 
residues and the last 70 C-terminal residues were not included, see Fig. S3A in SI) and 
was capped at its N- and C-termini by the acetyl and N-methylamide groups, 
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respectively. A palmitoyl moiety was attached at position C397 based on the structural 
information of the β2 adrenergic receptor (PDB accession code, 2RH1). All MD 
simulations started from the same 5-HT2AR structure and the initial positioning of the 
agonists in the ligand binding pocket of 5-HT2AR was carried out by using several 
docking protocols (i.e., Autodock 4254, Simulated Annealing Docking255, and Glide 
and IFD (Schrödinger Inc.)) and were consistent with experimental information233. 
The 5-HT2AR systems were embedded in a physiologically relevant lipid membrane 
composed of a symmetric 7:7:6 mixture of SDPC (1-stearoyl-2-docosa-hexaenoyl-sn-
Glycero-3-phosphocholine):POPC (phosphatidylcholine):Cholesterol, respectively. 
The GPCR-membrane systems were then hydrated by using the TIP3P water model 
followed by neutralization of the entire system by introducing ions to generate a NaCl 
salt concentration of 0.15 M233.  
The parameters for the different ligands were obtained as described previously233.  
3.4.1.1.3.  All-atom molecular dynamics simulations.  
Details of the 5-HT2AR simulations are as described previously233. Briefly, unbiased 
all-atom MD simulations were performed using NAMD178 with the all-atom 
CHARMM27 force field with CMAP corrections for proteins and lipids176 for 
trajectories of at least 1 microsecond. Langevin dynamics and the hybrid Nosé-Hoover 
Langevin piston were used to maintain constant temperature (310 K) and constant 
pressure (1 atm), respectively. Full electrostatics were evaluated using PME 
techniques with grid spacing less that 1.0 Å in each dimension and a fourth-order 
interpolation. Bond lengths involving hydrogen atoms were constrained to their 
equilibrium values by the SHAKE algorithm256. All MD simulations were performed 
with a 2 fs time step.  
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3.4.1.1.4. Structural alignment.  
For the structural analyses, all the structures were aligned to the structure of the β2 
adrenergic receptor (PDB accession code, 2RH1) oriented with respect to the lipid 
bilayer according to the Orientations of Proteins in Membranes (OPM) database257 by 
using the Cα atoms of the TM helices. Such alignment ensured that the Z-coordinate 
axis coincided with the helical axis of the TM bundle. 
3.4.1.1.5. Principal component analysis.  
We used PCA to quantify the major motions in ICL2. Using the Cα and heavy atom 
covariance matrices, we first found the first principal component (PC1) of the ICL2 
movement in each system, which represented a large portion of the variance in all 
systems except for APO. To investigate differences in ICL2 dynamics in all five 
systems, we calculated PC1 for each simulation and then calculated the variance 
across that principal component for each other simulation. Atomic fluctuation 
correlations were calculated using carma179, and PCA was performed with in-house 
programs.  
3.4.1.2. Results 
3.4.1.2.1. ICL2 rigid-body dynamics are modulated upon ligand binding.  
The application of the total intercorrelation and entropy decomposition measures to 
characterize rigid-body behavior was illustrated with the analysis of the results from 
for 1 microsecond MD simulations of 5-HT2AR, in the apo and 5-HT-bound states.  
The analysis focused on the secondary structure of ICL2 of the 5HT2AR. Residues 
I181-F186 were helical within the initial structures of both states, and traditional 
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secondary structure calculation using stride 258 indicates that the interior helical turn, 
composed of residues H182-R185, is stable throughout our simulations, with the turn 
being entirely helical for 84.3% of the apo trajectory and 89.7% of the 5-HT-bound 
trajectory. For the remainder of the analysis, we consider residues I181-F186 as ICL2. 
We then calculated generalized correlation coefficients (Eq. (1.140)) using N-body 
mutual information (Eq.(1.141)) and N-body total intercorrelation (Eq. (1.168)) for 
ICL2 in both simulations to quantify the rigid-body behavior of the helical segment 
and to assess if there were differences in rigid-body behavior between the two states 
that could not be observed by calculating the secondary structure alone.  We found 
that the apo state displayed weak rigid-body dynamics (rmutual = 0.30 and rTCinter = 
0.60), while the 5-HT bound state displayed stronger rigid-body dynamics (rmutual = 
0.52 and rTCinter = 0.89). These results indicate that there are increased rigid-body 
motions in the 5-HT bound simulation, although both states have a helical segment in 
the ICL2.  
Using the entropy decomposition framework to analyze the dynamics of IL2, one 
would expect a high RBF and CO if the helical segment truly behaves as a rigid body 
helix, and a moderate RBF and low CO if the backbone is behaving like a rigid body 
but the side chains are not (likely a more accurate expectation based on the previously 
calculated generalized correlation coefficients).  Conversely, if ICL2 were behaving as 
a completely disordered segment, which is not expected from its helical secondary 
structure, RBF and CO would be low. We find that while ICL2 is helical when the 
receptor is unbound, the RBF and CO parameters calculated from both the mutual 
information and total intercorrelation are low (see Table 7), indicating that ICL2 
contains a very flexible helix. In addition, we find that the RBF increases in the 5-HT 
bound state of the 5-HT2AR. Interestingly, the comparison of COmutual to COinter reveals 
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different trends upon 5-HAT binding, indicating that the choice of information 
measure can influence the interpretation of the system’s dynamics. Thus, most of the 
high-order correlation are identified as rigid body using total intercorrelation, but not 
when using mutual information. These results indicate that there is a significant 
increase in the rigidity of the IL2 upon ligand binding although the helical secondary 
structure is retained and comparable in both states.  
Table 7. Rigid-body parameters of the apo and 5-HT-bound 5-HT2AR. The 
standard error on the mean of 50 bootstraps is displayed in parenthesis. 
 Apo 5-HAT 
Mutual Inter mutual inter 
r 0.30 
(0.002) 
0.60 
(0.003) 
0.52 
(0.002) 
0.89 
(0.002) 
RB
F 
0.16 
(0.002) 
0.50 
(0.002) 
0.39 
(0.002) 
0.90 
(0.002) 
CO 0.77 
(0.001) 
1.91 
(0.001) 
1.11 
(0.004) 
0.67 
(0.005) 
Moreover, a greater overall rigidity is indicated for both systems when using total 
intercorrelation as opposed to mutual information, as seen in the N-body generalized 
correlation coefficient and rigid-body fraction. We expect this result to be general and 
apply to other systems as well. However, we find that the RBF and CO parameters are 
greater when using mutual information. Thus, we find that ICL2 of 5-HT2AR 
transitions from a flexible helix to a more rigid-body helix upon binding the 
endogenous agonist 5-HT. As previous crystallography data 33,44,259,260 and 
computational analysis 261,262 have pointed to the helix properties of IL2 in relation to 
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GPCR activation for different pathways, it is possible that ligands can determine their 
agonist bias by allosterically modulating the rigid-body properties of IL2 upon 
binding. 
3.4.1.2.2. ICL2 adopts distinct conformations in 5-HT2AR complexes with different 
ligands.  
From the analyses of the microsecond MD simulation trajectories of 5-HT2AR with 
different ligands, we found that ICL2 conformations favored in the HL-bound systems 
are different from those favored in the NHL-bound and in the unbound constructs. The 
distinct conformations were monitored by defining the center of mass of the helical 
segment on ICL2 as a collective variable, and calculating the root-mean-square 
deviation (rmsd) of the center of mass of the ICL2 along the trajectories, relative to the 
center of mass of the ICL2 in the initial structure. The distributions of the rmsd values 
show two distinct conformations for the ICL2 (see Figure 40). 
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Figure 40. RMSD distribution and representative structures of ICL2.  
(A) The distributions of rmsd values, relative to the starting structure, are shown for 
the five simulated systems, 5-HT2AR/5-HT, 5-HT2AR/LIS, 5-HT2AR/LSD, 5-
HT2AR/DOI and 5-HT2AR (APO), respectively. The more outward-upward 
conformations (blue) are highly favored in just the hallucinogenic systems. (B) 
Representative ICL2 structures for the five simulated systems, as seen from the 
intracellular side, are shown. As a reference, the initial structure (gray) is also depicted 
in each case. The more outward-upward ICL2 conformations are colored blue whereas 
the more inward-downward conformations are colored yellow. In these views, the 
more outward ICL2 conformations correspond to larger values in the X-axis 
coordinate. Interestingly, the outward-upward conformations (blue) are preferentially 
stabilized in the hallucinogenic systems, LSD and DOI. The thickness of the ICL2 
representation corresponds to the percentages of the distributions from (A). In the case 
of LIS, any of the conformations was sorted as part of the “blue” conformations. The 
helical axis of the TM bundle is represented by a magenta triangle in each case. 
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The more “outward” and more “upward” oriented ICL2 conformations (colored blue 
in Figure 40B) are seen to be highly favored by HL (DOI and LSD, see middle panel 
in Figure 40B) in contrast to the more “inward” and more “downward” ICL2 
conformations (colored yellow in Figure 40B) adopted when the NHL (5-HT and 
LIS) are bound or when the unbound (APO) receptor is simulated. The representative 
structures of the ICL2 segment conformations in each of the studied systems (Fig. 1B) 
show that the more outward conformations (favored by HL) situate the ICL2 segment 
farther away from the axis of the TM helical bundle, whereas more upward 
conformations place the ICL2 segment closer to the center of the membrane bilayer 
Representative structures in the 5-HT2AR/DOI complex are also depicted in Figure 
41. In this particular complex, ICL2 selectively prefers more outward-upward 
conformations (colored blue), but explores as well the inward-downward ICL2 
conformations preferred by the NHL (colored yellow), see Figure 41. All ligand-
bound receptors exhibited dynamic transitions between states, but with notable 
preferences related to their pharmacological class (see Figure 40B).  
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Figure 41. Conformations explored by the ICL2 in the 5-HT2AR/DOI complex.  
Lateral view of two representative structures of the 5-HT2AR/DOI system. The more 
outward (relative to the helical axis of the TM bundle, shown here as a magenta line) 
and more upward (that is, closer to the center of the lipid bilayer) are preferred in the 
hallucinogenic systems (DOI and LSD), colored here in blue. In these views, the more 
outward ICL2 conformations correspond to larger values in the X-axis coordinate 
while the more upward conformations correspond to larger values in the Z-axis 
coordinate. The more inward-downward conformations are preferentially sampled in 
the non-hallucinogenic systems (5-HT and LIS) and in the APO form, colored here in 
yellow. As a magnitude reference, the Cα atoms of residue H183 are depicted in both 
structures and the distance for these particular structures is 5.3 Å (indicated as a red 
line). The predicted intracellular boundary of the bilayer is depicted as a brown line.  
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In addition, we calculated the generalized correlation coefficient between the center of 
mass and the first principal component (PC1) of the ICL2 motion, which indicated that 
the center of mass motion of ICL2 was strongly correlated with the PC1 in each 
system (see Table 8A). This finding further supports the use of the center of mass as a 
collective variable, as described above. From the PCA we further found that the PC1 
motion in the 5-HT2AR/DOI system accounts for a large fraction of the variation 
present in 5-HT2AR/DOI and 5-HT2AR/LSD systems, but not in the 5-HT2AR/5-HT, 5-
HT2AR/LIS, or 5-HT2AR (APO) systems, indicating that this motion is HL-specific 
(see Table 8B). 
 
Table 8.  The major motion in ICL2 is highly correlated to the COM and 
discriminates hallucinogens from non-hallucinogens. 
A. Cα motions in ICL2  
 5-HT  LSD  LIS  DOI  APO  
r(PC1, COM)  0.894  0.971  0.935  0.964  0.470 
PC15-HT  0.637  0.502  0.452  0.248  0.098  
PC1LSD  0.498  0.629  0.477  0.469  0.106  
PC1LIS  0.545  0.573  0.523  0.384  0.104  
PC1DOI  0.215  0.473  0.316  0.605  0.092  
PC1APO  0.057  0.034  0.043  0.024  0.296  
B. Heavy atom motions in ICL2  
 5-HT  LSD  LIS  DOI  APO  
r(PC1, COM)  0.871 0.888 0.830 0.880 0.608 
PC15-HT  0.460  0.376  0.225  0.180  0.071  
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The major Cα (A) and heavy atom (B) motions of ICL2 are presented. Row 1 
corresponds to the generalized correlation coefficient9 between the first principal 
component of the ICL2 motions (PC1) and the center of mass of ICL2 (COM). Rows 
2 – 6 correspond to the fraction of total variance in ICL2 that is contributed by a given 
principal component. PC1X corresponds to the first principal component of ICL2 
motion found in system X. 
To identify specific molecular interactions involved in the observed differential 
conformations of the ICL2 segment, we analyzed comparatively the contacts involving 
residues in ICL2. The direct interaction between residue D1723.49 (from the conserved 
DRY motif) and H183 (located in the middle of the ICL2) was found to be more 
extensively maintained in the trajectories of HL systems compared to the NHL 
counterparts or the APO (see Figure 42A). Figure 42B shows that the minimal 
distance between any of the carboxylate oxygen atoms from the side chain of D1723.49 
with any of the imidazole nitrogen atoms from the side chain of H183ICL2 in the HL 
systems, fluctuates mainly to values ~ 4 Å or shorter. In contrast in the NHL systems 
the values are mostly larger than 4 Å (the 4 Å is selected as reference distance to 
match the cutoff distance value used herein to define a molecular contact). This 
interaction is proposed to play a key role in determining the different conformational 
and dynamic properties of the ICL2 in the HL versus NHL systems. 
PC1LSD  0.351  0.484  0.262  0.355  0.095  
PC1LIS  0.366  0.437  0.287  0.313  0.082  
PC1DOI  0.151  0.345  0.183  0.475  0.071  
PC1APO  0.068  0.083  0.057  0.062  0.261  
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Figure 42. Distances of residues D172 and H183. 
(A) Representative structure from the 5-HT2AR/DOI complex where the interaction of 
D1723.49 and ICL2 residue H183ICL2, is depicted. In the context of the DRY motif, this 
position in the ICL2 is a residue that can establish polar interactions by using its side 
chain and is located in the sequence position Z in the “DRY(X)5P(X)2Z” motif. (B) 
The minimal distances between any of the carboxylate oxygen atoms from the side 
chain of D1723.49 with any of the imidazole nitrogen atoms from the side chain of 
H183 are depicted. The distance (gray) and its moving average (black) are displayed. 
As a reference, a dashed line at 4 Å is also displayed (the same cutoff value used to 
define a receptor-ligand interaction contact). 
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3.4.1.2.3. Binding site interactions of 5-HT2AR agonists.  
The receptor-ligand contacts were evaluated by considering all positions at which any 
heavy atom from the ligand comes within 4 Å of any heavy atom from the protein in 
the course of the trajectory. From this set we identified six contact loci (I2104.60, 
G2385.42, S2395.43, F2435.47, W3366.48, and N3436.55) that were found in all the 
simulated complexes, but that exhibited differences in the frequency of contacts for 
HL versus NHL ligands (Fig. 5A and 5B). An additional position (W1513.28) was also 
found to have differential contact frequencies between HL and NHL but only in the 
case of the larger ergoline ligands, LSD and LIS (see Figure 43A and Figure 43B). 
Figure 43A and Figure 43B depict the seven residues in the context of their positions 
inside the binding site whereas Figure 43C displays their respective contact 
frequencies as the percentage of trajectory time in which each of the positions is in 
contact with the ligand. The location of this set of residues suggests that HL agonists 
preferentially interact with residues located in TM6, whereas their NHL counterparts 
preferentially establish contacts with residues in TM4 and TM3 (see Figure 43A). 
Both classes of compounds interact with residues in TM5 but the HL preferentially 
contact residues that are located at the helical interface formed with TM6, whereas the 
NHL contact residues located at the helical interface formed with TM3 and TM4 (see 
Figure 43A). Residues G2385.42 and S2395.43 present an interesting example of this 
selectivity because they occupy neighboring positions in the vicinity of the indole 
nitrogen of the 5-HT ligand (or equivalent atoms in the other ligands), see Figure 
43A. Yet, position 5.42 is preferentially contacted by NHL (94%, 98% for 5-HT, and 
LIS versus 37% and 79% for DOI and LSD, respectively), whereas position 5.43 is 
contacted more extensively by HL compounds (24%, 31% for 5-HT, and LIS, versus 
82% and 54%, by DOI and LSD, respectively). Interestingly, even though all the 
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ligands contact the same residues in the orthosteric binding site (albeit with different 
frequencies), two of the residues preferentially contacted by the HL are large aromatic 
amino acids that are located deep in the orthosteric binding pocket, i.e., the highly 
conserved W3366.48, known to be implicated in signal transduction in different 
GPCRs263, and F2435.47, known to modulate DOI-dependent downstream signaling in 
5-HT2AR264(see Figure 43B).  
It is noteworthy that in spite of the minimal chemical and structural similarity of the 
HL ligands, they both have a positively charged nitrogen atom and an indole-like 
nitrogen atom (or equivalent) which have long been considered to be particularly 
important in interacting in the 5-HT2AR orthosteric binding site264,265. This is also the 
case for the NHL ligands. The lack of chemical and structural similarity within the 
groups, and the much greater similarity of compounds belonging to the different 
groups (cf. LSD and LIS), accentuates the significance of the identified common set of 
residues that establish different protein-ligand contacts in the HL versus the NHL 
systems. 
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Figure 43. Ligand binding contacts in the 5-HT2AR. 
(A) Extracellular and (B) lateral views that show the seven residues (W1513.28, 
I2104.60, G2385.42, S2395.43, F2435.47, W3366.48, and N3436.55) that display preferential 
frequency contacts between HL (blue) and NHL (yellow) ligands (C) The percentage 
of time that each of the seven positions are in contact with the ligands along the 
trajectories are shown. Similar color code is used, 5-HT (orange), DOI (red), LIS 
(green) and LSD (cyan). The different agonist types are arranged: small agonists (first 
row), large agonists (second row), NHL (first column) and HL (second column). To 
discern contact frequency differences between NHL and HL compounds compare data 
in the different columns in each case. Similarly, by discern contact frequency 
differences between small and large agonists compare data in the different rows. The 
first three residues show a tendency to directly interact with NHL (W1513.28 only 
interacts with the ergoline ligands, LSD and LIS) whereas the other four show a 
preference for the HL. 
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3.4.1.3. Discussion 
Our findings described here, identifying a role for the second intracellular loop of the 
5-HT2AR in discriminant pathway activations, are consistent with previous 
observations about the signaling of class A GPCRs through various intracellular 
signaling partners230,266–268. Thus, the ICL2 of the 5-HT2AR has been shown to be 
involved in the interaction with G protein (including desensitization)269 and with β-
arrestin268, whereas for the related serotonin 1A receptor, ICL2 has been directly 
implicated in G protein coupling270. The more recent structural information, for the β2 
adrenergic receptor complexed with the Gs protein, shows the ICL2 establishing 
extensive interactions with the β2/β3 loop in the N-terminus of the Gα subunit and 
with the C-terminus of helix α544,271. In this context, the extensive unbiased MD 
simulations presented here provide evidence that different ligand classes bound to the 
5-HT2AR can produce distinct conformations of the ICL2. Thus, ICL2 favors more 
outward-upward conformations in the HL-bound systems (i.e., the 5-HT2AR/DOI and 
5-HT2AR/LSD complexes), while these conformations are not highly explored in the 
NHL systems, or in the unbound receptor. The spatial distributions of the ICL2 
conformations relative to the helical bundle are similar among the HL systems (DOI 
and LSD), as quantitatively depicted by the calculation of the overlap coefficient of 
the ICL2 center of mass and the projections of the principal components, and are 
different from those adopted by the NHL counterparts (5-HT and LIS) or the unbound 
receptor. This is consonant with previous results from Lefkowitz and coworkers who 
used quantitative mass spectrometry to identify ligand-specific conformations of the β2 
adrenergic receptor and found that ICL2 adopts distinct conformations that differ 
between agonists122.  
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Our computational analysis shows that the ICL2 conformations are likely to be largely 
dependent on the extent of the interaction between D1723.49, from the conserved DRY 
motif in TM3, and H183 in the ICL2. Interestingly, interactions of D1723.49 with 
H183-equivalent residues in ICL2 has been observed in the crystal structures of 
several other GPCRs: in all the opioids and the aminergic muscarinic receptors (with 
an Arg in the corresponding position)266, and in the serotonin 1B receptor (with a Tyr 
in that position)246. Moreover, in another related GPCR, the aminergic β1 adrenergic 
receptor, a hydrogen bond is formed between D1723.49 and a tyrosine residue (Y149) 
in the equivalent ICL2 position, and introduction of the Y149A mutation, decreases 
receptor stability39. The relevance of this interaction is further emphasized by the fact 
the in the β2 adrenergic receptor, the phosphorylation of the equivalent tyrosine 
(Y141) shifts the conformational equilibrium so as to facilitate active state 
conformations272. In the context of the DRY motif in TM3, this particular ICL2 
position is located in the sequence position Z in the “DRY(X)5P(X)2Z” motif, where in 
all the aforementioned examples position Z is a residue able to establish side chain 
polar contacts with D1723.49.  
3.4.2. Identification of Hallucinogen-Specific Allosteric Modulation of Pairwise 
Interactions using a Random Forest-based Method 
The original comparative analysis of HLs and NHLs identified hallucinogen-specific 
modulation of ICL2 by manually testing potential differences through trial and error. 
Additionally, we identified differences in the binding site and local to ICL2, but not a 
specific mechanism of allosteric transmission. To seek more hallucinogen-specific 
allosteric modulation that might be more general to all HL, we increased our 
comparison to include two new HLs, psilocin (PSI) and mescaline (MES), and another 
NHL, ergotamine (ERG) that has been crystalized in complex with 5HT2BR. We then 
	  213	  
analyzed all of the HL and NHL simulations using the 2-step random forest-based 
method we developed to identify allosteric modulation of pairwise interactions. As we 
had previously identified a hallucinogen-specific change in the of D1723.49 /H183ICL2 
interaction, the approach was expected to reproduce the finding of our original 
analysis as well as identify new pairwise interaction that were subject to hallucinogen-
specific allosteric modulation. 
3.4.2.1. Methods 
Systems were prepared and simulated as described in the previous section. All new 
simulations were initiated from a representative frame of the lisuride-bound complex 
(see Figure 44). 
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Figure 44. Additional simulations of psilocin, mescaline, and ergotamine.  
While previously the last 500 ns of each simulation were analyzed, here we applied a 
recently described method273 to identify how much of the initial portion of the 
trajectories should be discarded. In brief, the goal of the method is to find the time 
point, t0, at which discarding all prior time points leads to maximization of the 
effective number of statistically independent data points, neff. Because it is impractical 
to apply this criterion to all pairwise interactions, we used the RMSD of TMs 1-4, 
after alignment using iterative fitting, as a global measure of convergence. We found 
that when plotting neff versus t0, there was often an increase in neff  after removing 
most of the trajectory (see Figure 45), and this sometimes resulted in a maxima 
towards the end of the trajectory. This behavior is likely due to a departure from the 
assumptions of the method (e.g. monotonic convergence to a specific average value), 
and thus we chose to ignore these end maxima in our choice of t0. 
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Figure 45. Convergence analysis.  
An example RMSD time series is shown over 1.2 microseconds of simulation. Neff is 
also shown (blue line) as a function of t0, normalized to its maximum. 
In order to identify pairwise interactions (PIs) throughout the trajectories, we used the 
PI Analyzer software. For this analysis, we used the default distance and geometry-
based interaction parameters to identify pairwise interaction between all possible 
residues, without distinguishing between side chain or backbone interactions. All 
interactions that were not made at least once in all systems at any point in the 
simulations (including the discarded region) were removed in order to prevent rarely 
sampled interactions from dominating the analysis. In addition, since we aim for a 
classification of the class of ligand that is not limited to the trivial classification from 
the binding site alone, even if allosteric effects are present, but rather one that reveals 
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the class of the ligand from specifically identified distant allosteric modulation, the 
ligand-protein contacts were removed from the analysis. 
3.4.2.2. Results 
An important parameter in the two-step random forest analysis is k, which sets the cut-
off for variable importance in both steps. Our analysis revealed two values of l that 
result in an α value of greater than 1 (see Figure 46). Here, we will present the 
analysis using the highest k cut-off of that still has α > 1. By investigating the raw κ 
values for both within-class and between-class classification, we find that the lowest 
cut-off results in nearly no remaining accuracy to predict class (κ = 0.1412), whereas 
the highest cut-off that still has α > 1 has reasonable accuracy (κ = 0.472). This is a 
weakness of using only the ratio to select the cut-off, and an improved automated 
selection method is required for the future. 
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Figure 46. Class-specific classification of ligand as a function of the cut-off k.  
A representative plot of the class-specific classification score, α, is shown as a 
function of cut-off used, k.  
  
	  218	  
Our analysis finds that PIs that contribute to discrimination between HL and NHLs 
occur throughout the TM region of 5-HT2AR. While it may certainly be the case that 
the PI signature of HLs may span the entirety of the TM region, and recent analysis of 
NMR data274 suggests that activation-associated conformational changes are present 
throughout the TM region, we investigated the top 7 PIs in further detail. As expected, 
an interaction was identified that involves H183ICL2. However, while we had 
previously identified an interaction between H183ICL2 and D1723.49 as being 
discriminant, the new analysis found the interaction between H183ICL2 and E3186.30 to 
be discriminant (see Figure 47). Overall, the results reinforce the finding that 
allosteric modulation of the interaction of ICL2 with the ionic lock / DRY motif 
region is a characteristic of HLs.  
 
Figure 47. Hallucinogen-specific PIs.  
4 of the top 7 interactions that are modulated in a hallucinogen-specific manner are 
presented. Residues denoted in red have been implicated in function, whereas residues 
in blue are conserved.  
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In addition to the H183ICL2 / E3186.30 PI, an additional TM5 / TM6 interaction, I2585.62 
/ K3236.35, was also identified. Notably, K3236.35 is strongly conserved among class A 
GPCRs and is local to E3186.30, and conformational changes in TM5 / TM6 are a 
hallmark of activation.  
Finally, two pairs of inter-TM interactions were identified at the interface of TM5 and 
TM, S2425.46 / I1633.40 and P2465.50 / C1633.44. These inter-TM interactions are both 
separated by a turn and indicate a HL-specific modulation of this interface. Interesting, 
P2465.50 and I1633.40 composed the so-called PIF motif that has recently been proposed 
to be involved in the difference in ergoline-induced activation of 5-HT1BR and 5-
HT2BR247. Additionally, interaction with S2425.46 has been proposed to be involved in 
ligand efficacy275,276, and the two interactions are local to two residues that we 
previously identified to make HL-favored contacts, S2395.43 and F2435.47, which are 
reproduced in the new analysis. 
3.4.2.3 Discussion 
Based on the new analysis, we hypothesize a process in which HL-specific 
engagement of TM5 triggers the propagation through TM5 to TM6 and TM3, which 
leads to allosteric modulation of the PIs between ICL2 and TM6 and the release of 
ICL2 into its previously described hallucinogen-specific conformation. These results 
provide a clear mechanism of hallucinogen-specific activation of 5-HT2AR, in which 
HLs engage the existing activation mechanism (involving conserved and functionally 
relevant residues in TM5) in a ligand-specific manner leading to the stabilization of a 
functionally selective conformation of ICL2. Indeed, mutations in ICL2 have recently 
been shown to induce receptor bias277, and comparison of x-ray structures of β2AR 
bound to a heterotrimeric G protein complex and rhodopsin bound to arrestin-1 
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suggest that these downstream effectors differentially engage ICL2 and thus their 
binding would be differentially affected by hallucinogen-specific modulation of ICL2.  
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4. Expanding Allostery Past the Two-State Model 
Little theory is available to describe allostery rigorously outside of the two-state 
models described in Section 1.1.1.2. Theoretical Background. However, there is no 
reason to assume systems will behave in a strictly two-state manner, and some systems 
are know to be more complex, as it was shown for the intracellular gate of LeuT in 
Section 3.1.2.2. Results. Thus, it is important to develop of a more general theory of 
allostery, even at the phenomenological level. Here, we derive a statistical mechanical 
form of the allosteric efficacy between collective variables that are either continuous 
or discrete.  
4.1. Derivation 
We would like to derive an analogous allosteric efficacy for the transformations of 
continuous or discrete variables. Let  represent the coordinates of a system that 
define the microstate. The microstates are distributed according to the Boltzmann 
distribution: 
 
 
p !r( ) = e
−βU !r( )
e−βU !r( )
!r∈R
∑
  (1.179) 
where U(r) is the potential energy function. The free energy of this distribution is: 
 
 
A p !r( )⎡⎣ ⎤⎦ = −
1
β
log e−βU !r( )
!r∈R
∑⎛⎝⎜
⎞
⎠⎟
  (1.180) 
We consider a collective variable (CV), X(r), which is a function of the coordinates.  
The probability density f(x) expresses the probability that X(r) takes value x.   
	 r∈!N
	  222	  
 
 
p x( ) =
δX !r( )−xe−βU
!r( )
!r∈R
∑
e−βU !r( )
!r∈R
∑   (1.181) 
where 
 
 
δX !r( )−x
1 X !r( )− x = 0
0 X !r( )− x > 0
⎧
⎨
⎪
⎩⎪
  (1.182) 
An analogous probability density function can be written for another CV, Y(r). For 
each CV, we can calculate the free energy of the distribution conditional on a value of 
the CV as: 
 
 
A p !r X !r( ) = x( )⎡⎣ ⎤⎦ = − 1β log δX !r( )−xe
−βU !r( )
!r∈R
∑⎛⎝⎜
⎞
⎠⎟
  (1.183) 
Equation (1.183) can be rewritten as: 
 
 
A p !r X !r( ) = x( )⎡⎣ ⎤⎦ = − 1β log p x( )( ) +A p
!r( )⎡⎣ ⎤⎦   (1.184) 
We can also write a joint probability mass function for the two CVs: 
 
 
p x,y( ) =
δX !r( )−xδY !r( )−ye−βU
!r( )
!r∈R
∑
e−βU !r( )
!r∈R
∑   (1.185) 
And then an analogous free energy conditional on values of both CVs: 
 
 
A p !r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦ = − 1β log δX !r( )−xδY !r( )−ye
−βU !r( )
!r∈R
∑⎛⎝⎜
⎞
⎠⎟
  (1.186) 
or 
 
 
A p !r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦ = − 1β log p x,y( )( ) +A p
!r( )⎡⎣ ⎤⎦   (1.187) 
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We would now like to see if it is possible to calculate an allosteric efficacy between 
transformations of these collective variables, given the equilibrium joint probability 
distribution is known. Therefore, we will calculate the allosteric efficacy for 
transformations in which the CVs are constrained to specific values: 
 
 
p !r( ) ΔA1⎯ →⎯← ⎯⎯ p !r X !r( ) = x( )
ΔA4⎯ →⎯⎯← ⎯⎯
ΔΔA = ΔA2 − ΔA1
ΔΔA = ΔA3 − ΔA4
ΔA3⎯ →⎯⎯← ⎯⎯
p !r Y !r( ) = y( ) ΔA2⎯ →⎯⎯← ⎯⎯ p !r X !r( ) = x,Y !r( ) = y( )
  (1.188) 
We will refer to this class of thermodynamic cycles as “allosteric cycles”. The 
thermodynamic coupling in this cycle can be calculated as: 
 
 
ΔΔA x,y( ) = A p !r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦ −A p !r X !r( ) = x( )⎡⎣ ⎤⎦ −A p !r Y !r( ) = y( )⎡⎣ ⎤⎦ +A p !r( )⎡⎣ ⎤⎦  (1.189) 
Equation (1.189) simplifies to: 
 ΔΔA x,y( ) = − 1
β
log p x,y( )p x( )p y( )
⎛
⎝⎜
⎞
⎠⎟
  (1.190) 
Interestingly, ΔΔA in (1.190) is proportional to the pointwise mutual information 
(PMI).  
 PMI x,y( ) = log p x,y( )p x( )p y( )
⎛
⎝⎜
⎞
⎠⎟
  (1.191) 
From the perspective of information theory, the PMI is quantifies the loss in 
information gained from measuring one variable given that one has already measured 
another variable, when the measurements are those specified. The measure is 
symmetric, i.e. the order of variables does not matter. In fact, the mutual information 
is the average PMI, weighted by the equilibrium probability mass function.  
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 I p x,y( )⎡⎣ ⎤⎦ = p x,y( )log
p x,y( )
p x( )p y( )
⎛
⎝⎜
⎞
⎠⎟y∈Y
∑
x∈X
∑   (1.192) 
One can immediately see the weakness of using the mutual information between two 
CVs as a description of their allosteric coupling. Functionally significant perturbations 
to allosterically coupled collective variables are not required to drive the system 
towards a region of the collective variable phase space that is already high probability 
at equilibrium. In fact, perturbations such as ligands generally drive the system away 
from its unbound equilibrium (e.g. from the inactive state to the active state). Thus, the 
mutual information does not necessarily capture the allosteric couplings that determine 
the response to physiological or synthetic modulators of function. It is instead 
preferable to analyze the entire 2-dimensional coupling surface, which we call the 
“allosteric landscape”, as it contains information regarding the allosteric efficacy for 
all possible perturbations to the distribution of those CVs. 
4.2. Illustration on Alanine Dipeptide 
To illustrate the utility of this representation of allostery, we analyzed the allosteric 
landscape of alanine dipeptide. The alanine dipeptide free energy landscape is 
generally described by two CVs – the ϕ and ψ angles around the peptide bond – and is 
a popular model system for free energy methods. However, the irregular free energy 
surface indicates that these CVs are thermodynamically coupled in a non-trivial way. 
Thus, alanine dipeptide is an ideal model allosteric system.  
4.2.1. Methods 
The alanine dipeptide (N-Acetyl-Alanine-N'-Methyl amide, see Figure 48A) was 
modeled with the all-atom charmm36278 force field and solvated in explicit TIP3P 
water molecules. Molecular dynamics simulation were performed using the Charmm 
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port279 in the Gromacs 4.5 program280 with particle-mesh Ewald281 treatment of 
electrostatics and Lennard-Jones interactions switched off between 10Å and 12Å. 
The systems were maintained at temperature T=300K with Nosé-Hoover chain 
thermostats190. Enhanced sampling was achieved with the driven adiabatic free energy 
dynamics282,283 (dAFED), also known as temperature accelerated molecular 
dynamics284 (TAMD), implemented in the PLUMED plugin285. Two collective 
variables (CVs), defined as the backbone dihedral angles ϕ and ψ were coupled 
(harmonic constant 1000 kJ/mol/rad2) to heavy fictitious particles (pseudo-mass 50 
amu•nm2/rad2) held at temperature Ts=600K or Ts=1000K by generalized Gaussian 
Moment thermostats (order 2)286. After a standard equilibration phase, simulations 
were conducted in five independent replicates of 50ns each.  Free energy surfaces 
(FESs) in the (ϕ,ψ) plane were reconstructed287 using the reweighted histogram 
smoothed with multivariate Gaussian kernel regression in Matlab (release 2014b, The 
MathWorks, Inc., Natick, Massachusetts, United States). A cutoff of 50 kJ/mol was 
used for the FESs, above which sampling was too poor for reliable surface estimation.  
In principle, estimating an observable from a dAFED/TAMD simulation requires 
binning the observable values in the CV space, and reweighting each bin by a function 
of the FES at this point288. However, the allosteric coupling depends only on the 
density at 300K in the CV space, p(ϕ,ψ). This can be obtained directly from the 
density obtained from the dAFED/TAMD simulation, pobs(ϕ,ψ), by rescaling and re-
normalizing: 
 !p Φ ,Ψ( )∝ padb Φ ,Ψ( )⎡⎣ ⎤⎦TsT   (1.193) 
Due to the surface smoothing steps, propagation of uncertainties is not practical to 
estimate confidence intervals on the allosteric landscape. Instead, we use the 
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bootstrapping approach. Specifically, because observations from MD time series are 
notoriously not independent, we use block bootstrapping289, i.e. we generate artificial 
samples by drawing at random (with replacement) segments of trajectory of 1 ns in 
length. We then compute local standard deviations on the allosteric landscape 
calculated from each of these samples.  
4.2.1. Results 
The free energy landscape was recovered using the histogram method is shown in 
Figure 48B. 
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Figure 48. The allosteric couplings in alanine dipeptide.  
(A) Alanine dipeptide, colored by atom type (carbon in cyan, hydrogen in white, 
nitrogen in blue, oxygen in red). (B) The ϕ,ψ free energy surface. (C) The allosteric 
landscape calculated from the thermodynamic coupling between ϕ,ψ for different 
perturbations of the equilibrium distribution. (D) The normalized allosteric landscape 
using AC. 
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We find significant allosteric couplings in the regions of the left-handed α-helix and 
the C7ax (see Figure 48C), indicating that if ϕ is driven to the 0° to 120° region, the 
transition of ψ to the 0° to 120° and -60° to -180° region becomes thermodynamically 
more favorable. While these regions are low probability, the allosteric coupling may 
account for the small populations of the left-handed α-helix and C7ax conformations 
that appear at equilibrium. We also see significant allosteric coupling in the disallowed 
regions, indicating that an energetically unfavorable interaction is involved in the high 
free energy. 
It should be noted that the allosteric landscape has a natural normalization. If the two 
CVs are maximally coupled, constraining one CV will fully constrain the other. Thus, 
at maximum coupling, 
 
 
A p !r X !r( ) = x( )⎡⎣ ⎤⎦ = A p !r Y !r( ) = y( )⎡⎣ ⎤⎦ = A p !r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦   (1.194) 
and thus 
 
 
ΔΔAmax x,y( ) = A p
!r( )⎡⎣ ⎤⎦ −A p
!r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦   (1.195) 
We can then normalize (1.190) to this upper bound to find the normalized allosteric 
coupling, AC: 
 
 
−ΔΔA x,y( )
A p !r X !r( ) = x,Y !r( ) = y( )⎡⎣ ⎤⎦ −A p !r( )⎡⎣ ⎤⎦
=
log p x( )p x( )( )
log p x,y( )( ) −1= AC x,y( )   (1.196) 
The AC ranges from 1 to -1 and matches the convention of commonly used positive 
and negative allostery; positive values indicate that constraining one variable reduces 
the free energy required to constrain the other, whereas negative values indicates that 
constraining one variables increases the free energy required to constrain the other. In 
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essence, the AC describes what fraction of potential positive or negative allostery is 
contributing to the free energy of the joint state. In the AC landscape of alanine 
dipeptide (see Figure 48D), both the left-handed α-helix and C7ax regions have ACs of 
around 0.5, indicating a substantial amount of their stability is due to allostery. 
Similarly, the regions sampled around the highly unfavorable mid-ϕ region indicate 
ACs around -0.5, indicating that a substantial amount of the instability is due to 
allostery. 
4.3. Conclusions 
We have derived the generalized form of the allosteric coupling between continuous 
and discrete collective variables. We find that it is related to the pointwise mutual 
information, and is best represented in the form of an allosteric landscape to 
demonstrate the allosteric response to all possible perturbations of the CVs. Our 
calculation of the allosteric landscape of alanine dipeptide reveals positive allosteric 
coupling between the ϕ and ψ angles, which appear to stabilize the left-handed α-helix 
and C7ax conformations, and negative allosteric coupling due to steric clashes, which 
defines the unpopulated regions of CV space. This method is applicable to larger 
systems, and should be a strong tool in understanding allosteric molecular mechanisms 
and identifying novel allosteric sites for the modulation of functionally important CVs 
and reaction coordinates. 
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5. Concluding Remarks 
Allostery is a ubiquitous biophysical phenomenon that plays a crucial role in many 
cellular processes. Despite this ubiquity, the study of allostery has primarily been 
phenomenological in nature and limited to the quantification of specific observations 
of allosteric behavior rather than the construction of the detailed molecular 
mechanisms that give rise to those observations. In this dissertation, several theoretical 
models and computational methods have been presented that were constructed with 
the goal of creating the framework required for the study of allostery to move from an 
observational science to a mechanistic science. 
An essential component of the dissertation is the rigorous definition of the relationship 
between allostery and information theory. Information theory has been invoked to 
describe allostery, and cellular signaling in general, mostly due to the intuition that 
human communication systems and cellular signaling systems are likely to share 
essential features. However, it is important to recognize that prior to the use of 
information theory as a framework for allostery, simple covariance and correlation 
was the dominant language of allostery. The choice of the framework used to describe 
allostery has historically been pragmatic and empirical, not theory-driven. By seeking 
to bridge the relationship between mutual information and allosteric efficacy, it has 
become clear that while allostery can be described in the language of information 
theory, the intuitive information theoretical measure, mutual information, is actually 
misleading. By deriving the allosteric efficacy for coupled perturbations away from 
equilibrium, we find that the mutual information is actually the average allosteric 
efficacy over all perturbations. This ensemble average can be misleading, as functional 
perturbations, such as the binding of a ligand, generally push the system away from 
the unbound equilibrium, towards regions of conformational space that are low 
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probability and thus have little contribution to the mutual information prior to 
perturbation. This finding indicates that the NbIT method, which was built based on 
the intuition that a fundamental relationship existed between allostery and mutual 
information, must be recast into the language of coupled perturbations to the 3-
dimensional free energy landscape.  
In addition, analytical approaches similar to the Allosteric Ising Models must be 
constructed based on the analytical form of the allosteric efficacy for discrete and 
continuous distributions described here. While the two-state models described here are 
useful in providing a qualitative conceptual basis for more complex systems, it should 
be possible to relax the current assumptions and approximations in order to make the 
models more directly applicable to real, allosteric protein systems.  
The illustrations of the methodology and models to two essential membrane protein 
systems, transporters and receptors, revealed that allostery plays an essential role in 
much of the complex, previously unexplained ligand-specific behavior that has been 
documented over the last decade. By identifying specific residues that play crucial 
roles in ligand-specific allostery, it becomes clear overly generalized descriptions of 
the functional architecture of proteins, such as the “binding site”, the “allosteric site”, 
or the “channel”, must be replaced with a more detailed description of the structural 
components that compose these proteins and a physical model describing their 
thermodynamic couplings. A ligand or substrate does not simply bind to a binding 
site; it engages multiple partners whom may have thermodynamic couplings to other 
structural components distant within the protein. In the case of LeuT, differential 
engagement with a single residue can have substantial effects on the transporter’s rate 
of transport for a substrate. Additionally, a differential engagement within a small 
fraction of the ligand binding site in 5-HT2AR can initiate a downstream signaling 
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cascade resulting in the remarkable hallucinogenic phenotype. Functional differences 
of these magnitudes, initiated by structural differences that are often regarded as 
minor, demonstrate the importance of building a more complete understanding of the 
implicit allosteric properties of these proteins. 
Finally, most of the analysis present in this dissertation was performed using 
ensembles generated from MD. However, the analysis is not in anyway specific to a 
method of ensemble estimation. As experimental techniques such as smFRET, EPR, 
and cryoEM expand our ability to estimate multi-dimensional ensemble, it will be of 
great importance to be able to identify allosteric couplings directly from the 
experimental data. By combining experimentally derived ensembles with physics-
based models of allostery, it will be possible to truly the mechanism underlying 
protein function at the molecular level. 
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